CNL Healthcare Properties (CHTH) 10-K 21 Mar 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Mar. 15, 2019	Jun. 30, 2018
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Trading Symbol	CHP
Entity Registrant Name	CNL Healthcare Properties, Inc.
Entity Central Index Key	0001496454
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		173,963,445
Entity Public Float			$ 1.8

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Dec. 31, 2018	Dec. 31, 2017
ASSETS
Real estate investment properties, net (including VIEs $146,341 and $174,263, respectively)		$ 1,455,149	$ 1,495,574
Assets held for sale, net (including VIEs $39,601 and $44,998, respectively)		1,147,645	1,184,750
Cash (including VIEs $342 and $2,203 respectively)		57,109	64,522
Other assets (including VIEs $678 and $384 respectively)		23,488	26,248
Deferred rent and lease incentives (including VIEs $7,160 and $3,577 respectively)		14,763	11,051
Restricted cash (including VIEs $208 and $1,212 respectively)		6,119	7,284
Intangibles, net		1,614	4,112
Total assets		2,705,887	2,793,541
Liabilities:
Mortgages and other notes payable, net (including VIEs $102,578 and $118,378 respectively)		530,644	539,498
Credit facilities		425,613	372,743
Liabilities associated with assets held for sale (including VIEs $30,695 and $35,848, respectively)		774,019	779,709
Accounts payable and accrued liabilities (including VIEs $784 and $4,026 respectively)		21,882	38,036
Other liabilities (including VIEs $1,321 and $947 respectively)		8,548	6,954
Due to related parties	[1]	3,255	3,941
Total liabilities		1,763,961	1,740,881
Commitments and contingencies (Note 15)
Redeemable noncontrolling interest		579	425
Stockholders' equity:
Preferred stock, $0.01 par value per share, 200,000 shares authorized; none issued or outstanding
Excess shares, $0.01 par value per share, 300,000 shares authorized; none issued or outstanding
Common stock, $0.01 par value per share, 1,120,000 shares authorized, 186,626 and 184,493 shares issued, and 173,963 and 174,634 shares outstanding, respectively		1,740	1,747
Capital in excess of par value		1,516,543	1,523,372
Accumulated loss		(233,847)	(208,775)
Accumulated distributions		(345,347)	(264,283)
Accumulated other comprehensive income (loss)		1,177	(985)
Total stockholders' equity		940,266	1,051,076
Noncontrolling interest		1,081	1,159
Total equity		941,926	1,052,660
Total liabilities and equity		$ 2,705,887	$ 2,793,541
[1]	Amounts are recorded as due to related parties in the accompanying consolidated balance sheets.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands		Dec. 31, 2018	Dec. 31, 2017
Real estate investment properties, net		$ 1,455,149	$ 1,495,574
Assets held for sale, net		1,147,645	1,184,750
Cash		57,109	64,522
Other assets		23,488	26,248
Deferred rent and lease incentives		14,763	11,051
Restricted cash		6,119	7,284
Mortgages and other notes payable, net		530,644	539,498
Liabilities associated with assets held for sale		774,019	779,709
Accounts payable and accrued liabilities		21,882	38,036
Other liabilities		$ 8,548	$ 6,954
Preferred stock, par value		$ 0.01	$ 0.01
Preferred stock, shares authorized		200,000,000	200,000,000
Preferred stock, shares issued		0	0
Preferred stock, shares outstanding		0	0
Excess shares, par value		$ 0.01	$ 0.01
Excess shares, shares authorized		300,000,000	300,000,000
Excess shares, shares issued		0	0
Excess shares, shares outstanding		0	0
Common stock, par value		$ 0.01	$ 0.01
Common stock, shares authorized		1,120,000,000	1,120,000,000
Common stock, shares issued		186,626,000	184,493,000
Common stock, shares outstanding		173,963,000	174,634,000
VIEs
Real estate investment properties, net		$ 146,341	$ 174,263
Assets held for sale, net	[1]	39,601	44,998
Cash		342	2,203
Other assets		678	384
Deferred rent and lease incentives		7,160	3,577
Restricted cash		208	1,212
Mortgages and other notes payable, net		102,578	118,378
Liabilities associated with assets held for sale	[1]	30,695	35,848
Accounts payable and accrued liabilities		784	4,026
Other liabilities		$ 1,321	$ 947
[1]	Refer to Note 6. “Assets and Associated Liabilities Held For Sale and Discontinued Operations” for additional information.

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenues:
Rental income and tenant reimbursements	$ 34,971	$ 35,807	$ 32,836
Resident fees and services	$ 276,623	$ 248,900	$ 232,363
Type of revenue [extensible list]	us-gaap:HealthCareResidentServiceMember	us-gaap:HealthCareResidentServiceMember	us-gaap:HealthCareResidentServiceMember
Total revenues	$ 311,594	$ 284,707	$ 265,199
Operating expenses:
Property operating expenses	181,299	164,866	155,404
General and administrative	12,839	11,924	11,938
Acquisition fees and expenses			206
Financing coordination fees		2,748
Contingent purchase price consideration adjustments			250
Depreciation and amortization	54,130	64,377	77,589
Impairment provision	7,922	0	0
Total operating expenses	288,654	276,116	273,459
Gain on sale of real estate	1,049		15,415
Operating income	23,989	8,591	7,155
Other income (expense):
Interest and other income	335	133	62
Interest expense and loan cost amortization	(41,924)	(36,104)	(32,034)
Equity in earnings of unconsolidated entity	489	403	258
Total other expense	(41,100)	(35,568)	(31,714)
Loss before income tax	(17,111)	(26,977)	(24,559)
Income tax (expense) benefit	(3,631)	8,438	(276)
Loss from continuing operations	(20,742)	(18,539)	(24,835)
Loss from discontinued operations	(4,409)	(7,773)	(6,949)
Net loss	(25,151)	(26,312)	(31,784)
Less: Amounts attributable to noncontrolling interest
Net loss from continuing operations	(85)	(341)	(120)
Net income (loss) from discontinued operations	6	(9)	3
Net loss attributable to common stockholders	$ (25,072)	$ (25,962)	$ (31,667)
Net loss per share of common stock (basic and diluted)
Continuing operations	$ (0.12)	$ (0.11)	$ (0.14)
Discontinued operations	$ (0.03)	$ (0.04)	$ (0.04)
Weighted average number of shares of common stock outstanding (basic and diluted)	174,247	175,151	175,121
Asset Management Fees
Operating expenses:
Asset / Property management fees	$ 18,389	$ 17,600	$ 13,630
Property Management Fees
Operating expenses:
Asset / Property management fees	$ 14,075	$ 14,601	$ 14,442

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement Of Income And Comprehensive Income [Abstract]
Net loss	$ (25,151)	$ (26,312)	$ (31,784)
Other comprehensive income (loss):
Unrealized gain on derivative financial instruments, net	1,909	6,586	1,903
Reclassification of cash flow hedges upon derecognition	253	318
Reclassification of cash flow hedges due to ineffectiveness		(26)	(18)
Unrealized loss on derivative financial instruments of equity method investments			(1)
Total other comprehensive income	2,162	6,878	1,884
Comprehensive loss	(22,989)	(19,434)	(29,900)
Less: Comprehensive loss attributable to noncontrolling interest	(79)	(350)	(117)
Comprehensive loss attributable to common stockholders	$ (22,910)	$ (19,084)	$ (29,783)

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND REDEEMABLE NONCONTROLLING INTEREST - USD ($) $ in Thousands	Total	Redeemable Noncontrolling Interest	Common Stock	Capital in Excess of Par Value	Accumulated Loss	Accumulated Distributions	Accumulated Other Comprehensive Income (Loss)	Total Stockholders' Equity	Non- controlling Interest
Beginning Balance at Dec. 31, 2015	$ 1,259,102	$ 551	$ 1,744	$ 1,528,781	$ (151,146)	$ (112,543)	$ (9,747)	$ 1,257,089	$ 1,462
Beginning Balance (in shares) at Dec. 31, 2015			174,430,000
Subscriptions received for common stock through reinvestment plan	$ 42,554		$ 44	42,510				42,554
Subscriptions received for common stock through public offering and reinvestment plan (in shares)	4,400,000		4,365,000
Redemptions of common stock	$ (36,243)		$ (37)	(36,206)				(36,243)
Redemption of common stock, shares			(3,725,000)
Net loss	(31,784)	(79)			(31,667)			(31,667)	(38)
Other comprehensive income	1,884						1,884	1,884
Distribution to noncontrolling interest	(38)								(38)
Distributions to holders of promoted interest	(6,650)			(6,650)				(6,650)
Cash distributions declared	(74,008)					(74,008)		(74,008)
Ending Balance at Dec. 31, 2016	1,154,817	472	$ 1,751	1,528,435	(182,813)	(186,551)	(7,863)	1,152,959	1,386
Ending Balance (in shares) at Dec. 31, 2016			175,070,000
Subscriptions received for common stock through reinvestment plan	$ 43,220		$ 43	43,177				43,220
Subscriptions received for common stock through public offering and reinvestment plan (in shares)	4,300,000		4,304,000
Redemptions of common stock	$ (47,332)		$ (47)	(47,285)				(47,332)
Redemption of common stock, shares			(4,740,000)
Net loss	(26,312)	(97)			(25,962)			(25,962)	(253)
Other comprehensive income	6,878						6,878	6,878
Distribution to noncontrolling interest	(34)								(34)
Distributions to holders of promoted interest	(955)			(955)				(955)
Cash distributions declared	(77,732)					(77,732)		(77,732)
Contribution from noncontrolling interests	110	50							60
Ending Balance at Dec. 31, 2017	$ 1,052,660	425	$ 1,747	1,523,372	(208,775)	(264,283)	(985)	1,051,076	1,159
Ending Balance (in shares) at Dec. 31, 2017	174,634,000		174,634,000
Subscriptions received for common stock through reinvestment plan	$ 22,013		$ 21	21,992				22,013
Subscriptions received for common stock through public offering and reinvestment plan (in shares)	2,100,000		2,133,000
Redemptions of common stock	$ (28,443)		$ (28)	(28,415)				(28,443)
Redemption of common stock, shares			(2,804,000)
Net loss	(25,151)	(16)			(25,072)			(25,072)	(63)
Other comprehensive income	2,162						2,162	2,162
Distribution to noncontrolling interest	(30)	(15)							(15)
Distributions to holders of promoted interest	(406)			(406)				(406)
Cash distributions declared	(81,064)					(81,064)		(81,064)
Contribution from noncontrolling interests	185	185
Ending Balance at Dec. 31, 2018	$ 941,926	$ 579	$ 1,740	$ 1,516,543	$ (233,847)	$ (345,347)	$ 1,177	$ 940,266	$ 1,081
Ending Balance (in shares) at Dec. 31, 2018	173,963,000		173,963,000

CONSOLIDATED STATEMENTS OF ST_2

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement Of Stockholders Equity [Abstract]
Cash distributions, declared per share	$ 0.46556	$ 0.44440	$ 0.42320

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Operating activities:
Net loss	$ (25,151)	$ (26,312)	$ (31,784)
Loss from discontinued operations	(4,409)	(7,773)	(6,949)
Net loss from continuing operations	(20,742)	(18,539)	(24,835)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	54,130	64,377	77,589
Amortization of loan costs	2,284	2,261	2,033
Amortization of above and below market intangibles	(41)	(38)	(38)
Straight-line rent adjustments	(2,219)	(2,521)	(1,260)
Deferred income tax benefit	3,267	(9,131)
Loss on extinguishment of debt	96	10	1,495
Impairment provision	7,922
Gain on sale of real estate	(1,049)		(15,415)
Other operating activities	725	(751)	1,055
Changes in operating assets and liabilities:
Other assets	(1,392)	(1,006)	(1,786)
Deferred rent and lease incentives	(12)	(2,960)	(40)
Accounts payable and accrued liabilities	(3,992)	6,714	(521)
Other liabilities	399	2,275	2,505
Due to related parties	(688)	476	1,721
Net cash flows provided by operating activities - continuing operations	38,688	41,167	42,503
Net cash flows provided by operating activities - discontinued operations	28,572	34,079	32,028
Net cash flows provided by operating activities	67,260	75,246	74,531
Investing activities:
Acquisition of properties		(1,056)
Development of properties	(1,658)	(47,887)	(95,142)
Proceeds from sale of real estate	5,761		33,629
Capital expenditures	(9,789)	(8,516)	(5,384)
Other investing activities	173	(1,264)	(2)
Net cash used in investing activities - continuing operations	(5,513)	(58,723)	(66,899)
Net cash used in investing activities - discontinued operations	(8,869)	(5,822)	(32,544)
Net cash used in investing activities	(14,382)	(64,545)	(99,443)
Financing activities:
Distributions to stockholders, net of distribution reinvestments	(59,051)	(34,512)	(31,454)
Redemptions of common stock	(40,153)	(46,019)	(28,585)
Distribution to holder of promoted interest	(955)	(2,000)	(4,650)
Draws under credit facilities	102,000	52,000	105,113
Repayments on credit facilities	(59,875)	(64,863)	(120,250)
Proceeds from mortgage and other notes payable	65,878	166,306	157,620
Principal payments on mortgage and other notes payable	(67,979)	(71,543)	(54,272)
Contingent purchase price consideration payments		(3,645)	(2,992)
Payment of loan costs	(1,590)	(2,988)	(1,805)
Payment on extinguishment of debt			(1,127)
Other financing activities	(343)	16	(657)
Net cash flows (used in) provided by financing activities	(62,068)	(7,248)	16,941
Net (decrease) increase in cash and restricted cash	(9,190)	3,453	(7,971)
Cash and restricted cash at beginning of period, including assets held for sale	74,691	71,238	79,209
Cash and restricted cash at end of period, including assets held for sale	65,501	74,691	71,238
Supplemental disclosure of cash flow information (continuing operations):
Cash paid for interest, net of capitalized interest of approximately $0.0 million, $1.9 million and $2.4 million, respectively	38,734	33,283	26,403
Cash paid for income taxes	796	688	745
Amounts incurred but not paid (including amounts due to related parties):
Accrued development costs	291	450	12,497
Redemptions payable		11,711	10,397
Contingent purchase price consideration			4,000
Distribution to holder of promoted interest	$ 406	$ 955	$ 2,000

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement Of Cash Flows [Abstract]
Interest paid, capitalized	$ 0	$ 1.9	$ 2.4

Organization

Organization	12 Months Ended
	Dec. 31, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization	CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES YEAR ENDED DECEMBER 31, 2018 1. The Company is a Maryland corporation that incorporated on June 8, 2010 and elected to be taxed as a REIT for U.S. federal income tax purposes beginning with the year ended December 31, 2012. The Company’s intention is to be organized and operate in a manner that allows it to remain qualified as a REIT for federal income tax purposes. The Company conducts substantially all of its operations either directly or indirectly through: (1) an Operating Partnership, in which the Company is the sole limited partner and its wholly owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly-owned TRS, CHP TRS Holding, Inc.; (3) property owner and lender subsidiaries, which are single purpose entities; and (4) investments in joint ventures. The Company is externally advised by the Advisor. The Company’s properties were also managed by the Property Manager through June 28, 2018 as the property management agreement with the Property Manager was not renewed. Subsequently, the responsibilities previously undertaken by the Property Manager have been performed by the Advisor. Both the Advisor and Property Manager are affiliates of the Sponsor. The Advisor is responsible for managing the Company’s day-to-day operations, serving as a consultant in connection with policy decisions to be made by the board of directors, and for identifying, recommending and executing acquisitions (through the completion of the Company’s acquisition phase in 2016) and dispositions on the Company’s behalf pursuant to an advisory agreement among the Company, the Operating Partnership and the Advisor. Substantially all of the Company’s acquisition services were, and substantially all of the Company’s operating, administrative and certain property management services are provided by affiliates of the Advisor. In addition, third-party sub-property managers have been engaged to provide certain property management services. On September 30, 2015, the Company completed its Offerings pursuant to a registration statement on Form S-11 under the Securities Act of 1933 with the SEC. Through the close of its Offerings, the Company received aggregate subscription proceeds of approximately $1.7 billion. In October 2015, the Company deregistered the unsold shares of its common stock under its previous registration statement on Form S-11, except for 20 million shares that it concurrently registered on Form S-3 under the Securities Exchange Act of 1933 with the SEC for the sale of additional shares of common stock through the Reinvestment Plan. Effective as of July 11, 2018, the Company suspended both its Reinvestment Plan and its Redemption Plan. The Company substantially completed its acquisition stage in 2016. In 2017, the Company began evaluating strategic alternatives to provide liquidity to its stockholders. In April 2018, the Company’s board of directors formed a Special Committee to consider Possible Strategic Alternatives, including, but not limited to (i) the listing of the Company’s or one of its subsidiaries’ common stock on a national securities exchange, (ii) an orderly disposition of the Company’s assets or one or more of the Company’s asset classes and the distribution of the net sale proceeds thereof to the stockholders of the Company and (iii) a potential business combination or other transaction with a third party or parties that provides the stockholders of the Company with cash and/or securities of a publicly traded company. The Special Committee engaged HFF Securities L.P. and KeyBanc Capital Markets Inc. to act as financial advisors to the aforementioned Special Committee. As of December 2018, as part of executing on strategic alternatives, the Company committed to a plan to sell a total of 70 properties. In December 2018, the Company entered into the MOB Sale Agreement with a subsidiary of Welltower Inc. (NYSE: WELL) related to the MOB Sale for a gross price of $1.25 billion, subject to certain pro-rations and other adjustments as described in the MOB Sale Agreement. The parties anticipate that the closing of the MOB Sale will occur in the first half of 2019, subject to customary closing conditions, governmental and other third-party consents. There can be no assurance that the closing conditions will be satisfied or that the MOB Sale will be consummated. The anticipated net sales proceeds are expected to exceed the net carrying value of the 55 properties comprising the MOB Sale. Additionally, in December 31, 2018, the Company committed to a plan to sell Welbrook Senior Living Grand Junction, one of the 70 properties classified as held for sale. In March 2019, the Company entered into the IRF Sale Agreement with subsidiaries of Global Medical REIT Inc. (NYSE: GMRE) related to the IRF Sale. Refer to Note 18 – “Subsequent Events” for additional information. 1. Organization (continued) The Company’s healthcare investment portfolio is geographically diversified with properties in 34 states. As of December 31, 2018, the Company’s healthcare investment portfolio, including the 70 properties classified as held for sale, consisted of interests in 142 properties, including 72 seniors housing properties, 53 MOBs, 12 post-acute care facilities and five acute care hospitals. The Company has primarily leased its seniors housing properties to wholly owned TRS entities and engaged independent third-party managers under management agreements to operate the properties under the RIDEA structures; however, the Company has also leased its properties to third-party tenants under triple-net or similar lease structures, where the tenant bears all or substantially all of the costs (including cost increases for real estate taxes, utilities, insurance and ordinary repairs). In addition, most of the Company’s investments have been wholly owned, although, it has invested through partnerships with other entities where it is believed to be appropriate and beneficial. The Company has and continues to invest in existing property developments or properties that have not reached full stabilization.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation and Consolidation — The accompanying consolidated financial statements include the Company’s accounts, the accounts of wholly owned subsidiaries or subsidiaries for which the Company has a controlling interest, the accounts of VIEs in which the Company is the primary beneficiary, and the accounts of other subsidiaries over which the Company has a controlling financial interest. All material intercompany accounts and transactions have been eliminated in consolidation. In accordance with the guidance for the consolidation of a VIE, the Company is required to identify entities for which control is achieved through means other than voting rights and to determine the primary beneficiary of its VIEs. The Company qualitatively assesses whether it is the primary beneficiary of a VIE and considers various factors including, but not limited to, the design of the entity, its organizational structure including decision-making ability and financial agreements, its ability and the rights of others to participate in policy making decisions, as well as its ability to replace the VIE manager and/or liquidate the entity. Use of Estimates — The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted stock shares issued to the Advisor. Accordingly, actual results could differ from those estimates. Allocation of Purchase Price for Real Estate Acquisitions — Upon acquisition of real estate, the Company first determines whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets in order to determine whether the acquisition should be accounted for as an asset acquisition. If the substantially all threshold is not met, the Company then determines whether the acquisition meets the definition of a business (i.e. does it include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create outputs). The Company estimates the fair value of acquired tangible assets (consisting of land, building and improvements, tenant improvements and equipment), intangible assets (consisting of in-place leases and above- or below-market leases), liabilities assumed and any contingent assets or liabilities in order to allocate the purchase price. In estimating the fair value of the assets acquired and liabilities assumed, the Company considers information obtained about each property as a result of its due diligence and utilizes various valuation methods, such as estimated cash flow projections using appropriate discount and capitalization rates, estimates of replacement costs net of depreciation and available market information. The fair value of the tangible assets of an acquired leased property is determined by valuing the property as if it were vacant, and the “as-if-vacant” value is then allocated to land and building. 2. Summary of Significant Accounting Policies (continued) The purchase price is allocated to in-place lease intangibles based on management’s evaluation of the specific characteristics of the acquired lease(s). Factors considered include estimates of carrying costs during hypothetical expected lease-up periods, including estimates of lost rental income during the expected lease-up periods, and costs to execute similar leases such as leasing commissions, legal and other related expenses. Above- and below-market lease intangibles are recorded based on the present value of the difference between the contractual rents to be paid pursuant to the lease and management’s estimate of the fair market lease rates for each in-place lease and may include assumptions for lease renewals of below-market leases. The Company also enters into contingent purchase price consideration arrangements in connection with acquisitions, which result in either an asset or liability being recognized as part of the purchase price allocation. In calculating the estimated fair value of contingent purchase price consideration arrangements, the Company considers information obtained during the due diligence and budget process as well as discount rates to determine the fair value. The Company evaluates the fair value of the arrangements at each reporting period and records any adjustments to the fair value as a component of operating income (expense) in the consolidated statement of operations. Depreciation and Amortization — Real estate costs related to the acquisition and improvement of properties are capitalized. Repair and maintenance costs are charged to expense as incurred and significant replacements and improvements are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Real estate assets are stated at cost less accumulated depreciation, which is computed using the straight-line method of accounting over the estimated useful lives of the related assets. Buildings and improvements are depreciated on the straight-line method over their estimated useful lives, which generally are the lesser of 39 and 15 years, respectively, or the remaining life of the ground lease. Amortization of intangible assets is computed using the straight-line method of accounting over the shorter of the respective lease term or estimated useful life. If a lease is terminated or modified prior to its scheduled expiration, the Company recognizes a loss on lease termination related to the unamortized lease-related costs not deemed to be recoverable. Impairment of Real Estate Assets — Real estate assets are reviewed on an ongoing basis to determine whether there are any indicators, including property operating performance and general market conditions, that the value of the real estate properties (including any related amortizable intangible assets or liabilities) may be impaired. To assess if an asset group is potentially impaired, management compares the estimated current and projected undiscounted cash flows, including estimated net sales proceeds, of the asset group over its remaining useful life to the net carrying value of the asset group. Such cash flow projections consider factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition and other factors. In the event that the carrying value exceeds the undiscounted operating cash flows, the Company would recognize an impairment provision to adjust the carrying value of the asset group to the estimated fair value less costs to sell. When impairment indicators are present for real estate indirectly owned, through an investment in a joint venture or other similar investment structure accounted for under the equity method, the Company compares the estimated fair value of its investment to the carrying value. An impairment charge will be recorded to the extent fair value of the investment is less than the carrying value and the decline in value is determined to be other than a temporary decline. Real Estate Under Development — The Company records real estate under development at cost, including acquisition fees and closing costs incurred. The cost of the real estate under development includes direct and indirect costs of development, including interest and miscellaneous costs incurred during the development period until the project is substantially complete and available for occupancy. In addition, during active development, all operating expenses related to the project, including property expenses such as real estate taxes and insurance, are capitalized rather than expensed and incidental revenue is recorded as a reduction of capitalized development costs. Preleasing costs are expensed as incurred. 2. Summary of Significant Accounting Policies (continued) Assets Held For Sale, net and Discontinued Operations — The Company determines to classify a property as held for sale once management has the authority to approve and commits to a plan to sell the property, the property is available for immediate sale, there is an active program to locate a buyer, the sale of the property is probable and the transfer of the property is expected to occur within one year. Upon the determination to classify a property as held for sale, the Company ceases recording further depreciation and amortization relating to the associated assets and those assets are measured at the lower of its carrying amount or fair value less disposition costs and are presented separately in the consolidated balance sheets for all periods presented. In addition, the Company classifies assets held for sale as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on the Company’s operations and financial results. For any disposal(s) qualifying as discontinued operations, the Company allocates interest expense and loan cost amortization that directly relates to either: (1) expense on mortgages and other notes payable collateralized by properties classified as discontinued operations; or (2) expense on the Company’s Credit Facilities, which is allocated based on the value of the properties that are classified as discontinued operations since these properties are included in the Credit Facilities’ unencumbered pool of assets and the related indebtedness is required to be repaid upon sale of the properties. Capitalized Interest — Interest and loan cost amortization attributable to funds used to finance real estate under development is capitalized as additional costs of development. The Company capitalizes interest at the weighted average interest rate of the Company’s outstanding indebtedness and based on its weighted average expenditures for the period. Capitalization of interest on a specific project ceases when the project is substantially complete and ready for occupancy. During the years ended December 31, 2018, 2017 and 2016, the Company incurred interest expense and loan cost amortization of approximately $41.9 million, $38.2 million and $34.8 million, respectively, of which approximately $0.0 million, $2.1 million and $2.8 million, respectively, was capitalized according to this policy. Cash — Cash consists of demand deposits at commercial banks. The Company also invests in cash equivalents consisting of highly liquid investments in money market funds with original maturities of three months or less. As of December 31, 2018, certain of the Company’s cash deposits exceeded federally insured amounts. However, the Company continues to monitor the third-party depository institutions that hold the Company’s cash, primarily with the goal of safeguarding principal. The Company attempts to limit cash investments to financial institutions with high credit standing; therefore, the Company believes it is not exposed to any significant credit risk on cash. Restricted Cash — Certain amounts of cash are escrowed to fund capital expenditures, property taxes and/or insurance as required by loan or lease terms, and certain security deposits represent restricted use funds. Loan Costs — Financing costs paid in connection with obtaining debt are deferred and amortized over the estimated life of the debt using the effective interest method. As of December 31, 2018 and 2017, the accumulated amortization of loan costs was approximately $13.1 million and $10.0 million, respectively. Deferred Lease-Related Costs – The Company defers lease-related costs that it incurs to obtain new or extend existing leases. The Company amortizes these costs using the straight-line method of accounting over the shorter of the respective lease term or estimated useful life. If a lease is terminated or modified prior to its scheduled expiration, the Company recognizes a loss on lease termination related to the unamortized deferred lease-related costs not deemed to be recoverable. 2. Summary of Significant Accounting Policies (continued) Revenue Recognition — Rental income and tenant reimbursements includes rental income that is recorded on the straight-line basis over the terms of the leases for new leases and the remaining terms of existing leases for those acquired as part of a property acquisition. The straight-line method records the periodic average amount of base rent earned over the term of a lease, taking into account contractual rent increases over the lease term. The Company records the difference between base rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to deferred rent and lease incentives in the accompanying consolidated balance sheets. Rental income and tenant reimbursements also includes amounts for which tenants are required to reimburse the Company related to expenses incurred on behalf of the tenants, in accordance with the terms of the leases. Tenant reimbursements are recognized in the period in which the related reimbursable expenses are incurred, such as real estate taxes, common area maintenance, and similar items. Some of the Company’s leases require the tenants to pay certain additional contractual amounts that are set aside by the Company for replacements of fixed assets and other improvements to the properties. These amounts are and will remain the property of the Company during and after the term of the lease. The amounts are recorded as capital improvement reserve income at the time such amounts are earned and are included in rental income and tenant reimbursements in the accompanying consolidated statement of operations. Additional percentage rent that is due contingent upon tenant performance thresholds, such as gross revenues, is deferred until the underlying performance thresholds have been achieved. Resident fees and services are operating revenues relating to the Company’s managed seniors housing properties, which are operated under RIDEA structures. Resident fees and services directly relate to the provision of monthly goods and services that are generally bundled together under a single resident agreement. The Company accounts for its resident agreements as a single performance obligation under ASC 606 given the Company’s overall promise to provide a series of stand-ready goods and services to its residents each month. Resident fees and services are recorded in the period in which the goods are provided and the services are performed and generally consist of (1) monthly rent, which covers occupancy of the residents’ unit as well as basic services, such as utilities, meals and certain housekeeping services, and (2) service level charges, such as assisted living care, memory care and ancillary services. Resident agreements are generally short-term in nature, billed monthly in advance and cancelable by the residents with a 30-day notice. Resident agreements may require the payment of upfront fees prior to moving into the community with any non-refundable portion of such fees being recorded as deferred revenue and amortized over the estimated resident stay. Reclassifications – Certain amounts in the prior years’ consolidated balance sheet, statements of operations and statements of cash flows have been reclassified to conform to the current year’s presentation, primarily related to classification of certain properties as held for sale and/or discontinued operations, with no effect on the other previously reported consolidated financial statements. In addition, certain amounts in the statements of operations have been reclassified to change the presentation of Company’s gain on sale of real estate and include it as a component of operating income in accordance with ASC 360-10-45-5 as a result of the SEC’s elimination of Rule 3-15(a) of Regulation S-X as part of Release No. 33-10532; 34-83875; IC-33203, which had previously required REITs to present any gains or losses on the sale of real estate outside of continuing operations. 2. Summary of Significant Accounting Policies (continued) Derivative Financial Instruments — The Company and an unconsolidated equity method investment held by the Company use or have used derivative financial instruments to partially offset the effect of fluctuating interest rates on the cash flows associated with its variable-rate debt. Upon entry into a derivative, the Company or its unconsolidated equity method investment formally designates and documents the financial instrument as a hedge of a specific underlying exposure, as well as the risk management objectives and strategies for undertaking the hedge transaction. The Company or its unconsolidated equity method investment accounts for derivatives through the use of a fair value concept whereby the derivative positions are stated at fair value in the accompanying consolidated balance sheets. The fair value of derivatives used to hedge or modify risk fluctuates over time. As such, the fair value amounts should not be viewed in isolation, but rather in relation to the cash flows or fair value of the underlying hedged transaction and to the overall reduction in the exposure relating to adverse fluctuations in interest rates on the Company’s or its unconsolidated equity method investment’s variable-rate debt. Realized and unrealized gain (loss) on derivative financial instruments designated by either the Company or its unconsolidated equity method investment as cash flow hedges are reported as a component of other comprehensive income (loss), a component of stockholders’ equity, in the accompanying consolidated statements of comprehensive income (loss) to the extent they are effective; reclassified into earnings on the same line item associated with the hedged transaction and in the same period the hedged transaction affects earnings. Realized and unrealized gain (loss) on derivative financial instruments designated as cash flow hedges that are entered into by the Company’s equity method investment are reported as a component of the Company’s other comprehensive income (loss) in proportion to the Company’s ownership percentage in the investment, with reclassifications being included in equity in earnings (loss) of unconsolidated entity in the accompanying consolidated statements of operations. Fair Value Measurements — Fair value assumptions are based on the framework established in the fair value accounting guidance under GAAP. The framework specifies a hierarchy of valuation inputs which was established to increase consistency, clarity and comparability in fair value measurements and related disclosures. The guidance describes the following fair value hierarchy based upon three levels of inputs that may be used to measure fair value, two of which are considered observable and one that is considered unobservable: • Level 1 — Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. • Level 2 — Inputs, other than quoted prices included in Level 1, that are observable for the asset or liability either directly or indirectly; such as, quoted prices for similar assets or liabilities or other inputs that can be corroborated by observable market data. • Level 3 — Unobservable inputs for the asset or liability, which are typically based on the Company’s own assumptions, as there is little, if any, related market activity. When market data inputs are unobservable, the Company utilizes inputs that it believes reflects the Company’s best estimate of the assumptions market participants would use in pricing the asset or liability. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. Mortgages and Other Notes Payable — Mortgages and other notes payable are recorded at the stated principal amount and are generally collateralized by the Company’s properties. Mortgages and other notes payable assumed in connection with an acquisition are recorded at fair market value as of the date of the acquisition. Redemptions — Under the Company’s Redemption Plan, a stockholder’s shares were deemed to have been redeemed as of the date that the Company accepted the stockholder’s request for redemption. From and after such date, the stockholder by virtue of such redemption was no longer entitled to any rights as a stockholder in the Company. Shares redeemed were retired and not available for reissue. 2. Summary of Significant Accounting Policies (continued) Net Loss per Share — Net loss per share is calculated based upon the weighted average number of shares of common stock outstanding during the period in which the Company was operational. Share Based Payments to Non-Employees — In connection with the expense support agreement described in Note 11. “Related Party Arrangements,” the Company may issue Restricted Stock to the Advisor on an annual basis in exchange for providing expense support in the event that cash distributions declared exceed MFFO as defined by the expense support agreement. The Restricted Stock is forfeited if shareholders do not ultimately receive their original invested capital back with at least a 6% annualized return of investment upon a future liquidity or disposition event of the Company. Upon issuance of Restricted Stock, the Company measures the fair value at its then-current lowest aggregate fair value pursuant to ASC 505-50. On the date in which the Advisor satisfies the vesting criteria, the Company remeasures the fair value of the Restricted Stock pursuant to ASC 505-50 and records expense equal to the difference between the original fair value and that of the remeasurement date. In addition, given that performance is outside the control of the Advisor and involves both market conditions and counterparty performance conditions, the shares are treated as unissued for accounting purposes and the Company only includes the Restricted Stock in the calculation of diluted earnings per share to the extent their effect is dilutive and the vesting conditions have been satisfied as of the reporting date. Pursuant to the expense support agreement, the Advisor shall be the record owner of the Restricted Stock until the shares of common stock are sold or otherwise disposed of, and shall be entitled to all of the rights of a stockholder of the Company including, without limitation, the right to vote such shares (to the extent permitted by the Company’s articles of incorporation) and receive all dividends and other distributions paid with respect to such shares. All dividends or other distributions actually paid to the Advisor in connection with the Restricted Stock shall vest immediately and will not be subject to forfeiture. The Company recognizes expense related to the dividends on the Restricted Stock shares as declared. Segment Information — Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and assess performance. The Company has determined that it operates in one operating segment, real estate ownership. The Company’s chief operating decision maker evaluates the Company’s operations from a number of different operational perspectives including, but not limited to, a property-by-property basis, by tenant or by operator. The Company derives all significant revenues from a single reportable operating segment of business, healthcare real estate, regardless of the type (seniors housing, medical office, etc.) or ownership structure (leased or managed). Accordingly, the Company does not report segment information; nevertheless, management periodically evaluates whether the Company continues to have one single reportable segment of business. Redeemable Noncontrolling Interest – The Company classifies redeemable equity securities in accordance with Accounting Standard Update (“ASU”) No. 2009-04, “Liabilities (Topic 480): Accounting for Redeemable Equity Instruments,” which requires that equity securities redeemable at the option of the holder be classified outside of permanent stockholders’ equity. The Company classifies redeemable equity securities as redeemable noncontrolling interest within the accompanying consolidated balance sheets and consolidated statements of stockholders’ equity and redeemable noncontrolling interest. The Company evaluates the probability that these equity securities will become redeemable at each reporting period and, if determined probable, the Company measures the redemption value and records an adjustment to the carrying value of the equity securities as a component of redeemable noncontrolling interest. Promoted Interest – The Company accounts for promoted interests with third-party developers in a manner similar to redeemable noncontrolling interests discussed above. The Company records the initial carrying value of the promoted interest at its issuance date fair value. Subsequently, as the completed developments stabilize and it becomes probable that the promoted interest thresholds will be met, the Company records a liability equal to the estimated redemption value at the end of each reporting period based on the conditions that exist as of the balance sheet date. In connection with the measurement of this liability, the Company records, as a reduction to capital in excess of par value, an amount equal to the difference between the promoted interests’ carrying value and the consideration paid or payable. 2. Summary of Significant Accounting Policies (continued) Acquisition Fees and Expenses — Acquisition fees, including investment services fees and expenses associated with transactions deemed to be business combinations (including investment transactions that are no longer under consideration), are expensed as incurred. Acquisition fees and expenses associated with making loans and with transactions deemed to be an asset purchase are capitalized. Income Taxes — The Company has elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended and related regulations beginning with the year ended December 31, 2012. In order to be taxed as a REIT, the Company is subject to certain organizational and operational requirements, including the requirement to make distributions to its stockholders each year of at least 90% of its annual REIT taxable income (which is computed without regard to the dividends-paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). If the Company qualifies for taxation as a REIT, the Company generally will not be subject to U.S. federal income tax on income that the Company distributes as dividends. If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to U.S. federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the IRS grants the Company relief under certain statutory provisions. Even if the Company qualifies for taxation as a REIT, it may be subject to certain state and local taxes on its income and property, and U.S. federal income and excise taxes on its undistributed income. The Company has and will continue to form subsidiaries which may elect to be taxed as a TRS for U.S. federal income tax purposes. Under the provisions of the Internal Revenue Code and applicable state laws, a TRS will be subject to tax on its taxable income from its operations. The Company will account for federal and state income taxes with respect to a TRS using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities, the respective tax bases, operating losses and/or tax-credit carryforwards. Investment in Unconsolidated Entity — The Company accounts for its investment in an unconsolidated joint venture under the equity method of accounting as the Company exercises significant influence, but does not maintain a controlling financial interest over these entities. The investment is recorded initially at cost and subsequently adjusted for cash contributions, distributions and equity in earnings (loss) of the unconsolidated entity. Based on the joint venture’s structure and any preference the Company receives on distributions and liquidation, the Company records its equity in earnings (loss) of the unconsolidated entity under the HLBV method of accounting. Under this method, the Company recognizes income or loss in each period as if the net book value of the assets in the venture were hypothetically liquidated at the end of each reporting period pursuant to the provisions of the joint venture agreement. In any given period, the Company could be recording more or less equity in earnings (loss) than actual cash distributions received or an investment balance that is more or less than what the Company may receive in the event of an actual liquidation. The Company determines whether distributions are classified as returns on investment or returns of investment based on the nature of the distribution. The Company’s investment in the unconsolidated entity was accounted for as an asset acquisition in which acquisition fees and expenses were capitalized as part of the basis in the investment in unconsolidated entity. These capitalized acquisition fees and expenses create an outside basis difference that are allocated to the assets of the investee and, if assigned to depreciable or amortizable assets, the basis differences are then amortized as a component of equity in earnings (loss) of unconsolidated entity. 2 . Summary of Significant Accounting Policies (continued) Adopted Accounting Pronouncements — In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers,” as a new ASC topic (Topic 606). The core principle of this ASU is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU further provides guidance for any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards (for example, lease contracts). The FASB subsequently issued ASU 2015-14 to defer the effective date of ASU 2014-09 until annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with earlier adoption permitted. In addition, the FASB issued ASU 2017-05, "Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20)," which clarifies the scope of subtopic 610-20, that was issued as a part of ASU 2014-09, as it relates to in-substance nonfinancial assets and must be adopted concurrently with ASC 606. Both ASUs can be adopted using one of two retrospective transition methods: (i) retrospectively to each prior reporting period presented or (ii) as a cumulative-effect adjustment as of the date of adoption. The Company adopted these ASUs using the modified retrospective approach as its transition method on January 1, 2018; the adoption of which did not have a material impact to its consolidated financial statements. In August 2017, the FASB issued ASU 2017-12 “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” which amended the hedge accounting model to better reflect an entity’s risk management activities. The ASU expands an entities ability to hedge nonfinancial and financial risk components as well as reduce the complexity related to fair value hedges of interest rate risk. The ASU further eliminat

Revenue

Revenue	12 Months Ended
	Dec. 31, 2018
Revenue From Contract With Customer [Abstract]
Revenue	3. Revenue The following tables represent the disaggregated revenue for resident fees and services during the years ended December 31, 2018, 2017 and 2016: Years Ended December 31, Number of Units Revenue (in millions) Percentage of Revenues Resident fees and services: 2018 2017 2016 2018 2017 2016 2018 2017 2016 Independent living 2,261 2,261 1,983 $ 71.7 $ 59.5 $ 46.8 25.9 % 23.9 % 20.1 % Assisted living 2,966 2,966 2,745 137.6 128.8 122.8 49.7 % 51.7 % 52.8 % Memory care 853 853 742 54.4 48.9 48.0 19.7 % 19.6 % 20.7 % Other revenues ― ― ― 12.9 11.7 14.8 4.7 % 4.8 % 6.4 % 6,080 6,080 5,470 $ 276.6 $ 248.9 $ 232.4 100.0 % 100.0 % 100.0 %

Real Estate Assets, net

Real Estate Assets, net	12 Months Ended
	Dec. 31, 2018
Real Estate [Abstract]
Real Estate Assets, net	4. Real Estate Assets, net The gross carrying amount and accumulated depreciation of the Company’s real estate assets as of December 31, 2018 and 2017 are as follows, excluding assets held for sale (in thousands): As of December 31, 2018 2017 Land and land improvements $ 130,133 $ 129,684 Building and building improvements 1,475,789 1,472,257 Furniture, fixtures and equipment 81,666 75,111 Less: accumulated depreciation (232,439) (181,478 ) Real estate investment properties, net $ 1,455,149 $ 1,495,574 Depreciation expense on the Company’s real estate investment properties, net was approximately $51.6 million, $52.0 million and $54.0 million for the years ended December 31, 2018, 2017 and 2016, respectively. These amounts include depreciation through the determination date on assets held for sale. As described in Note 1. “Organization,” during the year ended December 31, 2018, the Company committed to a plan to sell Welbrook Senior Living Grand Junction, one of the 70 properties classified as held for sale. In connection therewith, the Company recorded an impairment provision of $7.9 million to write-off the associated assets in excess of the estimated net sales proceeds, as it was determined that the carrying value of this property would not be recoverable. The Level 3 unobservable inputs used in determining the estimated net sales proceeds include, but are not limited to, comparable sales transactions and other information from brokers and potential buyers, as applicable. There were no impairments during the years ended December 31, 2017 and 2016. Refer to Note 6. “Assets and Associated Liabilities Held For Sale and Discontinued Operations” for additional information.

Intangibles, net

Intangibles, net	12 Months Ended
	Dec. 31, 2018
Goodwill And Intangible Assets Disclosure [Abstract]
Intangibles, net	5. Intangibles, net The gross carrying amount and accumulated amortization of the Company’s intangible assets as of December 31, 2018 and 2017 are as follows (in thousands): As of December 31, 2018 2017 In-place lease intangibles $ 83,113 $ 83,113 Less: accumulated amortization (81,499 ) (79,001 ) Intangible assets, net $ 1,614 $ 4,112 For the years ended December 31, 2018, 2017 and 2016, amortization on the Company’s intangible assets was approximately $2.5 million, $12.4 million, and $23.6 million, respectively, all of which were included in depreciation and amortization. The weighted average remaining useful life of the Company’s intangibles as of December 31, 2018 is 4.6 years. The estimated future amortization on the Company’s intangibles for each of the next five years and thereafter, in the aggregate, as of December 31, 2018 is as follows (in thousands): 2019 $ 394 2020 394 2021 394 2022 253 2023 74 Thereafter 105 $ 1,614

Assets and Associated Liabiliti

Assets and Associated Liabilities Held For Sale and Discontinued Operations	12 Months Ended
	Dec. 31, 2018
Real Estate Liabilities Associated With Assets Held For Development And Sale [Abstract]
Assets and Associated Liabilities Held For Sale and Discontinued Operations	6. Assets and Associated Liabilities Held For Sale and Discontinued Operations In August 2017, the Company committed to a plan to sell the Perennial Communities which are comprised of six skilled nursing facilities located in Arkansas, and classified the properties as held for sale. The sale of these properties would not cause a strategic shift in the Company nor would it be considered individually significant; therefore, the properties do not qualify as discontinued operations. In March 2018, the Company committed to a plan to sell Physicians Regional. In May 2018, the Company completed the sale of Physicians Regional, received net sales proceeds of approximately $5.8 million and recorded a gain on sale of real estate for financial reporting purposes of approximately $1.0 million in the accompanying consolidated statements of operations for the year ended December 31, 2018. The sale of Physicians Regional did not cause a strategic shift in the Company nor was it considered individually significant; therefore, it did not qualify as discontinued operations. As further described in Note 1. “Organization,” as part of evaluating Possible Strategic Alternatives to provide liquidity to stockholders, in September 2018, the Company committed to a plan to sell the MOB/Healthcare Portfolio, consisting of 63 properties, and classified the associated properties as held for sale. The sale of these properties would cause a strategic shift in the Company, as it is considered individually significant; therefore, the properties qualify as discontinued operations. 6. Assets and Associated Liabilities Held For Sale and Discontinued Operations (continued) In December 2018, the Company entered into the MOB Sale Agreement related to the 55 property MOB Sale for a gross price of $1.25 billion, subject to certain pro-rations and other adjustments as described in the MOB Sale Agreement. The parties anticipate that the closing of the MOB Sale will occur in the first half of 2019, subject to customary closing conditions, governmental and other third-party consents. There can be no assurance that the closing conditions will be satisfied or that the MOB Sale will be consummated. The anticipated net sales proceeds are expected to exceed the net carrying value of the 55 properties comprising the MOB sale. The Company evaluates its properties on an ongoing basis, including any changes to the intended use, operating performance or plans to dispose of assets to determine if the carrying value is recoverable. As further described in Note 1. “Organization,” the Company and its Special Committee have been actively exploring Possible Strategic Alternatives to provide liquidity to the Company’s stockholders. As part of this process, the Company evaluated each of the remaining 15 properties classified as held sale to determine whether it was likely that the carrying value of the Company’s properties would be recoverable. The Level 3 unobservable inputs used in determining the fair value of the real estate properties include, but are not limited to, appraisal information from an independent third-party valuation firm engaged as a valuation advisor, comparable sales transactions and other information from financial advisors of the Company and/or potential buyers, as applicable. As a result of this analysis, the Company recorded an impairment provision related to its Hurst Specialty Hospital of approximately $4.3 million, which is included in discontinued operations for the year ended December 31, 2018, to write-off the associated assets in excess of the estimated net sales proceeds, as it was determined that the carrying value of this property would not be recoverable. There were no impairments during the years ended December 31, 2017 and 2016. In December 2018, the Company committed to a plan to sell Welbrook Senior Living Grand Junction In March 2019, the Company entered into the IRF Sale Agreement with subsidiaries of Global Medical REIT Inc. (NYSE: GMRE) related to the IRF Sale. Refer to Note 18. “Subsequent Events” for additional information. As of December 31, 2018, the 70 properties classified as assets held for sale and liabilities associated with those assets held for sale consisted of the following (in thousands): As of December 31, 2018 MOB/Healthcare Portfolio Other Total Real estate held for sale, net $ 952,656 $ 51,339 $ 1,003,995 Real estate under development 3,490 ― 3,490 Intangibles, net 82,417 800 83,217 Deferred rent and lease incentives 36,562 6,501 43,063 Other assets 11,425 182 11,607 Restricted cash 2,013 260 2,273 Assets held for sale, net $ 1,088,563 $ 59,082 $ 1,147,645 Mortgages and other notes payable $ 492,701 $ 8,097 $ 500,798 Credit facilities 212,731 34,778 247,509 Other liabilities 16,653 634 17,287 Accounts payable and accrued liabilities 8,425 ― 8,425 Liabilities associated with assets held for sale $ 730,510 $ 43,509 $ 774,019 6. Assets and Associated Liabilities Held For Sale and Discontinued Operations (continued) As of December 31, 2017, the 71 assets classified as held for sale and liabilities associated with those assets consisted of the following (in thousands): As of December 31, 2017 MOB/Healthcare Portfolio Other Total Real estate held for sale, net $ 979,601 $ 59,914 $ 1,039,515 Intangibles, net 95,399 801 96,200 Deferred rent and lease incentives 30,353 6,357 36,710 Other assets 9,225 215 9,440 Restricted cash 2,532 353 2,885 Assets held for sale, net $ 1,117,110 $ 67,640 $ 1,184,750 Mortgages and other notes payable $ 492,655 $ — $ 492,655 Credit facilities 218,174 39,149 257,323 Other liabilities 19,388 1,678 21,066 Accounts payable and accrued liabilities 8,337 328 8,665 Liabilities associated with assets held for sale $ 738,554 $ 41,155 $ 779,709 6. Assets and Associated Liabilities Held For Sale and Discontinued Operations (continued) The Company classified the revenues and expenses related to the Company’s MOB/Healthcare Portfolio, which consists of 63 properties, as discontinued operations in the accompanying consolidated statements of operations, as it believes the sale of these properties represents a strategic shift in the Company’s operations. The following table is a summary of loss from discontinued operations for the years ended December 31, 2018, 2017 and 2016 (in thousands): Years Ended December 31, 2018 2017 2016 Revenues: Rental income and tenant reimbursements $ 114,719 $ 113,709 $ 111,856 Operating expenses: Property operating expenses 30,538 30,254 29,228 General and administrative 1,291 1,086 909 Acquisition fees and costs ― ― 768 Asset management fees 11,984 12,042 11,813 Property management fees 3,679 4,249 4,090 Financing coordination fees 2,326 ― ― Contingent purchase price consideration adjustment ― 47 (540 ) Impairment provision 4,392 ― ― Loss on lease terminations ― ― 785 Depreciation and amortization 31,961 43,567 45,396 Total operating expenses 86,171 91,245 92,449 Operating income 28,548 22,464 19,407 Other income (expense): Interest and other income (expense) 109 (73 ) 2 Interest expense and loan cost amortization (33,060 ) (30,089 ) (26,283 ) Total other expense (32,951 ) (30,162 ) (26,281 ) Loss before income taxes (4,403 ) (7,698 ) (6,874 ) Income tax expense (6 ) (75 ) (75 ) Loss from discontinued operations $ (4,409 ) $ (7,773 ) $ (6,949 )

Operating Leases

Operating Leases	12 Months Ended
	Dec. 31, 2018
Leases [Abstract]
Operating Leases	7. Operating Leases As of December 31, 2018, the Company owned 85 properties (of which 63 properties were classified as discontinued operations) that were leased to tenants on a triple-net, net or modified gross basis, and accounted for as operating leases; of which, 42 are single-tenant properties that are 100% leased under operating leases and the remaining 43 are multi-tenant properties that are leased under operating leases. The Company’s leases had a weighted average remaining lease term of 5.1 years based on annualized base rents expiring between 2019 and 2032, subject to the tenants’ options to extend the lease periods ranging from two to ten years. In addition, certain tenants hold options to extend their leases for multiple periods. Under the terms of the Company’s triple-net lease agreements, each tenant is responsible for the payment of property taxes, general liability insurance, utilities, repairs and maintenance, including structural and roof maintenance expenses. Each tenant is expected to pay real estate taxes directly to taxing authorities. However, if the tenant does not pay, the Company will be liable. The total annualized property tax assessed on these properties is approximately $5.1 million. 7. Operating Leases (continued) Under the terms of the multi-tenant lease agreements that have third-party property managers, each tenant is responsible for the payment of their proportionate share of property taxes, general liability insurance, utilities, repairs and common area maintenance. These amounts are billed monthly and recorded as tenant reimbursement income in the accompanying consolidated statements of operations. The following are future minimum lease payments to be received under non-cancellable operating leases for the next five years and thereafter, in the aggregate, as of December 31, 2018 (in thousands), excluding the 63 properties classified as discontinued operations: 2019 $ 34,070 2020 36,309 2021 37,073 2022 29,421 2023 18,506 Thereafter 50,655 $ 206,034 The above future minimum lease payments to be received excludes tenant reimbursements, straight-line rent adjustments, amortization of above- and below-market lease intangibles and base rent attributable to any renewal options exercised by the tenants in the future.

Variable Interest Entities

Variable Interest Entities	12 Months Ended
	Dec. 31, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Variable Interest Entities	8. Variable Interest Entities As of December 31, 2018 and 2017, the Company had eight and 10 subsidiaries, respectively, which are classified as VIEs. The change in the number of VIE’s across periods resulted from: (1) the sale of Physicians Regional in accordance with the put option in the air rights lease and (2) a reconsideration event related to the repayment of another development entity’s construction loan. The aggregate carrying amount and major classifications of the consolidated assets that can be used to settle obligations of the VIEs and liabilities of the consolidated VIEs that are non-recourse to the Company as of December 31, 2018 and 2017 are as follows (in thousands): As of December 31, 2018 2017 Assets: Real estate investment properties, net $ 146,341 $ 174,263 Assets held for sale, net (1) $ 39,601 $ 44,998 Cash $ 342 $ 2,203 Other assets $ 678 $ 384 Deferred rent and lease incentives $ 7,160 $ 3,577 Restricted cash $ 208 $ 1,212 Liabilities: Mortgages and other notes payable, net $ 102,578 $ 118,378 Liabilities associated with assets held for sale (1) $ 30,695 $ 35,848 Accounts payable and accrued liabilities $ 784 $ 3,117 Accrued development costs $ — $ 909 Other liabilities $ 1,321 $ 947 FOOTNOTE: (1) Refer to Note 6. “Assets and Associated Liabilities Held For Sale and Discontinued Operations” for additional information. 8. Variable Interest Entities (continued) The Company’s maximum exposure to loss as a result of its involvement with these VIEs is limited to its net investment in these entities which totaled approximately $57.2 million as of December 31, 2018. The Company’s exposure is limited because of the non-recourse nature of the borrowings of the VIEs. The Company had eight subsidiaries which are classified as VIEs due to the following factors and circumstances as of December 31, 2018: • Two • Three • Two • One The Company determined it is the primary beneficiary and holds a controlling financial interest in each of the aforementioned property and development entities due to its power to direct the activities that most significantly impact the economic performance of the entities, as well as its obligation to absorb the losses and its right to receive benefits from these entities that could potentially be significant to these entities. As such, the transactions and accounts of these VIEs are included in the accompanying consolidated financial statements.

Contingent Purchase Price Consi

Contingent Purchase Price Consideration	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Contingent Purchase Price Consideration	9. Contingent Purchase Price Consideration During the year ended December 31, 2018, the Company did not have any adjustments or cash flows related to contingent purchase price consideration as the Company had no remaining obligations as of December 31, 2017. The following tables provide a roll-forward of the fair value of the Company’s aggregate contingent purchase price consideration for the years ended December 31, 2017 and 2016: Year Ended December 31, 2017 Property Beginning asset (liability) as of December 31, 2016 Contingent Consideration Payment (Receipt) Change in Fair Value Contingent Consideration in Connection with Acquisition Ending asset (liability) as of December 31, 2017 Superior Residences of Panama City (1) $ (4,000 ) $ 4,000 $ — $ — $ — $ (4,000 ) $ 4,000 $ — $ — $ — 9. Contingent Purchase Price Consideration (continued) Year Ended December 31, 2016 Property Beginning asset (liability) as of December 31, 2015 Contingent Consideration Payment (Receipt) Change in Fair Value Contingent Consideration in Connection with Acquisition Ending asset (liability) as of December 31, 2016 Superior Residences of Panama City (1) $ (3,000 ) $ — $ (1,000 ) $ — $ (4,000 ) The Shores of Lake Phalen (2) (750 ) — 750 — — $ (3,750 ) $ — $ (250 ) $ — $ (4,000 ) FOOTNOTES: (1) In connection with the purchase of Superior Residences of Panama City, the Company entered into an earn-out agreement with the seller whereby up to $4 million in additional consideration was owed in the event that certain performance targets were met (“Panama City Earn-Out”) during the immediate 36 months post-closing. As of December 31, 2017, the Company had no remaining obligations pursuant to the Panama City Earn-Out agreement. (2) In connection with the purchase of Shores of Lake Phalen, the Company entered into an earn-out agreement with the seller whereby up to $0.8 million in additional consideration was owed in the event that certain net operating income targets were met (“Shores of Lake Phalen Earn-Out”) during the immediate 12 months post-closing. The Shores of Lake Phalen Earn-Out expired as of December 31, 2016. Fair Value Measurements The fair value of the contingent purchase price consideration was based on a then-current income approach that is primarily determined based on the present value and probability of future cash flows using internal underwriting models. The income approach further includes estimates of risk-adjusted rate of return and capitalization rates for each property.

Indebtedness

Indebtedness	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Indebtedness	10. Indebtedness The following table provides details of the Company’s indebtedness as of December 31, 2018 and 2017, excluding indebtedness related to assets held for sale (in thousands): As of December 31, 2018 2017 Mortgages payable and other notes payable: Fixed rate debt $ 358,843 $ 368,873 Variable rate debt (1) (2) 174,046 174,058 Mortgages and other notes payable (3) 532,889 542,931 Premium (discount), net (4) 184 225 Loan costs, net (2,429) (3,658) Total mortgages and other notes payable, net 530,644 539,498 Credit facilities: Revolving Credit Facility (1) (2) (5) ― ― First Term Loan Facility (1) 151,616 99,435 Second Term Loan Facility (1) (2) 275,000 275,000 Loan costs, net related to Term Loan Facilities (1,003) (1,692) Total credit facilities, net 425,613 372,743 Total indebtedness, net $ 956,257 $ 912,241 FOOTNOTES: (1) As of December 31, 2018 and 2017, the Company had entered into interest rate swaps with notional amounts of approximately $151.6 million and $99.4 million, respectively, which were settling on a monthly basis. Refer to Note 12. “Derivative Financial Instruments” for additional information. In February 2019, the Company extended the term of its First Term Loan to February 2020, refer to Note 18. “Subsequent Events” for additional information. (2) As of December 31, 2018 and 2017, the Company had entered into interest rate caps with notional amounts of approximately $330.0 million and $330.0 million, respectively. In addition, as of December 31, 2018 the Company had entered into interest rate caps with forward effective dates with notional amounts of approximately $151.6 million in order to hedge the Company’s exposure to interest rate changes in future periods. Refer to Note 12. “Derivative Financial Instruments” for additional information. (3) As of December 31, 2018 and 2017, the Company’s mortgages and other notes payable are collateralized by 37 and 38 properties, respectively, with total carrying value of approximately $0.8 billion and $0.8 billion, respectively. (4) Premium (discount), net is reflective of the Company recording mortgage note payables assumed at fair value on the respective acquisition dates. (5) As of December 31, 2018 and 2017, the Company had undrawn availability under the Revolving Credit Facility of approximately $14.7 million and $28.4 million, respectively, based on the value of the properties in the unencumbered pool of assets supporting the loan, which includes certain assets held for sale. 10. Indebtedness (continued) The following is a schedule of future principal payments and maturity for the Company’s total indebtedness for the next five years and thereafter, in the aggregate, as of December 31, 2018 (in thousands): 2019 $ 238,156 2020 404,822 2021 11,341 2022 282,496 2023 22,874 Thereafter ― $ 959,689 10. Indebtedness (continued) The Company has $238.2 million of indebtedness maturing in 2019, of which $151.6 million relates to the First Term Loan, which was extended through February 2020. In order to satisfy these maturing obligations, the Company determined it needs to access the debt markets to obtain capital. As such, the Company is actively negotiating with its lenders on a long-term refinancing of the Credit Facilities. In addition, the Company intends to execute on its strategic alternatives, as described in Note 1 “Organization,” including both the MOB Sale and the IRF Sale, which will further generate available liquidity. In the event these sources of capital are not sufficiently available, the Company will need to identify alternative sources of capital. The following table details the Company’s mortgages and other notes payable as of December 31, 2018 and 2017, excluding assets held for sale (in thousands): Interest Rate at December 31, Maturity December 31, Property and Loan Type 2018 (1) Payment Terms Date (2) 2018 2017 Primrose II Communities; Mortgage Loan 3.81% per annum Monthly principal and interest payments based on a 30-year amortization schedule 6/1/20 $ 21,047 $ 21,541 Pacific Northwest Communities; Mortgage Loans (3) 4.30% per annum Monthly principal and interest payments based on a 25-year amortization schedule 1/5/22 202,978 208,990 Capital Health Communities; Mortgage Loans (4) (4) Monthly principal and interest payments based on a 25-year amortization schedule 1/5/22 60,902 62,767 Primrose I Communities; Mortgage Loan (5) 4.11% per annum Monthly principal and interest payments based on a 30-year amortization schedule 9/1/22 48,753 49,899 Watercrest at Mansfield; Mortgage Loan (6) 4.68% per annum Monthly principal and interest payments based on a total payment of $143,330 6/1/23 25,163 25,676 Total fixed rate debt 358,843 368,873 Shores of Lake Phalen; Secured Term Loan 30-day LIBOR plus 2.42% per annum Monthly interest only payments through June 2019 6/30/19 16,859 ― HarborChase of Shorewood; Construction Loan 30-day LIBOR plus 3% per annum Monthly interest only payments through June 2017; principal and interest payments thereafter based on a 25-year amortization schedule 7/5/19 ― 14,706 Wellmore of Lexington; Construction Loan 30-day LIBOR plus 2.5% per annum Monthly interest only payments through September 2019 9/13/19 35,421 33,423 Watercrest at Katy Construction Loan 30-day LIBOR plus 2.75% per annum Monthly principal and interest payments based on a 30-year amortization schedule 12/27/19 21,552 26,300 Wellmore of Tega Cay; Construction Loan (7) 30-day LIBOR plus 2.65% per annum Monthly interest only payments for the first 12 months; principal and interest payments thereafter based on a 30-year amortization schedule 3/1/20 27,715 28,000 Palmilla Senior Living; Mortgage Loan (7) 30-day LIBOR plus 2.0% per annum Monthly interest only payments through April 2017; principal and interest payments thereafter based on a 30-year amortization schedule 3/22/20 26,478 26,799 Waterstone on Augusta; Construction Loan 30-day LIBOR plus 3.0% per annum Monthly interest only payments through September 2018; principal and interest payments thereafter based on a 30-year amortization schedule 9/1/20 18,830 18,302 10. Indebtedness (continued) Interest Rate at December 31, Maturity December 31, Property and Loan Type 2018 (1) Payment Terms Date (2) 2018 2017 Fieldstone at Pear Orchard; Construction Loan 30-day LIBOR plus 2.9% per annum Monthly interest only payments through September 2018; principal payments thereafter based on a 25-year amortization schedule 10/15/20 $ 10,791 $ 10,900 Dogwood Forest of Grayson; Construction Loan 30-day LIBOR plus 3.0% per annum Monthly interest only payments through December 2018; principal payments thereafter based on a 30-year amortization schedule 12/1/20 16,400 15,628 Total variable rate debt 174,046 174,058 Total mortgages and other notes payable, net $ 532,889 $ 542,931 FOOTNOTES: (1) The 30-day and 90-day LIBOR were approximately 2.50% and 2.81%, respectively, as of December 31, 2018 and approximately 1.56% and 1.70%, respectively, as of December 31, 2017. (2) Represents the initial maturity date (or, as applicable, the maturity date as extended). Certain of the Company’s mortgages and other notes payable agreements include extension options held by the Company under which the maturity dates may be extended beyond the date presented, subject to certain lender conditions and/or related fees. (3) In August 2017, the Company extended the maturity date on the existing loan of approximately $201.9 million from December 2018 to January 2022. In addition, the Company received approximately $9.5 million of additional borrowings through a supplemental loan with the same lender, which is co-terminus with the existing mortgage loans, collateralized by the communities and matures in January 2022. The supplemental loan further accrues interest at a fixed rate equal to 4.3% per annum and includes monthly interest only payments for the first 12 months followed by monthly principal and interest payments for the remaining term of the loan using a 30-year amortization period with the remaining principal balance payable at maturity. The loan may be prepaid, in whole or in part, with a prepayment premium equal to the greater of: (i) one percent (1%) of the principal amount being prepaid, multiplied by the quotient of the number of full months remaining until the maturity date of the loan (calculated as of the prepayment date) divided by the number of full months comprising the term of the loan; or (b) a “make-whole” payment equal to the present value of the loan less the amount of principal and accrued interest being prepaid calculated as of the prepayment date for the period between that date and the maturity date . (4) In August 2017, the Company extended the maturity date on the existing loan of approximately $35.4 million from January 2020 to January 2022. In addition, the Company received approximately $28.0 million of additional borrowings through a supplemental loan with the same lender, which is co-terminus with the existing mortgage loans, collateralized by the communities and matures in January 2022. The existing loan accrues interest at a fixed rate equal to 4.25% per annum. The supplemental loan accrues interest at a fixed rate equal to 4.3% per annum and includes monthly interest only payments for the first 12 months followed by monthly principal and interest payments for the remaining term of the loan using a 30-year amortization period with the remaining principal balance payable at maturity. The loan may be prepaid, in whole or in part, with a prepayment premium equal to the greater of: (i) one percent (1%) of the principal amount being prepaid, multiplied by the quotient of the number of full months remaining until the maturity date of the loan (calculated as of the prepayment date) divided by the number of full months comprising the term of the loan; or (b) a “make-whole” payment equal to the present value of the loan less the amount of principal and accrued interest being prepaid calculated as of the prepayment date for the period between that date and the maturity date. 10. Indebtedness (continued) (5) If prepaid prior to March 1, 2022, the Primrose I Communities Mortgage Loan is subject to a prepayment penalty in an amount equal to the greater of (i) 1% of the principal being repaid, or (ii) an amount calculated on the principal being repaid, multiplied by the difference between the Primrose I Communities Mortgage Loan interest rate, and a calculated yield rate tied to the rates on applicable U.S. Treasuries. If prepayment is made between March 1, 2022, and May 31, 2022, the prepayment penalty will be 1% of the outstanding principal balance of the Primrose I Communities Mortgage Loan. No prepayment fee is required if the Primrose I Communities Mortgage Loan is prepaid between June 1, 2022 and maturity. Partial prepayment of a loan is not permitted. The loan is transferable upon sale of the assets subject to lender approval. (6) The balance for this loan excludes a remaining premium of $0.2 million related to the mortgage note payable assumed being recorded at fair value on the acquisition date. (7) The Company entered into an interest rate cap with a remaining notional amount of $117.0 million, of which a portion has been designated to hedge these loans; see Note 12. “Derivative Financial Instruments” for additional information. The following table details the Company’s mortgages and other notes payable included within the liabilities associated with assets held for sale as of December 31, 2018 and 2017 (in thousands): Interest Rate at December 31, Maturity December 31, Property and Loan Type 2018 (1) Payment Terms Date (2) 2018 2017 Novi Orthopaedic Center; Mortgage Loan 3.61% per annum Monthly interest only payments through June 2018; principal and interest payments thereafter based on a 25-year amortization schedule 6/15/20 $ 19,581 $ 19,825 ProMed Medical Building I; Mortgage Loan 3.64% per annum (3) Monthly principal and interest payments based upon a 30-year amortization schedule 1/15/22 6,473 6,673 540 New Waverly Place; Mortgage Loan 4.08% per annum Monthly principal and interest payments based upon a 25-year amortization schedule 5/31/28 6,452 6,665 LaPorte Cancer Center; Mortgage Loan 4.25% per annum (through 2020) Monthly principal and interest payments based on a 25-year amortization schedule 6/14/28 7,335 7,571 Total fixed rate debt 39,841 40,734 Calvert Medical Office Properties; Mortgage Loan 30-day LIBOR plus 2.50% per annum Monthly interest only payments for the first 18 months; principal and interest payments thereafter based on a 30-year amortization schedule 8/29/18 ― 25,121 Welbrook Senior Living Grand Junction; Secured Term Loan 30-day LIBOR plus 2.42% per annum Monthly interest only payments through June 2019 6/30/19 8,141 ― Medical Portfolio II Properties; Mortgage Loan (4) 90-day LIBOR plus 2.35% at 0.25% LIBOR floor Monthly principal and interest payments based on a 25-year amortization schedule 7/14/19 77,074 79,295 Northwest Medical Park; Mortgage Loan 30-day LIBOR plus 2.30% per annum Monthly principal and interest payments based upon a 25-year amortization schedule 10/31/19 6,628 6,765 Lee Hughes Medical Building; Mortgage Loan 30-day LIBOR plus 1.85% per annum Monthly principal and interest payments based on a 30-year amortization schedule 3/5/20 17,043 17,572 10. Indebtedness (continued) Interest Rate at December 31, Maturity December 31, Property and Loan Type 2018 (1) Payment Terms Date (2) 2018 2017 Triangle Orthopaedic; Mortgage Loan (5) 30-day LIBOR plus 2.25% per annum Interest only payments through March 2017; principal payments thereafter based on a 30-year amortization schedule 4/11/21 $ 36,962 $ 37,475 Cobalt Rehabilitation Hospital Surprise; Mortgage Loan 30-day LIBOR plus 2.6% per annum at 0.4% LIBOR floor Monthly interest only payments through May 2017; principal payments thereafter based on a 25-year amortization schedule 5/19/22 14,829 15,167 Knoxville Medical Office Properties and Claremont Medical Office; Mortgage Loan (6) 30-day LIBOR plus 2.45% per annum Monthly principal and interest payments based on a 30-year amortization schedule 5/24/22 51,575 57,350 Cobalt Rehabilitation Hospital New Orleans; Mortgage Loan 30-day LIBOR plus 2.45% per annum at 0.55% LIBOR floor Monthly interest only payments through October 2017; principal payments thereafter based on a 25-year amortization schedule 10/19/22 19,055 19,421 MHOSH;Mortgage Loan (7) 30-day LIBOR plus 2.20% per annum Interest only payments through June 2020; principal payments thereafter based on a 30-year amortization schedule 5/24/23 57,630 47,072 Southeast Medical Office Properties; Mortgage Loan (8) 30-day LIBOR plus 2.0% per annum Interest only payments through January 2021; principal payments thereafter based on a 30-year amortization schedule 6/14/23 175,000 149,864 Total variable rate debt 463,937 455,102 Total indebtedness associated with assets held for sale $ 503,778 $ 495,836 FOOTNOTES: (1) The 30-day and 90-day LIBOR were approximately 2.50% and 2.81%, respectively, as of December 31, 2018 and approximately 1.56% and 1.70%, respectively, as of December 31, 2017. (2) Represents the initial maturity date (or, as applicable, the maturity date as extended). Certain of the Company’s mortgages and other notes payable agreements include extension options held by the Company under which the maturity dates may be extended beyond the date presented, subject to certain lender conditions and/or related fees. (3) (4) The Company entered into an interest rate swap with a remaining notional amount of $79.2 million; see Note 12. “Derivative Financial Instruments” for additional information. (5) The Company entered into an interest rate cap with a remaining notional amount of $117.0 million, of which a portion has been designated to hedge this loan; see Note 12. “Derivative Financial Instruments” for additional information. (6) In May 2017, the Company refinanced the loans related to the Claremont Medical Office property and the Knoxville Medical Office Properties of approximately $12.4 million and $37.2 million, respectively, into a combined loan. The original loans were scheduled to mature January 2018 and July 2018, respectively. The Company entered into an interest rate swap with a remaining notional amount of $51.6 million; see Note 12. “Derivative Financial Instruments” for additional information. 10. Indebtedness (continued) (7) The Company entered into an interest rate cap with a remaining notional amount of $57.6 million; see Note 12. “Derivative Financial Instruments” for additional information. (8) The Company entered into an interest rate cap with a remaining notional amount of $125.1 million; see Note 12. “Derivative Financial Instruments” for additional information. The following table provides the details of the fair market value and carrying value of the Company’s indebtedness as of December 31, 2018 and 2017 (in millions): December 31, 2018 December 31, 2017 Fair Value Carrying Value Fair Value Carrying Value Mortgages and other notes payable, net $ 528.7 $ 530.6 $ 543.8 $ 539.5 Credit facilities $ 426.6 $ 425.6 $ 374.4 $ 372.7 Indebtedness associated with assets held for sale $ 751.8 $ 748.3 $ 748.7 $ 750.1 These fair market values are based on current rates and spreads the Company would expect to obtain for similar borrowings. Since this methodology includes inputs that are less observable by the public and are not necessarily reflected in active markets, the measurement of the estimated fair values related to the Company’s mortgage notes payable is categorized as Level 3 on the three-level valuation hierarchy. The estimated fair value of accounts payable and accrued liabilities approximates the carrying value as of December 31, 2018 and 2017 because of the relatively short maturities of the obligations. In December 2014, the Company entered into a $230 million Revolving Credit Facility and a $175 million First Term Loan Facility. Pursuant to the associated credit agreement, the Company has the ability to increase the borrowing capacity to $700 million under the accordion feature of the Credit Facilities. The Company has exercised this accordion feature and increased our borrowing capacity to $445 million. In December 2018, the Company exercised its second and final 12-month extension option on the Revolving Credit Facility, resulting in the term ending December 2019. The First Term Loan Facility has an initial term through February 2019 plus one 12-month extension option through which the term can be extended through February 2020, which the Company exercised in February 2019, as described further in Note 18 – “Subsequent Events.” The Credit Facilities bear interest based on 30-day LIBOR and a spread that varies with the Company’s leverage ratio. In November 2015, the Company entered into a $250 million Second Term Loan Facility with an initial term through November 2020 and the ability to increase the Company’s borrowing capacity to $350 million under its accordion feature. The Second Term Loan bears interest based on the 30-day LIBOR and a spread that varies with the Company’s leverage ratio. To date, the Company has exercised this accordion feature and increased the borrowing capacity to $275 million. All of the Company’s mortgage and construction loans contain customary financial covenants and ratios; including (but not limited to) the following: debt service coverage ratio, minimum occupancy levels, limitations on incurrence of additional indebtedness, etc. The Credit Facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage and (viii) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the Credit Facilities, minimum debt service coverage ratio, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions include a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the Credit Facilities) and the minimum amount of distributions required to maintain the Company’s REIT status. As of December 31, 2018, the Company was in compliance with all financial covenants.

Related Party Arrangements

Related Party Arrangements	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
Related Party Arrangements	11. Related Party Arrangements The Company is externally advised and has no direct employees. Certain of the Company’s executive officers are executive officers of, or are on the board of managers of the Advisor. In addition, certain directors and officers hold similar positions with the Managing Dealer. In connection with services provided to the Company, affiliates are entitled to the following fees: Advisor — The Advisor and certain affiliates are entitled to receive fees and compensation in connection with the acquisition, management and sale of the Company’s assets, as well as the refinancing of debt obligations of the Company or its subsidiaries. In addition, the Advisor and its affiliates are entitled to reimbursement of actual costs incurred on behalf of the Company in connection with the Company’s organizational, offering, acquisition and operating activities. Pursuant to the advisory agreement, as amended, the Advisor receives investment services fees equal to 1.85% of the purchase price of properties (including its proportionate share of properties acquired through joint ventures) for services rendered in connection with the selection, evaluation, structure and purchase of assets. In addition, the Advisor is entitled to receive a monthly asset management fee of 0.08334% of the average real estate asset value (as defined in the advisory agreement) of the Company’s properties, including its proportionate share of properties owned through joint ventures. The Advisor will also receive a financing coordination fee for services rendered with respect to refinancing of any debt obligations of the Company or its subsidiaries equal to 1.0% of the gross amount of the refinancing The Company will pay the Advisor, if a substantial amount of services are provided as determined by the Company’s independent directors, a disposition fee in an amount equal to (a) 1% of the gross market capitalization of the Company upon the occurrence of a listing on a national securities exchange, or 1% of the gross consideration paid upon the occurrence of a liquidity event as a result of a merger, share exchange or acquisition or similar transaction pursuant to which the stockholders receive cash and/or listed or non-listed securities, or (b) 1% of the gross sales price upon the sale or transfer of one or more assets (including a sale of all the Company’s assets). The Company will not pay its Advisor a disposition fee in connection with the sale of investments that are securities; however, a disposition fee in the form of a usual and customary brokerage fee may be paid to an affiliate or related party of the Advisor, if such affiliate is properly licensed. Under the advisory agreement and the Company’s articles of incorporation, the Advisor will be entitled to receive certain subordinated incentive fees upon (a) sales of assets and/or (b) a listing (which would also include the receipt by the Company’s stockholders of securities that are approved for trading on a national securities exchange in exchange for shares of the Company’s common stock as a result of a merger, share acquisition or similar transaction). However, once a listing occurs, the Advisor will not be entitled to receive an incentive fee on subsequent sales of assets. The incentive fees are calculated pursuant to formulas set forth in the expense support agreement, the advisory agreement and the Company’s articles of incorporation. All incentive fees payable to the Advisor are subordinated to the return to investors of their invested capital plus a 6% cumulative, noncompounded annual return on their invested capital. Upon termination or non-renewal of the advisory agreement by the Advisor for good reason (as defined in the advisory agreement) or by the Company other than for cause (as defined in the advisory agreement), a listing or sale of assets after such termination or non-renewal will entitle the Advisor to receive a pro-rated portion of the applicable subordinated incentive fee. In addition, the Advisor or its affiliates may be entitled to receive fees that are usual and customary for comparable services in connection with the financing, development, construction or renovation of a property, subject to approval of the Company’s board of directors, including a majority of its independent directors. Pursuant to the advisory agreement, the Advisor shall reimburse the Company the amount by which the total operating expenses paid or incurred by the Company exceed, in any four consecutive fiscal quarters commencing with the Expense Year ending June 30, 2013, the greater of 2% of average invested assets or 25% of net income (as defined in the advisory agreement) (“Limitation”), unless a majority of the Company’s independent directors determines that such excess expenses are justified based on unusual and non-recurring factors (“Expense Cap Test”). In performing the Expense Cap Test, the Company uses operating expenses on a GAAP basis after making adjustments for the benefit of expense support under the Expense Support Agreement. For the Expense Year ended December 31, 2018, the Company did not incur operating expenses in excess of the Limitation. 11. Related Party Arrangements (continued) Property Manager — Through June 2018, pursuant to a property management agreement, as amended, with the Property Manager which was not renewed and expired on June 28, 2018, the Property Manager received property management fees of (a) 2% of annual gross rental revenues from single tenant properties, and (b) 4% of annual gross rental revenues from multi-tenant properties. In the event that the Company contracted directly with a third-party property manager, the Company paid the Property Manager an oversight fee of up to 1% of annual gross revenues of the property managed; however, in no event would the Company have paid both a property management fee and an oversight fee with respect to the same property. The Company paid to the Property Manager a construction management fee equal to 5% of hard and soft costs associated with the initial construction or renovation of a property, or with the management and oversight of expansion projects and other capital improvements, in those cases in which the value of the construction, renovation, expansion or improvements exceeded (i) 10% of the initial purchase price of the property, and (ii) $1.0 million, which the fee was due and payable upon completion of such projects Expense Support Agreement — Pursuant to the original expense support agreement, the Company’s Advisor agreed to forgo the payment of fees in cash and accept Restricted Stock for services in an amount equal to the positive excess, if any, of (a) aggregate stockholder cash distributions declared for the applicable quarter, over (b) aggregate MFFO, as defined. The Advisor expense support amount was determined for each calendar quarter, on a non-cumulative basis, on each quarter-end date ("Original Determination Date”). The Restricted Stock is subordinated and forfeited to the extent that shareholders do not receive their invested capital plus a 6% cumulative noncompounded annual return upon ultimate liquidity of the Company. Any amounts settled, and for which restricted stock shares were issued, pursuant to the original expense support agreement have been permanently settled and the Company has no further obligation to pay such amounts In March 2016, the Company’s board of directors approved the third amended and restated expense support agreement with the Advisor that was effective January 1, 2016. This amendment changed the calculation and determination date of the expense support amounts from each calendar quarter on a non-cumulative basis, to each calendar year on a cumulative year-to-date basis ("Amended Determination Date”). In February 2017, the Company’s board of directors approved the fourth amended and restated expense support agreement with the Advisor that was effective January 1, 2017. This amendment limited the annual expense support amount, in the aggregate, to an annualized four percent of the weighted average of the Board’s most recent determination of NAV per share and change the calculation to exclude the impact of completed development properties for a specified period of time after the property is placed into service (as defined in the agreement). The aforementioned amendment, along with the original expense support agreement and previous amendments govern the fees and expenses charged by the Advisor to the Company. Under the terms of the expense support agreement, for each quarter within a calendar expense support year, the Company will record a proportional estimate of the cumulative year-to-date period based on an estimate of expense support amounts for the calendar expense support year. Moreover, in exchange for services rendered and in consideration of the expense support provided under the expense support agreement, the Company will issue, within 90 days following the determination date, a number of shares of Restricted Stock equal to the quotient of the expense support amounts provided by the Advisor for the preceding calendar year divided by the Company’s then-current estimated NAV per share of common stock. The terms of the expense support agreement automatically renew for consecutive one year periods, subject to the right of the Advisor to terminate their respective agreements upon 30 days’ written notice to the Company. CNL Capital Markets LLC — CNL Capital Markets LLC, an affiliate of CNL, receives a sliding flat annual rate (payable monthly) based on the average number of investor accounts that will be open over the term of the agreement. For the years ended December 31, 2018, 2017 and 2016, the Company incurred approximately $0.9 million, $0.9 million and $0.9 million in such fees, respectively. These amounts are included in general and administrative expenses in the accompanying consolidated statements of operations 11. Related Party Arrangements (continued) Co-venture partners —The Company incurs operating expenses which, in general, relate to administration of the Company and its subsidiaries on an ongoing basis. The expenses and fees incurred by and reimbursable to the Company’s related parties, including amounts included in the loss from discontinued operations for the years ended December 31, 2018, 2017 and 2016, and related amounts unpaid as of December 31, 2018 and 2017 are as follows (in thousands): Unpaid amounts (1) Years Ended December 31, as of December 31, 2018 2017 2016 2018 2017 Reimbursable expenses: Operating expenses (2) $ 6,203 $ 5,791 $ 5,966 $ 722 $ 1,042 Acquisition fees and expenses — 6 104 ― 2 6,203 5,797 6,070 722 1,044 Investment services fees (3) 60 126 739 — — Disposition fee (4) 58 — 343 — — Financing coordination fees (5) 2,326 3,601 — — — Property management fees (6) 2,323 4,807 5,059 — 381 Asset management fees (7) 30,385 30,157 29,121 2,533 2,516 $ 41,355 $ 44,488 $ 41,332 $ 3,255 $ 3,941 FOOTNOTES: (1) (2) (3) (4) (5) 11. Related Party Arrangements (continued) (6) (7) The following fees have been settled and paid in the form of Restricted Stock in accordance with the expense support agreements for the years ended December 31, 2018, 2017 and 2016, and cumulatively as of December 31, 2018 (in thousands, except per share data): Years Ended As of December 31, December 31, 2018 2017 2016 2018 Asset management fees (1) $ — $ — $ 2,918 $ 13,565 Then-current NAV (2) $ 10.01 (3) $ 10.32 $ 10.04 $ 10.01 Restricted stock shares (3) — — 291 1,332 Cash distributions on Restricted Stock (4) $ 630 $ 571 $ 427 $ 2,012 FOOTNOTES: (1) (2) (3) (4)

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2018
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	12. Derivative Financial Instruments The following summarizes the terms of the Company’s derivative financial instruments and the corresponding asset (liability) as of December 31, 2018 and 2017, including properties classified as held for sale (in thousands): Fair value asset (liability) as of Notional Amount Strike (1) Credit Spread (1) Trade date Forward date Maturity date December 31, 2018 December 31, 2017 $ — (2) 1.3 % 2.6 % 1/17/2013 1/15/2015 1/16/2018 $ — $ 1 $ — (2) 2.7 % 2.5 % 9/6/2013 8/17/2015 7/10/2018 $ — $ (213 ) $ — (2) 2.8 % 2.5 % 9/6/2013 8/17/2015 8/29/2018 $ — $ (182 ) $ — (2)(3) 2.4 % 2.9 % 8/15/2014 6/1/2016 6/2/2019 $ — $ (280 ) $ 79,201 (2) 2.3 % 2.4 % 9/12/2014 8/1/2015 7/15/2019 $ 168 $ (424 ) $ 175,000 (2) 1.6 % 2.0 % 12/23/2014 12/19/2014 2/19/2019(5) $ 220 $ 464 $ 125,087 (2) 1.7 % 2.0 % 1/9/2015 12/10/2015 12/22/2019 $ 966 $ 516 $ — (3) 1.5 % — % 11/19/2015 11/19/2015 11/30/2018 $ — $ 681 $ — (4) 1.5 % — % 3/1/2016 3/1/2016 11/30/2018 $ — $ 393 $ 117,000 (4) 2.3 % — % 8/29/2017 8/29/2017 9/1/2019 $ 247 $ 95 $ 410,000 (4) 3.0 % — % 3/28/2018 11/30/2018 12/19/2019 $ 44 $ — $ 51,575 (4) 3.0 % — % 3/28/2018 7/10/2018 12/19/2019 $ 6 $ — $ 175,000 (4) 3.0 % — % 3/28/2018 2/19/2019 12/19/2019 $ 19 $ — $ 57,630 (4) 3.0 % — % 5/4/2018 5/4/2018 12/19/2019 $ 6 $ — 12. Derivative Financial Instruments (continued) The following summarizes the gross and net presentation of amounts related to the Company’s, or its equity method investment’s, derivative financial instruments as of December 31, 2018 and 2017 (in thousands): Gross and net amounts of asset (liability) as of December 31, 2018 Gross amounts as of December 31, 2018 Notional amount Gross amount Offset amount Net amount Financial Instruments Cash Collateral Net Amount $ 79,201 (2) $ 168 $ — $ 168 $ 168 $ — $ 168 $ 175,000 (2) $ 220 $ — $ 220 $ 220 $ — $ 220 $ 125,087 (2) $ 966 $ — $ 966 $ 966 $ — $ 966 $ 117,000 (4) $ 247 $ — $ 247 $ 247 $ — $ 247 $ 410,000 (4) $ 44 $ — $ 44 $ 44 $ — $ 44 $ 51,575 (4) $ 6 $ — $ 6 $ 6 $ — $ 6 $ 175,000 (4) $ 19 $ — $ 19 $ 19 $ — $ 19 $ 57,630 (4) $ 6 $ — $ 6 $ 6 $ — $ 6 Gross and net amounts of asset (liability) as of December 31, 2017 Gross amounts as of December 31, 2017 Notional amount Gross amount Offset amount Net amount Financial Instruments Cash Collateral Net Amount $ 11,842 (2) $ 1 $ — $ 1 $ 1 $ — $ 1 $ 36,839 (2) $ (213 ) $ — $ (213 ) $ (213 ) $ — $ (213 ) $ 25,103 (2) $ (182 ) $ — $ (182 ) $ (182 ) $ — $ (182 ) $ 47,072 (2) $ (280 ) $ — $ (280 ) $ (280 ) $ — $ (280 ) $ 80,841 (2) $ (424 ) $ — $ (424 ) $ (424 ) $ — $ (424 ) $ 175,000 (2) $ 464 $ — $ 464 $ 464 $ — $ 464 $ 129,722 (2) $ 516 $ — $ 516 $ 516 $ — $ 516 $ 260,000 (2) $ 681 $ — $ 681 $ 681 $ — $ 681 $ 150,000 (4) $ 393 $ — $ 393 $ 393 $ — $ 393 $ 117,000 (4) $ 95 $ — $ 95 $ 95 $ — $ 95 FOOTNOTES: (1) The all-in rates are equal to the sum of the Strike and Credit Spread detailed above. (2) Amounts related to interest rate swaps held by the Company which are recorded at fair value and included in either other assets or other liabilities in the accompanying consolidated balance sheets. (3) Amounts related to an interest rate swap that settled in May 2018 in connection with the refinancing of the underlying mortgage loan and the Company received approximately $0.1 million upon settlement. (4) Amounts related to the interest rate caps held by the Company, or its equity method investment, which are recorded at fair value and included in other assets in the accompanying consolidated balance sheets. (5) 12. Derivative Financial Instruments (continued) Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by the Company and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative financial instruments and has determined that the credit valuation adjustments on the overall valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company determined that its derivative financial instruments valuation in its entirety is classified in Level 2 of the fair value hierarchy. Determining fair value requires management to make certain estimates and judgments. Changes in assumptions could have a positive or negative impact on the estimated fair values of such instruments which could, in turn, impact the Company’s or its joint venture’s results of operations.

Equity

Equity	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Equity	13. Equity Redeemable Noncontrolling Interest: In connection with the Watercrest at Katy joint venture, the Company’s joint venture partner acquired a 5% noncontrolling interest that includes a put option of its membership to the Company commencing in July 2016 when the Watercrest at Katy development opened to residents and concluding in July 2021 when NOI is: (a) equal to or greater than the NOI threshold established in the joint venture agreement, and (b) has been equal to or greater than the NOI threshold established in the joint venture agreement for the three calendar months immediately preceding the calendar month during which the joint venture partner exercises the put option. The put option is redeemable for cash at a price equal to the appraised market value (less certain transaction-related costs) at the time the put option is exercised (“Put Price”). The Company’s maximum redemption exposure, as a result of these redeemable equity securities, is limited to the Put Price multiplied by the joint venture partner’s 5% membership interest. Stockholders’ Equity: Public Offerings — While the Company’s Offerings closed on September 30, 2015, pursuant to a Form S-3 filed under the Securities Exchange Act of 1933 with the SEC, the Company provided existing stockholders the opportunity to designate their cash distributions for reinvestment until the suspension of the Company’s Reinvestment Plan, which was effective July 11, 2018. Effective with the suspension of the Company’s Reinvestment Plan, stockholders who were participants in the Reinvestment Plan now receive cash distributions instead of additional shares of common stock. For the years ended December 31, 2018, 2017 and 2016, the Company received proceeds of approximately $22.0 million (2.1 million shares), $43.2 million (4.3 million shares) and $42.6 million (4.4 million shares), respectively, through the Reinvestment Plan. Distributions — For the years ended December 31, 2018, 2017 and 2016, the Company declared cash distributions of $81.1 million, $77.7 million and $74.0 million, respectively, of which $59.1 million, $34.5 million and $31.5 million, respectively, were paid in cash to stockholders and $22.0 million, $43.2 million and $42.6 million, respectively, were reinvested pursuant to the Reinvestment Plan. 13. Equity (continued) The tax composition of the Company’s distributions declared for the years ended December 31, 2018, 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 Ordinary income 0.0 % 0.0 % 21.5 % Capital gain 0.0 % 0.0 % 14.4 % Unrecaptured Sec. 1250 gain 0.0 % 0.0 % 1.2 % Return of capital 100.0 % 100.0 % 62.9 % Redemptions — For the years ended December 31, 2018, 2017 and 2016, the Company received requests for the redemption of common stock under its Redemption Plan of approximately 4.4 million, 4.7 million and 3.7 million shares, respectively, of which, 2.8 million, 4.7 million and 3.7 million were approved for redemption at an average price of $10.14, $9.99 and $9.73, respectively, and for a total of approximately $28.4 million, $47.3 million and $36.2 million, respectively. The remaining $16.4 million (1.6 million shares) of excess redemptions requests were placed in a redemption requests queue. In June 2018, in light of the Company’s decision to proceed with the exploration of Possible Strategic Alternatives, the Company suspended the Redemption Plan effective July 11, 2018. The $16.4 million in unsatisfied redemption requests were placed in the redemption queue and will remain there until such time, if at all, that the Company’s board of directors reinstates the Redemption Plan. Unless the Redemption Plan is reinstated by the Company’s board of directors, the Company will not as a general matter, accept or otherwise process any additional redemption requests received after July 11, 2018. There can be no guarantee that the Redemption Plan will be reinstated by the Company’s board of directors. Promoted Interest — In connection with the Company’s promoted interest agreements, certain operating targets have been established which, upon meeting such targets, result in the developer being entitled to additional payments based on enumerated percentages of the assumed net proceeds of a deemed sale, subject to achievement of an established internal rate of return on the Company’s investment in the development. For the years ended December 31, 2018, 2017 and 2016, the Company recorded, as a reduction to capital in excess of par value, the following distributions to holders of promoted interest (in thousands): Years Ended December 31, 2018 2017 2016 Dogwood Forest of Acworth $ — $ — $ (3,850 ) Wellmore of Tega Cay — — (2,800 ) HarborChase of Villages Crossing — (955 ) — Dogwood Forest of Grayson (406 ) — — $ (406 ) $ (955 ) $ (6,650 ) 13. Equity (continued) Other comprehensive income (loss) — The following table reflects the effect of derivative financial instruments held by the Company, or its equity method investment, and included in the consolidated statements of comprehensive loss for the years ended December 31, 2018, 2017 and 2016 (in thousands): Derivative financial instruments Gain (loss) recognized in other comprehensive loss on derivative financial instruments Location of gain (loss) reclassified into earnings Gain (loss) reclassified from accumulated other comprehensive loss into earnings Years Ended Years Ended December 31, December 31, 2018 2017 2016 2018 2017 2016 Interest rate swaps $ 1,219 $ 5,573 $ 3,487 Interest expense and loan cost amortization $ 2,457 $ (3,902 ) $ (7,150 ) Interest rate caps 690 1,013 (1,584 ) Interest expense and loan cost amortization (1,957 ) (849 ) (45 ) Reclassification of interest rate swaps upon derecognition 253 318 — Interest expense and loan cost amortization (253 ) (318 ) — Reclassification of interest rate swaps due to ineffectiveness — (26 ) (18 ) Interest expense and loan cost amortization — 26 18 Interest rate cap held by unconsolidated joint venture — — (1 ) Not applicable — — — Total $ 2,162 $ 6,878 $ 1,884 $ 247 $ (5,043 ) $ (7,177 )

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Taxes	14. Income Taxes For the years ended December 31, 2018, 2017, and 2016, the Company recorded net current tax expense and deferred tax assets related to deferred income at its TRS entities. The components of the income tax (expense) benefit for the years ended December 31, 2018, 2017 and 2016 were as follows (in thousands): Years Ended December 31, 2018 2017 2016 Current: Federal $ 113 $ (245 ) $ — State (477 ) (448 ) (276 ) Total current expense (364 ) (693 ) (276 ) Deferred: Federal (3,333 ) 8,826 ― State 66 305 ― Total deferred benefit (3,267 ) 9,131 ― Income tax (expense) benefit $ (3,631 ) $ 8,438 $ (276 ) 14. Income Taxes (continued) Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets as of December 31, 2018 and 2017 are as follows: 2018 2017 Carryforwards of net operating loss $ 6,046 $ 9,266 Minimum tax credit carryforward (1) 118 189 Prepaid rent 712 648 Valuation allowance (2) (946 ) (972 ) Deferred tax assets, net $ 5,930 $ 9,131 FOOTNOTES: (1) The Company expects to be refunded the full minimum tax credit carryforward over the next four years, beginning with the filing of its tax return for the year ended December 31, 2018 and continuing through to the year ending December 31, 2021. (2) . A reconciliation of the income tax (expense) benefit computed at the statutory federal tax rate on income before income taxes is as follows (in thousands): Years Ended December 31, 2018 2017 2016 Tax benefit computed at federal statutory rate $ 3,593 21.00 % $ 9,442 35.00 % $ 8,593 35.00 % Impact of REIT election (6,922 ) (40.45 )% (10,650 ) (39.48 )% (8,593 ) (35.00 )% State income tax expense net of federal benefit (399 ) (2.33 )% (331 ) (1.23 )% (276 ) (1.12 )% Effect of change in future tax rates ― ― % 1,861 6.90 ― ― Effect of change in valuation allowance 97 0.57 % 8,116 30.09 ― ― Income tax (expense) benefit $ (3,631 ) (21.21 )% $ 8,438 31.28 % $ (276) (1.12 )% The Company’s TRS entities had net operating loss carryforwards for federal and state purposes of approximately $23.3 million and $39.0 million as of December 31, 2018 and 2017, respectively, to offset future taxable income. If not utilized, the federal net operating loss carryforwards will begin to expire in 2019, and the state net operating loss carryforwards will begin to expire in 2035. The Company analyzed its material tax positions and determined that it has not taken any uncertain tax positions. The tax years 2015 through 2018 remain subject to examination by taxing authorities. In December 2017, the Tax Act was signed into law and reduces the U.S. federal corporate tax rate to 21%, effective January 1, 2018. All material impacts of the Tax Act have been reflected in the financial statements and their footnotes.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2018
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	15. Commitments and Contingencies From time to time, the Company may be a party to legal proceedings in the ordinary course of, or incidental to the normal course of, its business, including proceedings to enforce its contractual or statutory rights. While the Company cannot predict the outcome of these legal proceedings with certainty, based upon currently available information, the Company does not believe the final outcome of any pending or threatened legal proceeding will have a material adverse effect on its results of operations or financial condition. 15. Commitments and Contingencies (continued) As a result of the Company’s completed seniors housing developments continuing to move towards or achieving stabilization, the Company monitors the lease-up of these properties to determine whether the established performance metrics have been met as of each reporting period. The Company has six remaining promoted interest agreements with third-party developers pursuant to which certain operating targets have been established that, upon meeting such targets, result in the developer being entitled to additional payments based on enumerated percentages of the assumed net proceeds of a deemed sale, subject to achievement of an established internal rate of return on the Company’s investment in the development. As of December 31, 2018, one property had met its established performance metrics and the Company recorded a promoted interest obligation of $0.4 million; whereas for the remaining five promoted interest agreements, the established performance metrics were not met nor probable of being met as of December 31, 2018. The Company’s Advisor has approximately 1.3 million contingently issuable Restricted Stock shares for financial reporting purposes that were issued pursuant to the Advisor expense support agreement. Refer to Note 11. “Related Party Arrangements” for information on distributions declared related to these Restricted Stock shares. Under the terms of its ground lease agreements, the Company is responsible for the monthly or quarterly rental payments. These rental payments are recorded as property operating expenses within discontinued operations in the accompanying consolidated statements of operations as all of the Company’s ground leases relate to the MOB/Healthcare Portfolio. In some cases, the Company is able to pass this expense through to its tenants as tenant reimbursements. The Company incurred approximately $2.0 million, $2.0 million and $1.9 million in ground lease expense for the years ended December 31, 2018, 2017 and 2016, respectively, excluding straight-line rent adjustments and amortization of above- or below-market lease intangibles. The following is a schedule of future minimum lease payments to be paid under the ground leases for each of the next five years and thereafter, in the aggregate, as of December 31, 2018 (in thousands): 2019 $ 2,024 2020 2,047 2021 2,078 2022 2,108 2023 2,144 Thereafter 106,780 $ 117,181

Concentration of Credit Risk

Concentration of Credit Risk	12 Months Ended
	Dec. 31, 2018
Risks And Uncertainties [Abstract]
Concentration of Credit Risk	16. Concentration of Credit Risk For the years ended December 31, 2018, 2017 and 2016, the Company had a geographical concentration accounting for 10% or more of its total revenues, excluding the 63 properties classified as discontinued operations, as follows: Type of Years Ended December 31, Concentration 2018 2017 2016 State of Texas (1) Geographical 20.6 % 20.8 % 20.4 % FOOTNOTE: (1)

Selected Quarterly Financial Da

Selected Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]
Selected Quarterly Financial Data (Unaudited)	17. Selected Quarterly Financial Data (Unaudited) The following table presents selected unaudited quarterly financial data for the years ended December 31, 2018 and 2017 (in thousands, except per share data): 2018 Quarters First Second Third Fourth Full Year Total revenues $ 76,319 $ 77,189 $ 78,471 $ 79,615 $ 311,594 Operating income 5,176 8,597 10,098 118 23,989 Income (loss) from continuing operations (5,720 ) (2,700 ) (635 ) (11,687 ) (20,742 ) (Loss) income from discontinued operations (2,178 ) (4,634 ) (2,634 ) 5,037 (4,409 ) Net loss attributable to common stockholders (7,874 ) (7,308 ) (3,248 ) (6,642 ) (25,072 ) Net loss per share of common stock (basic and diluted) Continuing operations (0.03 ) (0.02 ) (0.00 ) (0.07 ) (0.12 ) Discontinued operations (0.01 ) (0.03 ) (0.02 ) 0.03 (0.03 ) Weighted average number of shares outstanding (basic and diluted) 174,854 174,201 173,974 173,973 174,247 2017 Quarters First Second Third Fourth Full Year Total revenues $ 67,046 $ 69,392 $ 73,219 $ 75,050 $ 284,707 Operating income (loss) 1,658 2,560 994 3,379 8,591 Income (loss) from continuing operations (5,981 ) (6,347 ) (8,562 ) 2,351 (18,539 ) Loss from discontinued operations (1,483 ) (1,649 ) (2,669 ) (1,972 ) (7,773 ) Net income (loss) attributable to common stockholders (7,324 ) (7,901 ) (11,170 ) 433 (25,962 ) Net loss per share of common stock (basic and diluted) Continuing operations (0.03 ) (0.04 ) (0.05 ) 0.01 (0.11 ) Discontinued operations (0.01 ) (0.01 ) (0.01 ) (0.01 ) (0.04 ) Weighted average number of shares outstanding (basic and diluted) 175,277 175,221 175,190 174,918 175,151

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
Subsequent Events	18. Subsequent Events First Term Loan Extension In February 2019, the Company exercised its final 12-month extension option on the First Term Loan Facility, which represented approximately $175 million of the debt maturing in 2019. The term was extended through February 2020 IRF Sale Agreement In March 2019, the Company entered into the IRF Sale Agreement related to the IRF Sale, consisting of four properties within the MOB/Healthcare Portfolio, for a gross sales price of $94 million, subject to certain pro-rations and other adjustments as described in the IRF Sale Agreement. In connection with the IRF Sale, approximately $1.5 million has been placed by the buyer in escrow, which is non-refundable, except for a seller breach or default under the IRF Sale Agreement, and will be applied to the purchase price at closing. The anticipated net sales proceeds are expected to exceed the net carrying value of the IRF Sale.

SCHEDULE II-Valuation and Quali

SCHEDULE II-Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2018
Valuation And Qualifying Accounts [Abstract]
SCHEDULE II-Valuation and Qualifying Accounts	CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES YEARS ENDED DECEMBER 31, 2018, 2017 AND 2016 (in thousands) Year Description Balance at Beginning of Year Charged to Costs and Expenses Charged to Other Accounts Balance at End of Year 2016 Deferred tax asset valuation allowance $ (5,839 ) $ (3,713 ) $ — $ (9,552 ) Allowance for doubtful accounts (1,170 ) (346 ) — (1,516 ) $ (7,009 ) $ (4,059 ) $ — $ (11,068 ) 2017 Deferred tax asset valuation allowance $ (9,552 ) $ 8,465 $ — $ (1,087 ) Allowance for doubtful accounts (1,516 ) (834 ) — (2,350 ) $ (11,068 ) $ 7,631 $ — $ (3,437 ) 2018 Deferred tax asset valuation allowance $ (1,087 ) $ (829 ) $ — $ (1,916 ) Allowance for doubtful accounts (2,350 ) (1,489 ) — (3,839 ) $ (3,437 ) $ (2,318 ) $ — $ (5,755 )

SCHEDULE III-Real Estate and Ac

SCHEDULE III-Real Estate and Accumulated Depreciation	12 Months Ended
	Dec. 31, 2018
Real Estate And Accumulated Depreciation Disclosure [Abstract]
SCHEDULE III-Real Estate and Accumulated Depreciation	CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES AS OF DECEMBER 31, 2018 (in thousands) Initial Costs Costs Capitalized Subsequent to Acquisition Gross Amounts at which Carried at Close of Period (2) Property/Location Encum- brances Land & Land Improve- ments Building and Building Improve- ments Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Total Accumu-lated Depreci-ation Date of Construction Date Acquired Life on which depreciation in latest income statement is computed Primrose Retirement Community of Casper Casper, Wyoming $ 11,270 $ 1,910 $ 16,310 $ 30 $ 296 $ — $ 1,940 $ 16,606 $ — $ 18,546 $ (3,004 ) 2004 2/16/2012 (1) Primrose Retirement Community of Grand Island Grand Island, Nebraska $ 7,950 $ 719 $ 12,140 $ 56 $ 0 $ — $ 775 $ 12,140 $ — $ 12,915 $ (2,296 ) 2005 2/16/2012 (1) Primrose Retirement Community of Mansfield Mansfield, Ohio $ 10,817 $ 650 $ 16,720 $ 229 $ 71 $ — $ 879 $ 16,791 $ — $ 17,670 $ (3,182 ) 2007 2/16/2012 (1) Primrose Retirement Community of Marion Marion, Ohio $ 8,972 $ 889 $ 16,305 $ — $ — $ — $ 889 $ 16,305 $ — $ 17,194 $ (3,040 ) 2006 2/16/2012 (1) Sweetwater Retirement Community Billings, Montana $ 9,744 $ 1,578 $ 14,205 $ 19 $ 0 $ — $ 1,597 $ 14,205 $ — $ 15,802 $ (2,583 ) 2006 2/16/2012 (1) HarborChase of Villages Crossing Lady Lake, Florida ("The Villages") $ — $ 2,165 $ — $ 986 $ 15,424 $ — $ 3,151 $ 15,424 $ — $ 18,575 $ (2,106 ) 2013 8/29/2012 (1) Primrose Retirement Community Cottages Aberdeen, South Dakota $ — $ 311 $ 3,794 $ — $ — $ — $ 311 $ 3,794 $ — $ 4,105 $ (631 ) 2005 12/19/2012 (1) Primrose Retirement Community of Council Bluffs Council Bluffs, Iowa ("Omaha") $ — $ 1,144 $ 11,117 $ 5 $ — $ — $ 1,149 $ 11,117 $ — $ 12,266 $ (1,903 ) 2008 12/19/2012 (1) Primrose Retirement Community of Decatur Decatur, Illinois $ 9,888 $ 513 $ 16,706 $ — $ 154 $ — $ 513 $ 16,860 $ — $ 17,373 $ (2,751 ) 2009 12/19/2012 (1) Primrose Retirement Community of Lima Lima, Ohio $ — $ 944 $ 17,115 $ 8 $ 4 $ — $ 952 $ 17,119 $ — $ 18,071 $ (2,796 ) 2006 12/19/2012 (1) Primrose Retirement Community of Zanesville Zanesville, Ohio $ 11,159 $ 1,184 $ 17,292 $ — $ 67 $ — $ 1,184 $ 17,359 $ — $ 18,543 $ (2,837 ) 2008 12/19/2012 (1) Symphony Manor Baltimore, Maryland $ 14,167 $ 2,319 $ 19,444 $ — $ 81 $ — $ 2,319 $ 19,525 $ — $ 21,844 $ (3,139 ) 2011 12/21/2012 (1) Curry House Assisted Living & Memory Care Cadillac, Michigan $ 7,452 $ 995 $ 11,072 $ 8 $ 2 $ — $ 1,003 $ 11,074 $ — $ 12,077 $ (1,805 ) 1966 12/21/2012 (1) Tranquillity at Fredericktowne Frederick, Maryland $ 20,125 $ 808 $ 14,291 $ — $ 5,960 $ — $ 808 $ 20,251 $ — $ 21,059 $ (2,697 ) 2000 12/21/2012 (1) Brookridge Heights Assisted Living & Memory Care Marquette, Michigan $ 12,697 $ 595 $ 11,339 $ — $ 4,697 $ — $ 595 $ 16,036 $ — $ 16,631 $ (2,288 ) 1998 12/21/2012 (1) Woodholme Gardens Assisted Living & Memory Care Pikesville, Maryland ("Baltimore") $ 6,460 $ 1,603 $ 13,472 $ 54 $ 8 $ — $ 1,657 $ 13,480 $ — $ 15,137 $ (2,195 ) 2010 12/21/2012 (1) Batesville Healthcare Center Batesville, Arkansas $ — $ 397 $ 5,382 $ 113 $ — $ — $ 510 $ 5,382 $ — $ 5,892 $ (598 ) 1975 5/31/2013 (1) Broadway Healthcare Center West Memphis, Arkansas $ — $ 438 $ 10,560 $ — $ 77 $ — $ 438 $ 10,637 $ — $ 11,075 $ (1,189 ) 1994 5/31/2013 (1) CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION AS OF DECEMBER 31, 2018 (in thousands) Initial Costs Costs Capitalized Subsequent to Acquisition Gross Amounts at which Carried at Close of Period (2) Property/Location Encum- brances Land & Land Improve- ments Building and Building Improve- ments Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Total Accumu-lated Depreci-ation Date of Construction Date Acquired Life on which depreciation in latest income statement is computed Jonesboro Healthcare Center Jonesboro, Arkansas $ — $ 527 $ 13,493 $ — $ 5 $ — $ 527 $ 13,498 $ — $ 14,025 $ (1,494 ) 2012 5/31/2013 (1) Magnolia Healthcare Center Magnolia, Arkansas $ — $ 421 $ 10,454 $ — $ — $ — $ 421 $ 10,454 $ — $ 10,875 $ (1,177 ) 2009 5/31/2013 (1) Mine Creek Healthcare Center Nashville, Arkansas $ — $ 135 $ 2,942 $ 11 $ 36 $ — $ 146 $ 2,978 $ — $ 3,124 $ (347 ) 1978 5/31/2013 (1) Searcy Healthcare Center Searcy, Arkansas $ — $ 648 $ 6,017 $ — $ 222 $ — $ 648 $ 6,239 $ — $ 6,887 $ (710 ) 1973 5/31/2013 (1) LaPorte Cancer Center Westville, Indiana $ 7,335 $ 433 $ 10,846 $ 96 $ 0 $ — $ 529 $ 10,846 $ — $ 11,375 $ (1,554 ) 2010 6/14/2013 (1) Jefferson Medical Commons Jefferson City, Tennessee ("Knoxville") $ 8,086 $ 151 $ 10,236 $ — $ 381 $ — $ 151 $ 10,617 $ — $ 10,768 $ (1,433 ) 2001 7/10/2013 (1) Physicians Plaza A at North Knoxville Medical Center Powell, Tennessee ("Knoxville") $ 13,234 $ 262 $ 16,976 $ — $ 85 $ — $ 262 $ 17,061 $ — $ 17,323 $ (2,379 ) 2005 7/10/2013 (1) Physicians Plaza B at North Knoxville Medical Center Powell, Tennessee ("Knoxville") $ 16,081 $ 303 $ 18,754 $ — $ 435 $ — $ 303 $ 19,189 $ — $ 19,492 $ (2,638 ) 2008 7/10/2013 (1) HarborChase of Jasper Jasper, Alabama $ — $ 355 $ 6,358 $ 0 $ 36 $ — $ 355 $ 6,394 $ — $ 6,749 $ (918 ) 1998 7/31/2013 (1) Chestnut Commons MOB Elyria, Ohio ("Cleveland") $ — $ 2,053 $ 15,650 $ 59 $ — $ — $ 2,112 $ 15,650 $ — $ 17,762 $ (2,352 ) 2008 8/16/2013 (1) Doctors Specialty Hospital Leawood, Kansas ("Kansas City") $ — $ 924 $ 5,771 $ 69 $ — $ — $ 993 $ 5,771 $ — $ 6,764 $ (842 ) 2001 8/16/2013 (1) Escondido Medical Arts Center Escondido, California ("San Diego") $ — $ 1,863 $ 12,199 $ — $ 50 $ — $ 1,863 $ 12,249 $ — $ 14,112 $ (1,645 ) 1994 8/16/2013 (1) John C. Lincoln Medical Office Plaza I Phoenix, Arizona $ — $ 233 $ 2,779 $ — $ 146 $ — $ 233 $ 2,925 $ — $ 3,158 $ (463 ) 1980 8/16/2013 (1) John C. Lincoln Medical Office Plaza II Phoenix, Arizona $ — $ 138 $ 1,908 $ — $ 100 $ — $ 138 $ 2,008 $ — $ 2,146 $ (274 ) 1984 8/16/2013 (1) North Mountain Medical Plaza Phoenix, Arizona $ — $ 297 $ 4,079 $ — $ 204 $ — $ 297 $ 4,283 $ — $ 4,580 $ (635 ) 1994 8/16/2013 (1) Raider Ranch Lubbock, Texas $ — $ 4,992 $ 48,818 $ 481 $ 13,048 $ — $ 5,473 $ 61,866 $ — $ 67,339 $ (7,896 ) 2009 8/29/2013 (1) CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION AS OF DECEMBER 31, 2018 (in thousands) Initial Costs Costs Capitalized Subsequent to Acquisition Gross Amounts at which Carried at Close of Period (2) Property/Location Encum- brances Land & Land Improve- ments Building and Building Improve- ments Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Total Accumu-lated Depreci-ation Date of Construction Date Acquired Life on which depreciation in latest income statement is computed Town Village Oklahoma City, Oklahoma $ — $ 1,020 $ 19,847 $ 87 $ 1,271 $ — $ 1,107 $ 21,118 $ — $ 22,225 $ (2,955 ) 2004 8/29/2013 (1) Calvert Medical Arts Center Prince Frederick, Maryland ("Washington D.C.") $ — $ 20 $ 17,838 $ 1 $ 86 $ — $ 21 $ 17,924 $ — $ 17,945 $ (2,352 ) 2009 8/30/2013 (1) Calvert MOBs I, II & III Prince Frederick, Maryland ("Washington D.C.") $ — $ 51 $ 14,334 $ — $ 329 $ — $ 51 $ 14,663 $ — $ 14,714 $ (1,959 ) 1991/1999/2000 8/30/2013 (1) Dunkirk Medical Center Dunkirk, Maryland ("Washington D.C.") $ — $ 351 $ 2,991 $ 20 $ 34 $ — $ 371 $ 3,025 $ — $ 3,396 $ (518 ) 1997 8/30/2013 (1) Prestige Senior Living Beaverton Hills Beaverton, Oregon ("Portland") $ 8,747 $ 1,387 $ 10,324 $ 6 $ — $ — $ 1,393 $ 10,324 $ — $ 11,717 $ (1,413 ) 2000 12/2/2013 (1) Prestige Senior Living High Desert Bend, Oregon $ 7,659 $ 835 $ 11,252 $ 13 $ 37 $ — $ 848 $ 11,289 $ — $ 12,137 $ (1,602 ) 2003 12/2/2013 (1) MorningStar of Billings Billings, Montana $ 19,167 $ 4,067 $ 41,373 $ 51 $ 109 $ — $ 4,118 $ 41,482 $ — $ 45,600 $ (5,972 ) 2009 12/2/2013 (1) MorningStar of Boise Boise, Idaho $ 20,539 $ 1,663 $ 35,752 $ 14 $ 229 $ — $ 1,677 $ 35,981 $ — $ 37,658 $ (4,869 ) 2007 12/2/2013 (1) Prestige Senior Living Huntington Terrace Gresham, Oregon ("Portland") $ 9,815 $ 1,236 $ 12,083 $ 2 $ 64 $ — $ 1,238 $ 12,147 $ — $ 13,385 $ (1,684 ) 2000 12/2/2013 (1) MorningStar of Idaho Falls Idaho Falls, Idaho $ 17,104 $ 2,006 $ 40,397 $ 5 $ 193 $ — $ 2,011 $ 40,590 $ — $ 42,601 $ (5,620 ) 2009 12/2/2013 (1) Prestige Senior Living Arbor Place Medford, Oregon $ 8,069 $ 355 $ 14,083 $ 6 $ 29 $ — $ 361 $ 14,112 $ — $ 14,473 $ (1,908 ) 2003 12/2/2013 (1) Prestige Senior Living Orchard Heights Salem, Oregon $ 11,769 $ 545 $ 15,544 $ 8 $ 81 $ — $ 553 $ 15,625 $ — $ 16,178 $ (2,102 ) 2002 12/2/2013 (1) Prestige Senior Living Southern Hills Salem, Oregon $ 7,344 $ 653 $ 10,753 $ 37 $ 2 $ — $ 690 $ 10,755 $ — $ 11,445 $ (1,482 ) 2001 12/2/2013 (1) MorningStar of Sparks Sparks, Nevada ("Reno") $ 22,755 $ 3,986 $ 47,968 $ 3 $ 36 $ — $ 3,989 $ 48,004 $ — $ 51,993 $ (6,714 ) 2009 12/2/2013 (1) Prestige Senior Living Five Rivers Tillamook, Oregon $ 7,530 $ 1,298 $ 14,064 $ 18 $ 62 $ — $ 1,316 $ 14,126 $ — $ 15,442 $ (2,048 ) 2002 12/2/2013 (1) Prestige Senior Living Riverwood Tualatin, Oregon ("Portland") $ 4,446 $ 1,028 $ 7,429 $ 12 $ 80 $ — $ 1,040 $ 7,509 $ — $ 8,549 $ (1,064 ) 1999 12/2/2013 (1) Chula Vista Medical Arts Center - Plaza II Chula Vista, California ("San Diego") $ — $ 2,462 $ 7,453 $ 9 $ 802 $ — $ 2,471 $ 8,255 $ — $ 10,726 $ (1,006 ) 1985 12/23/2013 (1) Coral Springs MOB I Coral Springs, Florida $ — $ 2,614 $ 11,220 $ 1 $ — $ — $ 2,615 $ 11,220 $ — $ 13,835 $ (1,575 ) 2005 12/23/2013 (1) Coral Springs MOB II Coral Springs, Florida $ — $ 2,614 $ 12,130 $ 1 $ 59 $ — $ 2,615 $ 12,189 $ — $ 14,804 $ (1,575 ) 2008 12/23/2013 (1) CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION AS OF DECEMBER 31, 2018 (in thousands) Initial Costs Costs Capitalized Subsequent to Acquisition Gross Amounts at which Carried at Close of Period (2) Property/Location Encum- brances Land & Land Improve- ments Building and Building Improve- ments Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Total Accumu-lated Depreci-ation Date of Construction Date Acquired Life on which depreciation in latest income statement is computed Chula Vista Medical Arts Center - Plaza I Chula Vista, California ("San Diego") $ — $ 6,130 $ 10,293 $ 14 $ 350 $ — $ 6,144 $ 10,643 $ — $ 16,787 $ (1,346 ) 1975 1/21/2014 (1) Prestige Senior Living Auburn Meadows Auburn, Washington ("Seattle") $ 10,261 $ 2,537 $ 17,261 $ — $ 174 $ — $ 2,537 $ 17,435 $ — $ 19,972 $ (2,338 ) 2003/2010 2/3/2014 (1) Prestige Senior Living Bridgewood Vancouver, Washington ("Portland") $ 12,918 $ 1,603 $ 18,172 $ 10 $ 9 $ — $ 1,613 $ 18,181 $ — $ 19,794 $ (2,424 ) 2001 2/3/2014 (1) Prestige Senior Living Monticello Park Longview, Washington $ 17,234 $ 1,981 $ 23,056 $ 1 $ 20 $ — $ 1,982 $ 23,076 $ — $ 25,058 $ (3,036 ) 2001/2010 2/3/2014 (1) Prestige Senior Living Rosemont Yelm, Washington $ 9,062 $ 668 $ 14,564 $ — $ 26 $ — $ 668 $ 14,590 $ — $ 15,258 $ (1,898 ) 2004 2/3/2014 (1) Wellmore of Tega Cay Tega Cay, South Carolina ("Charlotte") $ 27,715 $ 2,445 $ — $ 2,743 $ 23,447 $ — $ 5,188 $ 23,447 $ — $ 28,635 $ (2,743 ) (3 ) 2/7/2014 (1) Isle at Cedar Ridge Cedar Park, Texas ("Austin") $ — $ 1,525 $ 16,277 $ — $ 185 $ — $ 1,525 $ 16,462 $ — $ 17,987 $ (2,226 ) 2011 2/28/2014 (1) Prestige Senior Living West Hills Corvallis, Oregon $ 8,561 $ 842 $ 12,603 $ 11 $ 4 $ — $ 853 $ 12,607 $ — $ 13,460 $ (1,698 ) 2002 3/3/2014 (1) HarborChase of Plainfield Plainfield, Illinois $ — $ 1,596 $ 21,832 $ — $ — $ — $ 1,596 $ 21,832 $ — $ 23,428 $ (2,811 ) 2010 3/28/2014 (1) Legacy Ranch Alzheimer's Special Care Center Midland, Texas $ — $ 917 $ 9,982 $ — $ — $ — $ 917 $ 9,982 $ — $ 10,899 $ (1,310 ) 2012 3/28/2014 (1) The Springs Alzheimer's Special Care Center San Angelo, Texas $ — $ 595 $ 9,658 $ — $ — $ — $ 595 $ 9,658 $ — $ 10,253 $ (1,267 ) 2012 3/28/2014 (1) Isle at Watercrest - Bryan Bryan, Texas $ — $ 3,223 $ 40,581 $ 36 $ 972 $ — $ 3,259 $ 41,553 $ — $ 44,812 $ (5,399 ) 2011 4/21/2014 (1) Isle at Watercrest - Mansfield Mansfield, Texas ("Dallas/Fort Worth") $ — $ 997 $ 24,635 $ — $ 82 $ — $ 997 $ 24,717 $ — $ 25,714 $ (3,053 ) 2011 5/5/2014 (1) Memorial Hermann Orthopedic & Spine Hospital Bellaire, Texas ("Houston") $ 32,273 $ 3,867 $ 32,761 $ — $ — $ — $ 3,867 $ 32,761 $ — $ 36,628 $ (3,702 ) 2007 6/2/2014 (1) MHOSH MOB Bellaire, Texas ("Houston") $ 25,353 $ 3,738 $ 20,525 $ 792 $ 257 $ — $ 4,530 $ 20,782 $ — $ 25,312 $ (2,422 ) 2007 6/2/2014 (1) Watercrest at Katy Katy, Texas ("Houston") $ 21,551 $ 4,000 $ — $ 90 $ 32,374 $ — $ 4,090 $ 32,374 $ — $ 36,464 $ (2,161 ) (3 ) 6/27/2014 (1) Watercrest at Mansfield Mansfield, Texas ("Dallas/Fort Worth") $ 25,163 $ 2,191 $ 42,740 $ — $ 921 $ — $ 2,191 $ 43,661 $ — $ 45,852 $ (5,169 ) 2010 6/30/2014 (1) CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION AS OF DECEMBER 31, 2018 (in thousands) Initial Costs Costs Capitalized Subsequent to Acquisition Gross Amounts at which Carried at Close of Period (2) Property/Location Encum- brances Land & Land Improve- ments Building and Building Improve- ments Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Total Accumu-lated Depreci-ation Date of Construction Date Acquired Life on which depreciation in latest income statement is computed HarborChase of Shorewood Shorewood, Wisconsin ("Milwaukee") $ — $ 2,200 $ — $ 301 $ 19,862 $ — $ 2,501 $ 19,862 $ — $ 22,363 $ (1,630 ) (3 ) 7/8/2014 (1) Oklahoma City Inpatient Rehabilitation Hospital Oklahoma City, Oklahoma $ 14,994 $ 3,341 $ 19,249 $ — $ — $ — $ 3,341 $ 19,249 $ — $ 22,590 $ (2,305 ) 2012 7/15/2014 (1) Las Vegas Inpatient Rehabilitation Hospital Las Vegas, Nevada $ 13,106 $ 2,650 $ 16,979 $ — $ — $ — $ 2,650 $ 16,979 $ — $ 19,629 $ (2,056 ) 2007 7/15/2014 (1) South Bend Inpatient Rehabilitation Hospital Mishawaka, Indiana ("South Bend") $ 11,899 $ 2,339 $ 16,239 $ 4 $ — $ — $ 2,343 $ 16,239 $ — $ 18,582 $ (1,992 ) 2009 7/15/2014 (1) Beaumont Specialty Hospital Beaumont, Texas ("Houston") $ 19,753 $ 2,749 $ 28,863 $ — $ — $ — $ 2,749 $ 28,863 $ — $ 31,612 $ (3,241 ) 2013 8/15/2014 (1) Hurst Specialty Hospital Hurst, Texas ("Dallas/Fort Worth") $ 17,324 $ 2,082 $ 20,186 $ — $ 155 $ — $ 2,082 $ 20,341 $ — $ 22,423 $ (2,708 ) 2004/2012 8/15/2014 (1) Claremont Medical Office Claremont, CA ("Los Angeles") $ 14,173 $ 6,324 $ 13,533 $ 3 $ 46 $ — $ 6,327 $ 13,579 $ — $ 19,906 $ (1,630 ) 2008 8/29/2014 (1) Lee Hughes MOB Glendale, California ("Los Angeles") $ 17,043 $ 69 $ 22,967 $ — $ 232 $ — $ 69 $ 23,199 $ — $ 23,268 $ (2,378 ) 2008 9/29/2014 (1) Newburyport Medical Center Newburyport, Massachusetts ("Boston") $ — $ 2,614 $ 12,135 $ 41 $ — $ — $ 2,655 $ 12,135 $ — $ 14,790 $ (1,452 ) 2008 10/31/2014 (1) Northwest Medical Park Building Margate, Florida ("Fort Lauderdale") $ 6,628 $ 610 $ 6,170 $ — $ 155 $ — $ 610 $ 6,325 $ — $ 6,935 $ (779 ) 2004 10/31/2014 (1) Fairfield Village of Layton Layton, Utah ("Salt Lake City") $ — $ 5,217 $ 54,167 $ 66 $ 5 $ — $ 5,283 $ 54,172 $ — $ 59,455 $ (6,289 ) 2010 11/20/2014 (1) ProMed Building I Yuma, Arizona $ 6,473 $ 2,486 $ 6,728 $ — $ 49 $ — $ 2,486 $ 6,777 $ — $ 9,263 $ (756 ) 2006 12/19/2014 (1) Midtown Medical Plaza Charlotte, North Carolina $ 37,121 $ 10 $ 51,237 $ — $ 436 $ — $ 10 $ 51,673 $ — $ 51,683 $ (4,949 ) 1994 12/22/2014 (1) Presbyterian Medical Tower Charlotte, North Carolina $ 23,622 $ 40 $ 32,345 $ — $ 260 $ — $ 40 $ 32,605 $ — $ 32,645 $ (3,135 ) 1989 12/22/2014 (1) Metroview Professional Building Charlotte, North Carolina $ 12,936 $ 11 $ 15,910 $ — $ 109 $ — $ 11 $ 16,019 $ — $ 16,030 $ (1,539 ) 1971 12/22/2014 (1) Physicians Plaza Huntersville Huntersville, North Carolina ("Charlotte") $ 18,785 $ 520 $ 26,134 $ — $ 112 $ — $ 520 $ 26,246 $ — $ 26,766 $ (2,643 ) 2004 12/22/2014 (1) Matthews Medical Office Building Matthews, North Carolina ("Charlotte") $ 14,736 $ 350 $ 19,624 $ — $ 46 $ — $ 350 $ 19,670 $ — $ 20,020 $ (1,975 ) 1994 12/22/2014 (1) Outpatient Care Center Clyde, North Carolina ("Asheville") $ 10,500 $ 1,169 $ 12,079 $ 15 $ — $ — $ 1,184 $ 12,079 $ — $ 13,263 $ (1,191 ) 2012 12/22/2014 (1) CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION AS OF DECEMBER 31, 2018 (in thousands) Initial Costs Costs Capitalized Subsequent to Acquisition Gross Amounts at which Carried at Close of Period (2) Property/Location Encum- brances Land & Land Improve- ments Building and Building Improve- ments Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Total Accumu-lated Depreci-ation Date of Construction Date Acquired Life on which depreciation in latest income statement is computed 330 Physicians Center Rome, Georgia $ 19,380 $ 12 $ 26,868 $ 4 $ — $ — $ 16 $ 26,868 $ — $ 26,884 $ (2,587 ) 1987/2005 12/22/2014 (1) Spivey Station Physicians Center Atlanta, Georgia $ 8,700 $ 1,026 $ 12,246 $ 11 $ — $ — $ 1,037 $ 12,246 $ — $ 13,283 $ (1,292 ) 2007 12/22/2014 (1) Spivey Station ASC Building Atlanta, Georgia $ 8,700 $ 929 $ 13,769 $ 6 $ 2 $ — $ 935 $ 13,771 $ — $ 14,706 $ (1,428 ) 2009 12/22/2014 (1) Novi Orthopaedic Center Novi, Michigan $ 19,581 $ 1,314 $ 26,239 $ 61 $ 27 $ — $ 1,375 $ 26,266 $ — $ 27,641 $ (2,794 ) 2008 2/13/2015 (1) UT Cancer Institute Building Knoxville, Tennessee $ 20,520 $ 421 $ 27,621 $ — $ 130 $ — $ 421 $ 27,751 $ — $ 28,172 $ (2,642 ) 2012 2/20/2015 (1) Fieldstone Memory Care Yakima, Washington $ — $ 1,297 $ 9,965 $ — $ — $ — $ 1,297 $ 9,965 $ — $ 11,262 $ (1,060 ) 2014 3/31/2015 (1) Bend Memorial Clinic MOB Bend, Oregon $ — $ 9,069 $ 19,867 $ — $ — $ — $ 9,069 $ 19,867 $ — $ 28,936 $ (2,102 ) 1976 5/11/2015 (1) Stoneterra Medical Plaza San Antonio, Texas $ — $ 2,864 $ 10,412 $ — $ 23 $ — $ 2,864 $ 10,435 $ — $ 13,299 $ (998 ) 2006 5/29/2015 (1) Primrose Retirement Center of Anderson Anderson, Indiana ("Muncie") $ — $ 1,342 $ 19,083 $ — $ 33 $ — $ 1,342 $ 19,116 $ — $ 20,458 $ (1,933 ) 2008 5/29/2015 (1) Primrose Retirement Center of Lancaster Lancaster, Ohio ("Columbus") $ — $ 2,840 $ 21,884 $ — $ — $ — $ 2,840 $ 21,884 $ — $ 24,724 $ (2,437 ) 2007 5/29/2015 (1) Primrose Retirement Center of Wausau Wausau, Wisconsin ("Green Bay") $ — $ 1,089 $ 18,653 $ — $ — $ — $ 1,089 $ 18,653 $ — $ 19,742 $ (1,813 ) 2008 5/29/2015 (1) Triangle Orthopaedic Durham Durham, North Carolina $ 12,516 $ 3,191 $ 14,523 $ 134 $ — $ — $ 3,325 $ 14,523 $ — $ 17,848 $ (1,393 ) 2000 6/29/2015 (1) Triangle Orthopaedic Roxboro Roxboro, North Carolina $ 1,271 $ 287 $ 1,406 $ — $ — $ — $ 287 $ 1,406 $ — $ 1,693 $ (144 ) 2000 6/29/2015 (1) Triangle Orthopaedic Chapel Hill Chapel Hill, North Carolina $ 1,858 $ 360 $ 2,306 $ — $ — $ — $ 360 $ 2,306 $ — $ 2,666 $ (214 ) 2011 6/29/2015 (1) Triangle Orthopaedic Oxford Oxford, North Carolina $ 2,738 $ 658 $ 3,074 $ — $ — $ — $ 658 $ 3,074 $ — $ 3,732 $ (313 ) 2011 6/29/2015 (1) North Carolina Specialty Hospital Durham, North Carolina $ 18,579 $ 3,173 $ 22,762 $ — $ — $ 3,490 $ 3,173 $ 22,762 $ 3,490 $ 29,425 $ (2,048 ) 2004 6/29/2015 (1) Doctor's Park Building B Chula Vista, California ("San Diego") $ — $ 1,161 $ 2,919 $ — $ — $ — $ 1,161 $ 2,919 $ — $ 4,080 $ (278 ) 2008 6/30/2015 (1) Doctor's Park Building C Chula Vista, California ("San Diego") $ — $ 2,323 $ 6,351 $ — $ — $ — $ 2,323 $ 6,351 $ — $ 8,674 $ (597 ) 2006 6/30/2015 (1) CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION AS OF DECEMBER 31, 2018 (in thousands) Initial Costs Costs Capitalized Subsequent to Acquisition Gross Amounts at which Carried at Close of Period (2) Property/Location Encum- brances Land & Land Improve- ments Building and Building Improve- ments Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Total Accumu-lated Depreci-ation Date of Construction Date Acquired Life on which depreciation in latest income statement is computed Superior Residences of Panama City Panama City Beach, Florida $ — $ 2,099 $ 19,367 $ — $ — $ — $ 2,099 $ 19,367 $ — $ 21,466 $ (1,909 ) 2015 7/15/2015 (1) 540 New Waverly Place Cary, North Carolina ("Raleigh") $ 6,452 $ 2,476 $ 11,009 $ — $ 23 $ — $ 2,476 $ 11,032 $ — $ 13,508 $ (1,034 ) 2007 7/20/2015 (1) MedHelp Birmingham, Alabama $ — $ 2,270 $ 10,359 $ 11 $ — $ — $ 2,281 $ 10,359 $ — $ 12,640 $ (902 ) 2015 7/31/2015 (1) Patriot Professional Center Frederick, Maryland ("Baltimore") $ — $ 3,912 $ 11,781 $ 18 $ 50 $ — $ 3,930 $ 11,831 $ — $ 15,761 $ (1,115 ) 2006/2014 7/31/2015 (1) Liberty Professional Center Frederick, Maryland ("Baltimore") $ — $ 1,977 $ 4,462 $ 10 $ — $ — $ 1,987 $ 4,462 $ — $ 6,449 $ (414 ) 1979/2013 7/31/2015 (1) The Hampton at Meadows Place Meadows Place, Texas ("Houston") $ — $ 715 $ 24,281 $ — $ 34 $ — $ 715 $ 24,315 $ — $ 25,030 $ (2,169 ) 2007/2013/2014 7/31/2015 (1) The Pavilion at Great Hills Austin, Texas $ — $ 1,783 $ 29,318 $ 30 $ 97 $ — $ 1,813 $ 29,415 $ — $ 31,228 $ (2,646 ) 2010 7/31/2015 (1) The Beacon at Gulf Breeze Gulf Breeze, Florida ("Pensacola") $ — $ 824 $ 24,106 $ 72 $ 55 $ — $ 896 $ 24,161 $ — $ 25,057 $ (2,240 ) 2008 7/31/2015 (1) Parc at Piedmont Marietta, Georgia ("Atlanta") $ — $ 3,529 $ 43,080 $ 18 $ 78 $ — $ 3,547 $ 43,158 $ — $ 46,705 $ (4,015 ) 2001/2011 7/31/2015 (1) Parc at Duluth Duluth, Georgia ("Atlanta") $ — $ 5,951 $ 42,458 $ 13 $ 58 $ — $ 5,964 $ 42,516 $ — $ 48,480 $ (3,950 ) 2003/2012 7/31/2015 (1) Broadway Medical Plaza 1 Columbia, Missouri $ — $ 437 $ 9,281 $ — $ 135 $ — $ 437 $ 9,416 $ — $ 9,853 $ (831 ) 1994 8/21/2015 (1) Broadway Medical Plaza 2 Columbia, Missouri $ — $ 386 $ 12,460 $ — $ — $ — $ 386 $ 12,460 $ — $ 12,846 $ (1,064 ) 1999 8/21/2015 (1) Broadway Medical Plaza 4 Columbia, Missouri $ — $ 170 $ 12,118 $ — $ 86 $ — $ 170 $ 12,204 $ — $ 12,374 $ (993 ) 2007 8/21/2015 (1) Waterstone on Augusta Greenville, South Carolina $ 18,830 $ 2,253 $ — $ 2,116 $ 20,770 $ — $ 4,369 $ 20,770 $ — $ 25,139 $ (1,172 ) 2017 8/31/2015 (1) Welbrook Senior Living Grand Junction Grand Junction, Colorado $ 8,141 $ 966 $ — $ — $ 3,847 $ — $ 966 $ 3,847 $ — $ 4,813 $ (630 ) 2017 9/4/2015 (1) Wellmore of Lexington Lexington, South Carolina ("Columbia") $ 35,421 $ 2,300 $ — $ 3,150 $ 43,081 $ — $ 5,450 $ 43,081 $ — $ 48,531 $ (1,972 ) 2017 9/14/2015 (1) Palmilla Senior Living Albuquerque, New Mexico $ 26,478 $ 4,701 $ 38,321 $ — $ — $ — $ 4,701 $ 38,321 $ — $ 43,022 $ (3,412 ) 2013 9/30/2015 (1) Cedar Lake Assisted Living and Memory Care Lake Zurich, Illinois ("Chicago") $ — $ 2,412 $ 25,126 $ — $ 6 $ — $ 2,412 $ 25,132 $ — $ 27,544 $ (2,233 ) 2014 9/30/2015 (1) CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION AS OF DECEMBER 31, 2018 (in thousands) Initial Costs Costs Capitalized Subsequent to Acquisition Gross Amounts at which Carried at Close of Period (2) Property/Location Encum- brances Land & Land Improve- ments Building and Building Improve- ments Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Land & Land Improve- ments Building and Building Improve- ments Construc- tion in Process Total Accumu-lated Depreci-ation Date of Construction Date Acquired Life on which depreciation in latest income statement is computed Fieldstone at Pear Orchard Yakima Washington $ 10,791 $ 1,035 $ — $ 102 $ 13,498 $ — $ 1,137 $ 13,498 $ — $ 14,635 $ (733 ) 2016 10/12/2015 (1) The Shores at Lake Phalen Maplewood, Minnesota ("St. Paul") $ 16,859 $ 2,724 $ 25,093 $ 10 $ 55 $ — $ 2,734 $ 25,148 $ — $ 27,882 $ (2,158 ) 2012 11/10/2015 (1) Dogwood Forrest of Grayson Grayson, Georgia $ 16,400 $ 1,788 $ — $ 109 $ 22,257 $ — $ 1,897 $ 22,257 $ — $ 24,154 $ (910 ) 2017 11/24/2015 (1) Center One Jacksonville, Florida $ — $ 8,294 $ 21,756 $ 34 $ 173 $ — $ 8,328 $ 21,929 $ — $ 30,257 $ (1,789 ) 2006 11/30/2015 (1) Red Bank Professional Office Building Cincinnati, Ohio $ — $ 1,721 $ 7,721 $ — $ 11 $ — $ 1,721 $ 7,732 $ — $ 9,453 $ (618 ) 2001 12/14/2015 (1) Park Place Senior Living at WingHaven O'Fallon, Missouri ("St. Louis") $ — $ 1,283 $ 48,221 $ 40 $ 398 $ — $ 1,323 $ 48,619 $ — $ 49,942 $ (3,839 ) 2006/2014 12/17/2015 (1) Siena Pavilion IV Henderson, Nevada ("Las Vegas") $ — $ 1,454 $ 4,786 $ — $ 12 $ — $ 1,454 $ 4,798 $ — $ 6,252 $ (385 ) 2002 12/18/2015 (1) Siena Pavilion V Henderson, Nevada ("Las Vegas") $ — $ 3,944 $ 20,355 $ — $ 34 $ — $ 3,944 $ 20,389 $ — $ 24,333 $ (1,607 ) 2003 12/18/2015 (1) Siena Pavilion VI Henderson, Nevada ("Las Vegas") $ — $ 2,599 $ 18,725 $ — $ 76 $ — $ 2,599 $ 18,801 $ — $ 21,400 $ (1,390 ) 2005 12/18/2015 (1) Hearthside Senior Living of Collierville Collierville, Tennessee ("Memphis") $ — $ 1,756 $ 13,379 $ 7 $ 18 $ — $ 1,763 $ 13,397 $ — $ 15,159 $ (1,122 ) 2014 12/29/2015 (1) Cobalt Rehabilitation Hospital Surprise Surprise, Arizona ("Phoenix") $ 14,829 $ 2,464 $ 17,983 $ — $ — $ — $ 2,464 $ 17,983 $ — $ 20,447 $ (1,404 ) 2015 12/30/2015 (1) Cobalt Rehabilitation Hospital New Orleans New Orleans, Louisiana $ 19,055 $ 3,283 $ 20,142 $ — $ — $ — $ 3,283 $ 20,142 $ — $ 23,425 $ (1,050 ) 2016 10/19/2016 (1) Albuquerque, New Mexico - Unimproved Land Albuquerque, New Mexico $ — $ 1,056 $ — $ — $ — $ — $ 1,056 $ — $ — $ 1,056 $ — — 9/7/2017 $ 1,036,667 $ 240,642 $ 2,226,500 $ 12,603 $ 230,446 $ 3,490 $ 253,244 $ 2,456,947 $ 3,490 $ 2,713,680 $ (279,645 ) CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION AS OF DECEMBER 31, 2018 (in thousands) Transactions in real estate and accumulated depreciation as of December 31, 2018 are as follows: Balance December 31, 2015 $ 2,588,903 Balance December 31, 2015 $ (90,201 ) 2016 Acquisitions 23,425 2016 Depreciation (63,745 ) 2016 Improvements 97,767 2016 Accumulated depreciation on dispositions 822 2016 Dispositions (18,021 ) Balance December 31, 2016 (153,124 ) Balance December 31, 2016 2,692,074 2017 Depreciation (66,333 ) 2017 Acquisitions 1,056 Balance December 31, 2017 (219,457 ) 2017 Improvements 28,675 2018 Depreciation (60,821 ) Balance December 31, 2017 2,721,805 2018 Accumulated depreciation on dispositions 633 2018 Improvements 9,052 Balance December 31, 2018 $ (279,645 ) 2018 Dispositions (5,359 ) 2018 Impairments (11,818 ) Balance December 31, 2018 $ 2,713,680 FOOTNOTES: (1) (2) .

SCHEDULE IV-Mortgage Loans on R

SCHEDULE IV-Mortgage Loans on Real Estate	12 Months Ended
	Dec. 31, 2018
Mortgage Loans On Real Estate [Abstract]
SCHEDULE IV-Mortgage Loans on Real Estate	CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES YEARS ENDED DECEMBER 31, 2018, 2017 AND 2016 (in thousands) The following is a reconciliation of mortgages and other notes receivable on real estate for the years ended December 31, 2018, 2017 and 2016 (in thousands): 2018 2017 2016 Balance at beginning of year $ 1,179 $ — $ — Additions during period: New mortgage loans and additional advances 432 1,168 ― Accrued and deferred interest 77 11 ― Deductions during period: Collection of principal ― ― ― Balance at end of year $ 1,688 $ 1,179 $ —

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation — The accompanying consolidated financial statements include the Company’s accounts, the accounts of wholly owned subsidiaries or subsidiaries for which the Company has a controlling interest, the accounts of VIEs in which the Company is the primary beneficiary, and the accounts of other subsidiaries over which the Company has a controlling financial interest. All material intercompany accounts and transactions have been eliminated in consolidation. In accordance with the guidance for the consolidation of a VIE, the Company is required to identify entities for which control is achieved through means other than voting rights and to determine the primary beneficiary of its VIEs. The Company qualitatively assesses whether it is the primary beneficiary of a VIE and considers various factors including, but not limited to, the design of the entity, its organizational structure including decision-making ability and financial agreements, its ability and the rights of others to participate in policy making decisions, as well as its ability to replace the VIE manager and/or liquidate the entity.
Use of Estimates	Use of Estimates — The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted stock shares issued to the Advisor. Accordingly, actual results could differ from those estimates.
Allocation of Purchase Price for Real Estate Acquisitions	Allocation of Purchase Price for Real Estate Acquisitions — Upon acquisition of real estate, the Company first determines whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets in order to determine whether the acquisition should be accounted for as an asset acquisition. If the substantially all threshold is not met, the Company then determines whether the acquisition meets the definition of a business (i.e. does it include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create outputs). The Company estimates the fair value of acquired tangible assets (consisting of land, building and improvements, tenant improvements and equipment), intangible assets (consisting of in-place leases and above- or below-market leases), liabilities assumed and any contingent assets or liabilities in order to allocate the purchase price. In estimating the fair value of the assets acquired and liabilities assumed, the Company considers information obtained about each property as a result of its due diligence and utilizes various valuation methods, such as estimated cash flow projections using appropriate discount and capitalization rates, estimates of replacement costs net of depreciation and available market information. The fair value of the tangible assets of an acquired leased property is determined by valuing the property as if it were vacant, and the “as-if-vacant” value is then allocated to land and building. 2. Summary of Significant Accounting Policies (continued) The purchase price is allocated to in-place lease intangibles based on management’s evaluation of the specific characteristics of the acquired lease(s). Factors considered include estimates of carrying costs during hypothetical expected lease-up periods, including estimates of lost rental income during the expected lease-up periods, and costs to execute similar leases such as leasing commissions, legal and other related expenses. Above- and below-market lease intangibles are recorded based on the present value of the difference between the contractual rents to be paid pursuant to the lease and management’s estimate of the fair market lease rates for each in-place lease and may include assumptions for lease renewals of below-market leases. The Company also enters into contingent purchase price consideration arrangements in connection with acquisitions, which result in either an asset or liability being recognized as part of the purchase price allocation. In calculating the estimated fair value of contingent purchase price consideration arrangements, the Company considers information obtained during the due diligence and budget process as well as discount rates to determine the fair value. The Company evaluates the fair value of the arrangements at each reporting period and records any adjustments to the fair value as a component of operating income (expense) in the consolidated statement of operations.
Depreciation and Amortization	Depreciation and Amortization — Real estate costs related to the acquisition and improvement of properties are capitalized. Repair and maintenance costs are charged to expense as incurred and significant replacements and improvements are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Real estate assets are stated at cost less accumulated depreciation, which is computed using the straight-line method of accounting over the estimated useful lives of the related assets. Buildings and improvements are depreciated on the straight-line method over their estimated useful lives, which generally are the lesser of 39 and 15 years, respectively, or the remaining life of the ground lease. Amortization of intangible assets is computed using the straight-line method of accounting over the shorter of the respective lease term or estimated useful life. If a lease is terminated or modified prior to its scheduled expiration, the Company recognizes a loss on lease termination related to the unamortized lease-related costs not deemed to be recoverable.
Impairment of Real Estate Assets	Impairment of Real Estate Assets — Real estate assets are reviewed on an ongoing basis to determine whether there are any indicators, including property operating performance and general market conditions, that the value of the real estate properties (including any related amortizable intangible assets or liabilities) may be impaired. To assess if an asset group is potentially impaired, management compares the estimated current and projected undiscounted cash flows, including estimated net sales proceeds, of the asset group over its remaining useful life to the net carrying value of the asset group. Such cash flow projections consider factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition and other factors. In the event that the carrying value exceeds the undiscounted operating cash flows, the Company would recognize an impairment provision to adjust the carrying value of the asset group to the estimated fair value less costs to sell. When impairment indicators are present for real estate indirectly owned, through an investment in a joint venture or other similar investment structure accounted for under the equity method, the Company compares the estimated fair value of its investment to the carrying value. An impairment charge will be recorded to the extent fair value of the investment is less than the carrying value and the decline in value is determined to be other than a temporary decline.
Real Estate Under Development	Real Estate Under Development — The Company records real estate under development at cost, including acquisition fees and closing costs incurred. The cost of the real estate under development includes direct and indirect costs of development, including interest and miscellaneous costs incurred during the development period until the project is substantially complete and available for occupancy. In addition, during active development, all operating expenses related to the project, including property expenses such as real estate taxes and insurance, are capitalized rather than expensed and incidental revenue is recorded as a reduction of capitalized development costs. Preleasing costs are expensed as incurred.
Assets Held For Sale Net And Discontinued Operations	Assets Held For Sale, net and Discontinued Operations — The Company determines to classify a property as held for sale once management has the authority to approve and commits to a plan to sell the property, the property is available for immediate sale, there is an active program to locate a buyer, the sale of the property is probable and the transfer of the property is expected to occur within one year. Upon the determination to classify a property as held for sale, the Company ceases recording further depreciation and amortization relating to the associated assets and those assets are measured at the lower of its carrying amount or fair value less disposition costs and are presented separately in the consolidated balance sheets for all periods presented. In addition, the Company classifies assets held for sale as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on the Company’s operations and financial results. For any disposal(s) qualifying as discontinued operations, the Company allocates interest expense and loan cost amortization that directly relates to either: (1) expense on mortgages and other notes payable collateralized by properties classified as discontinued operations; or (2) expense on the Company’s Credit Facilities, which is allocated based on the value of the properties that are classified as discontinued operations since these properties are included in the Credit Facilities’ unencumbered pool of assets and the related indebtedness is required to be repaid upon sale of the properties.
Capitalized Interest	Capitalized Interest — Interest and loan cost amortization attributable to funds used to finance real estate under development is capitalized as additional costs of development. The Company capitalizes interest at the weighted average interest rate of the Company’s outstanding indebtedness and based on its weighted average expenditures for the period. Capitalization of interest on a specific project ceases when the project is substantially complete and ready for occupancy. During the years ended December 31, 2018, 2017 and 2016, the Company incurred interest expense and loan cost amortization of approximately $41.9 million, $38.2 million and $34.8 million, respectively, of which approximately $0.0 million, $2.1 million and $2.8 million, respectively, was capitalized according to this policy.
Cash	Cash — Cash consists of demand deposits at commercial banks. The Company also invests in cash equivalents consisting of highly liquid investments in money market funds with original maturities of three months or less. As of December 31, 2018, certain of the Company’s cash deposits exceeded federally insured amounts. However, the Company continues to monitor the third-party depository institutions that hold the Company’s cash, primarily with the goal of safeguarding principal. The Company attempts to limit cash investments to financial institutions with high credit standing; therefore, the Company believes it is not exposed to any significant credit risk on cash.
Restricted Cash	Restricted Cash — Certain amounts of cash are escrowed to fund capital expenditures, property taxes and/or insurance as required by loan or lease terms, and certain security deposits represent restricted use funds.
Loan Costs	Loan Costs — Financing costs paid in connection with obtaining debt are deferred and amortized over the estimated life of the debt using the effective interest method. As of December 31, 2018 and 2017, the accumulated amortization of loan costs was approximately $13.1 million and $10.0 million, respectively.
Deferred Lease-Related Costs	Deferred Lease-Related Costs – The Company defers lease-related costs that it incurs to obtain new or extend existing leases. The Company amortizes these costs using the straight-line method of accounting over the shorter of the respective lease term or estimated useful life. If a lease is terminated or modified prior to its scheduled expiration, the Company recognizes a loss on lease termination related to the unamortized deferred lease-related costs not deemed to be recoverable.
Revenue Recognition	Revenue Recognition — Rental income and tenant reimbursements includes rental income that is recorded on the straight-line basis over the terms of the leases for new leases and the remaining terms of existing leases for those acquired as part of a property acquisition. The straight-line method records the periodic average amount of base rent earned over the term of a lease, taking into account contractual rent increases over the lease term. The Company records the difference between base rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to deferred rent and lease incentives in the accompanying consolidated balance sheets. Rental income and tenant reimbursements also includes amounts for which tenants are required to reimburse the Company related to expenses incurred on behalf of the tenants, in accordance with the terms of the leases. Tenant reimbursements are recognized in the period in which the related reimbursable expenses are incurred, such as real estate taxes, common area maintenance, and similar items. Some of the Company’s leases require the tenants to pay certain additional contractual amounts that are set aside by the Company for replacements of fixed assets and other improvements to the properties. These amounts are and will remain the property of the Company during and after the term of the lease. The amounts are recorded as capital improvement reserve income at the time such amounts are earned and are included in rental income and tenant reimbursements in the accompanying consolidated statement of operations. Additional percentage rent that is due contingent upon tenant performance thresholds, such as gross revenues, is deferred until the underlying performance thresholds have been achieved. Resident fees and services are operating revenues relating to the Company’s managed seniors housing properties, which are operated under RIDEA structures. Resident fees and services directly relate to the provision of monthly goods and services that are generally bundled together under a single resident agreement. The Company accounts for its resident agreements as a single performance obligation under ASC 606 given the Company’s overall promise to provide a series of stand-ready goods and services to its residents each month. Resident fees and services are recorded in the period in which the goods are provided and the services are performed and generally consist of (1) monthly rent, which covers occupancy of the residents’ unit as well as basic services, such as utilities, meals and certain housekeeping services, and (2) service level charges, such as assisted living care, memory care and ancillary services. Resident agreements are generally short-term in nature, billed monthly in advance and cancelable by the residents with a 30-day notice. Resident agreements may require the payment of upfront fees prior to moving into the community with any non-refundable portion of such fees being recorded as deferred revenue and amortized over the estimated resident stay.
Reclassifications	Reclassifications – Certain amounts in the prior years’ consolidated balance sheet, statements of operations and statements of cash flows have been reclassified to conform to the current year’s presentation, primarily related to classification of certain properties as held for sale and/or discontinued operations, with no effect on the other previously reported consolidated financial statements. In addition, certain amounts in the statements of operations have been reclassified to change the presentation of Company’s gain on sale of real estate and include it as a component of operating income in accordance with ASC 360-10-45-5 as a result of the SEC’s elimination of Rule 3-15(a) of Regulation S-X as part of Release No. 33-10532; 34-83875; IC-33203, which had previously required REITs to present any gains or losses on the sale of real estate outside of continuing operations.
Derivative Financial Instruments	Derivative Financial Instruments — The Company and an unconsolidated equity method investment held by the Company use or have used derivative financial instruments to partially offset the effect of fluctuating interest rates on the cash flows associated with its variable-rate debt. Upon entry into a derivative, the Company or its unconsolidated equity method investment formally designates and documents the financial instrument as a hedge of a specific underlying exposure, as well as the risk management objectives and strategies for undertaking the hedge transaction. The Company or its unconsolidated equity method investment accounts for derivatives through the use of a fair value concept whereby the derivative positions are stated at fair value in the accompanying consolidated balance sheets. The fair value of derivatives used to hedge or modify risk fluctuates over time. As such, the fair value amounts should not be viewed in isolation, but rather in relation to the cash flows or fair value of the underlying hedged transaction and to the overall reduction in the exposure relating to adverse fluctuations in interest rates on the Company’s or its unconsolidated equity method investment’s variable-rate debt. Realized and unrealized gain (loss) on derivative financial instruments designated by either the Company or its unconsolidated equity method investment as cash flow hedges are reported as a component of other comprehensive income (loss), a component of stockholders’ equity, in the accompanying consolidated statements of comprehensive income (loss) to the extent they are effective; reclassified into earnings on the same line item associated with the hedged transaction and in the same period the hedged transaction affects earnings. Realized and unrealized gain (loss) on derivative financial instruments designated as cash flow hedges that are entered into by the Company’s equity method investment are reported as a component of the Company’s other comprehensive income (loss) in proportion to the Company’s ownership percentage in the investment, with reclassifications being included in equity in earnings (loss) of unconsolidated entity in the accompanying consolidated statements of operations.
Fair Value Measurements	Fair Value Measurements — Fair value assumptions are based on the framework established in the fair value accounting guidance under GAAP. The framework specifies a hierarchy of valuation inputs which was established to increase consistency, clarity and comparability in fair value measurements and related disclosures. The guidance describes the following fair value hierarchy based upon three levels of inputs that may be used to measure fair value, two of which are considered observable and one that is considered unobservable: • Level 1 — Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. • Level 2 — Inputs, other than quoted prices included in Level 1, that are observable for the asset or liability either directly or indirectly; such as, quoted prices for similar assets or liabilities or other inputs that can be corroborated by observable market data. • Level 3 — Unobservable inputs for the asset or liability, which are typically based on the Company’s own assumptions, as there is little, if any, related market activity. When market data inputs are unobservable, the Company utilizes inputs that it believes reflects the Company’s best estimate of the assumptions market participants would use in pricing the asset or liability. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement.
Mortgages and Other Notes Payable	Mortgages and Other Notes Payable — Mortgages and other notes payable are recorded at the stated principal amount and are generally collateralized by the Company’s properties. Mortgages and other notes payable assumed in connection with an acquisition are recorded at fair market value as of the date of the acquisition.
Redemptions	Redemptions — Under the Company’s Redemption Plan, a stockholder’s shares were deemed to have been redeemed as of the date that the Company accepted the stockholder’s request for redemption. From and after such date, the stockholder by virtue of such redemption was no longer entitled to any rights as a stockholder in the Company. Shares redeemed were retired and not available for reissue.
Net Loss per Share	Net Loss per Share — Net loss per share is calculated based upon the weighted average number of shares of common stock outstanding during the period in which the Company was operational.
Share Based Payments to Non-Employees	Share Based Payments to Non-Employees — In connection with the expense support agreement described in Note 11. “Related Party Arrangements,” the Company may issue Restricted Stock to the Advisor on an annual basis in exchange for providing expense support in the event that cash distributions declared exceed MFFO as defined by the expense support agreement. The Restricted Stock is forfeited if shareholders do not ultimately receive their original invested capital back with at least a 6% annualized return of investment upon a future liquidity or disposition event of the Company. Upon issuance of Restricted Stock, the Company measures the fair value at its then-current lowest aggregate fair value pursuant to ASC 505-50. On the date in which the Advisor satisfies the vesting criteria, the Company remeasures the fair value of the Restricted Stock pursuant to ASC 505-50 and records expense equal to the difference between the original fair value and that of the remeasurement date. In addition, given that performance is outside the control of the Advisor and involves both market conditions and counterparty performance conditions, the shares are treated as unissued for accounting purposes and the Company only includes the Restricted Stock in the calculation of diluted earnings per share to the extent their effect is dilutive and the vesting conditions have been satisfied as of the reporting date. Pursuant to the expense support agreement, the Advisor shall be the record owner of the Restricted Stock until the shares of common stock are sold or otherwise disposed of, and shall be entitled to all of the rights of a stockholder of the Company including, without limitation, the right to vote such shares (to the extent permitted by the Company’s articles of incorporation) and receive all dividends and other distributions paid with respect to such shares. All dividends or other distributions actually paid to the Advisor in connection with the Restricted Stock shall vest immediately and will not be subject to forfeiture. The Company recognizes expense related to the dividends on the Restricted Stock shares as declared.
Segment Information	Segment Information — Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and assess performance. The Company has determined that it operates in one operating segment, real estate ownership. The Company’s chief operating decision maker evaluates the Company’s operations from a number of different operational perspectives including, but not limited to, a property-by-property basis, by tenant or by operator. The Company derives all significant revenues from a single reportable operating segment of business, healthcare real estate, regardless of the type (seniors housing, medical office, etc.) or ownership structure (leased or managed). Accordingly, the Company does not report segment information; nevertheless, management periodically evaluates whether the Company continues to have one single reportable segment of business.
Redeemable Noncontrolling Interests	Redeemable Noncontrolling Interest – The Company classifies redeemable equity securities in accordance with Accounting Standard Update (“ASU”) No. 2009-04, “Liabilities (Topic 480): Accounting for Redeemable Equity Instruments,” which requires that equity securities redeemable at the option of the holder be classified outside of permanent stockholders’ equity. The Company classifies redeemable equity securities as redeemable noncontrolling interest within the accompanying consolidated balance sheets and consolidated statements of stockholders’ equity and redeemable noncontrolling interest. The Company evaluates the probability that these equity securities will become redeemable at each reporting period and, if determined probable, the Company measures the redemption value and records an adjustment to the carrying value of the equity securities as a component of redeemable noncontrolling interest.
Promoted Interest	Promoted Interest – The Company accounts for promoted interests with third-party developers in a manner similar to redeemable noncontrolling interests discussed above. The Company records the initial carrying value of the promoted interest at its issuance date fair value. Subsequently, as the completed developments stabilize and it becomes probable that the promoted interest thresholds will be met, the Company records a liability equal to the estimated redemption value at the end of each reporting period based on the conditions that exist as of the balance sheet date. In connection with the measurement of this liability, the Company records, as a reduction to capital in excess of par value, an amount equal to the difference between the promoted interests’ carrying value and the consideration paid or payable.
Acquisition Fees and Expenses	Acquisition Fees and Expenses — Acquisition fees, including investment services fees and expenses associated with transactions deemed to be business combinations (including investment transactions that are no longer under consideration), are expensed as incurred. Acquisition fees and expenses associated with making loans and with transactions deemed to be an asset purchase are capitalized.
Income Taxes	Income Taxes — The Company has elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended and related regulations beginning with the year ended December 31, 2012. In order to be taxed as a REIT, the Company is subject to certain organizational and operational requirements, including the requirement to make distributions to its stockholders each year of at least 90% of its annual REIT taxable income (which is computed without regard to the dividends-paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). If the Company qualifies for taxation as a REIT, the Company generally will not be subject to U.S. federal income tax on income that the Company distributes as dividends. If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to U.S. federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the IRS grants the Company relief under certain statutory provisions. Even if the Company qualifies for taxation as a REIT, it may be subject to certain state and local taxes on its income and property, and U.S. federal income and excise taxes on its undistributed income. The Company has and will continue to form subsidiaries which may elect to be taxed as a TRS for U.S. federal income tax purposes. Under the provisions of the Internal Revenue Code and applicable state laws, a TRS will be subject to tax on its taxable income from its operations. The Company will account for federal and state income taxes with respect to a TRS using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities, the respective tax bases, operating losses and/or tax-credit carryforwards.
Investments in Unconsolidated Entities	Investment in Unconsolidated Entity — The Company accounts for its investment in an unconsolidated joint venture under the equity method of accounting as the Company exercises significant influence, but does not maintain a controlling financial interest over these entities. The investment is recorded initially at cost and subsequently adjusted for cash contributions, distributions and equity in earnings (loss) of the unconsolidated entity. Based on the joint venture’s structure and any preference the Company receives on distributions and liquidation, the Company records its equity in earnings (loss) of the unconsolidated entity under the HLBV method of accounting. Under this method, the Company recognizes income or loss in each period as if the net book value of the assets in the venture were hypothetically liquidated at the end of each reporting period pursuant to the provisions of the joint venture agreement. In any given period, the Company could be recording more or less equity in earnings (loss) than actual cash distributions received or an investment balance that is more or less than what the Company may receive in the event of an actual liquidation. The Company determines whether distributions are classified as returns on investment or returns of investment based on the nature of the distribution. The Company’s investment in the unconsolidated entity was accounted for as an asset acquisition in which acquisition fees and expenses were capitalized as part of the basis in the investment in unconsolidated entity. These capitalized acquisition fees and expenses create an outside basis difference that are allocated to the assets of the investee and, if assigned to depreciable or amortizable assets, the basis differences are then amortized as a component of equity in earnings (loss) of unconsolidated entity.
Adopted Accounting Pronouncements	Adopted Accounting Pronouncements — In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers,” as a new ASC topic (Topic 606). The core principle of this ASU is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU further provides guidance for any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards (for example, lease contracts). The FASB subsequently issued ASU 2015-14 to defer the effective date of ASU 2014-09 until annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with earlier adoption permitted. In addition, the FASB issued ASU 2017-05, "Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20)," which clarifies the scope of subtopic 610-20, that was issued as a part of ASU 2014-09, as it relates to in-substance nonfinancial assets and must be adopted concurrently with ASC 606. Both ASUs can be adopted using one of two retrospective transition methods: (i) retrospectively to each prior reporting period presented or (ii) as a cumulative-effect adjustment as of the date of adoption. The Company adopted these ASUs using the modified retrospective approach as its transition method on January 1, 2018; the adoption of which did not have a material impact to its consolidated financial statements. In August 2017, the FASB issued ASU 2017-12 “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” which amended the hedge accounting model to better reflect an entity’s risk management activities. The ASU expands an entities ability to hedge nonfinancial and financial risk components as well as reduce the complexity related to fair value hedges of interest rate risk. The ASU further eliminates the requirement to separately measure and report hedge ineffectiveness and generally requires the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item. The ASU is effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2018. The Company early adopted this ASU prospectively on January 1, 2018; the adoption of which did not have a material impact on the Company’s consolidated results of operations or cash flows.
Recent Accounting Pronouncements	Recent Accounting Pronouncements — In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842): Accounting for Leases,” which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The ASU requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by all leases with terms of more than 12 months. The ASU further modifies lessors’ classification criteria for leases and the accounting for sales-type and direct financing leases. The ASU also requires qualitative and quantitative disclosures designed to give financial statement users additional information on the amount, timing, and uncertainty of cash flows arising from leases. In July 2018, the FASB issued ASU 2018-11, “Leases (Topic 842): Targeted Improvements,” which includes a practical expedient for lessors that allows them to elect to not separate lease and non-lease components in a contract for the purpose of revenue recognition and disclosure if certain criteria are met. The Company elected the practical expedient and applied the guidance to all of the leases that qualified under the established criteria. In December 2018, the FASB issued ASU 2018-20, “Leases (Topic 842): Narrow-Scope Improvements for Lessors” which addressed challenges encountered in determining certain lessor costs paid by the lessee directly to third parties by allowing lessors to exclude these costs from its variable lease payments. This amendment did not have a material impact on the Company’s financial statements and related disclosures as it conformed ASC 842 to the Company’s historical accounting under ASC 840. All of the ASC 842 ASU’s are effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2018. The Company adopted these ASU’s on January 1, 2019 using a modified retrospective approach, which impacted the Company’s consolidated financial statements and related financial statement disclosures; specifically, the Company’s consolidated financial position as it relates to the required presentation for arrangements such as ground or other leases in which the Company is the lessee. However, the adoption of this ASU did not have a material impact on the Company’s consolidated results of operations or cash flows. 2. Summary of Significant Accounting Policies (continued) In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments (Topic 326),” which requires a new forward-looking expected loss model to be used for receivables, held-to-maturity debt, loans and other financial instruments. Previously, when credit losses were measured under current GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. The amendments eliminate the probable initial threshold for recognition of credit losses in current GAAP and, instead, reflect an entity’s current estimate of all expected credit losses over the life of the financial instrument. The ASU is effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2019. The Company has determined it will adopt this ASU on January 1, 2020 and is currently evaluating the impact of adoption on its consolidated financial statements. In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting,” which expands the scope to include share-based payment transactions for acquiring goods and services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payments. The amendments also clarify that this ASU does not apply to share-based payments used to provide financing to the issuer or awards granted in conjunction with selling of goods or services to customers as a part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). The ASU is effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2018. The Company adopted this ASU prospectively on January 1, 2019; the adoption of which did not have a material impact on the Company’s consolidated results of operations or cash flows.

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2018
Revenue From Contract With Customer [Abstract]
Summary of Disaggregation of Revenue	The following tables represent the disaggregated revenue for resident fees and services during the years ended December 31, 2018, 2017 and 2016: Years Ended December 31, Number of Units Revenue (in millions) Percentage of Revenues Resident fees and services: 2018 2017 2016 2018 2017 2016 2018 2017 2016 Independent living 2,261 2,261 1,983 $ 71.7 $ 59.5 $ 46.8 25.9 % 23.9 % 20.1 % Assisted living 2,966 2,966 2,745 137.6 128.8 122.8 49.7 % 51.7 % 52.8 % Memory care 853 853 742 54.4 48.9 48.0 19.7 % 19.6 % 20.7 % Other revenues ― ― ― 12.9 11.7 14.8 4.7 % 4.8 % 6.4 % 6,080 6,080 5,470 $ 276.6 $ 248.9 $ 232.4 100.0 % 100.0 % 100.0 %

Real Estate Assets, net (Tables

Real Estate Assets, net (Tables)	12 Months Ended
	Dec. 31, 2018
Real Estate [Abstract]
Schedule of Real Estate Investment Properties Excluding Assets Held For Sale	The gross carrying amount and accumulated depreciation of the Company’s real estate assets as of December 31, 2018 and 2017 are as follows, excluding assets held for sale (in thousands): As of December 31, 2018 2017 Land and land improvements $ 130,133 $ 129,684 Building and building improvements 1,475,789 1,472,257 Furniture, fixtures and equipment 81,666 75,111 Less: accumulated depreciation (232,439) (181,478 ) Real estate investment properties, net $ 1,455,149 $ 1,495,574

Intangibles, net (Tables)

Intangibles, net (Tables)	12 Months Ended
	Dec. 31, 2018
Goodwill And Intangible Assets Disclosure [Abstract]
Schedule of Net Book Value of Intangibles	The gross carrying amount and accumulated amortization of the Company’s intangible assets as of December 31, 2018 and 2017 are as follows (in thousands): As of December 31, 2018 2017 In-place lease intangibles $ 83,113 $ 83,113 Less: accumulated amortization (81,499 ) (79,001 ) Intangible assets, net $ 1,614 $ 4,112
Schedule of Estimated Future Amortization	The estimated future amortization on the Company’s intangibles for each of the next five years and thereafter, in the aggregate, as of December 31, 2018 is as follows (in thousands): 2019 $ 394 2020 394 2021 394 2022 253 2023 74 Thereafter 105 $ 1,614

Assets and Associated Liabili_2

Assets and Associated Liabilities Held For Sale and Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2018
Real Estate Liabilities Associated With Assets Held For Development And Sale [Abstract]
Schedule of Assets Classified as Held for Sale and Liabilities Associated with Those Assets Held for Sale	As of December 31, 2018, the 70 properties classified as assets held for sale and liabilities associated with those assets held for sale consisted of the following (in thousands): As of December 31, 2018 MOB/Healthcare Portfolio Other Total Real estate held for sale, net $ 952,656 $ 51,339 $ 1,003,995 Real estate under development 3,490 ― 3,490 Intangibles, net 82,417 800 83,217 Deferred rent and lease incentives 36,562 6,501 43,063 Other assets 11,425 182 11,607 Restricted cash 2,013 260 2,273 Assets held for sale, net $ 1,088,563 $ 59,082 $ 1,147,645 Mortgages and other notes payable $ 492,701 $ 8,097 $ 500,798 Credit facilities 212,731 34,778 247,509 Other liabilities 16,653 634 17,287 Accounts payable and accrued liabilities 8,425 ― 8,425 Liabilities associated with assets held for sale $ 730,510 $ 43,509 $ 774,019 6. Assets and Associated Liabilities Held For Sale and Discontinued Operations (continued) As of December 31, 2017, the 71 assets classified as held for sale and liabilities associated with those assets consisted of the following (in thousands): As of December 31, 2017 MOB/Healthcare Portfolio Other Total Real estate held for sale, net $ 979,601 $ 59,914 $ 1,039,515 Intangibles, net 95,399 801 96,200 Deferred rent and lease incentives 30,353 6,357 36,710 Other assets 9,225 215 9,440 Restricted cash 2,532 353 2,885 Assets held for sale, net $ 1,117,110 $ 67,640 $ 1,184,750 Mortgages and other notes payable $ 492,655 $ — $ 492,655 Credit facilities 218,174 39,149 257,323 Other liabilities 19,388 1,678 21,066 Accounts payable and accrued liabilities 8,337 328 8,665 Liabilities associated with assets held for sale $ 738,554 $ 41,155 $ 779,709
Summary of Loss from Discontinued Operations	The following table is a summary of loss from discontinued operations for the years ended December 31, 2018, 2017 and 2016 (in thousands): Years Ended December 31, 2018 2017 2016 Revenues: Rental income and tenant reimbursements $ 114,719 $ 113,709 $ 111,856 Operating expenses: Property operating expenses 30,538 30,254 29,228 General and administrative 1,291 1,086 909 Acquisition fees and costs ― ― 768 Asset management fees 11,984 12,042 11,813 Property management fees 3,679 4,249 4,090 Financing coordination fees 2,326 ― ― Contingent purchase price consideration adjustment ― 47 (540 ) Impairment provision 4,392 ― ― Loss on lease terminations ― ― 785 Depreciation and amortization 31,961 43,567 45,396 Total operating expenses 86,171 91,245 92,449 Operating income 28,548 22,464 19,407 Other income (expense): Interest and other income (expense) 109 (73 ) 2 Interest expense and loan cost amortization (33,060 ) (30,089 ) (26,283 ) Total other expense (32,951 ) (30,162 ) (26,281 ) Loss before income taxes (4,403 ) (7,698 ) (6,874 ) Income tax expense (6 ) (75 ) (75 ) Loss from discontinued operations $ (4,409 ) $ (7,773 ) $ (6,949 )

Operating Leases (Tables)

Operating Leases (Tables)	12 Months Ended
	Dec. 31, 2018
Leases [Abstract]
Schedule of Future Minimum Lease Payments to be Received Under Non-Cancellable Operating Leases Excluding Properties Classified as Discontinued Operations	The following are future minimum lease payments to be received under non-cancellable operating leases for the next five years and thereafter, in the aggregate, as of December 31, 2018 (in thousands), excluding the 63 properties classified as discontinued operations: 2019 $ 34,070 2020 36,309 2021 37,073 2022 29,421 2023 18,506 Thereafter 50,655 $ 206,034

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	12 Months Ended
	Dec. 31, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Aggregate Carrying Amount and Major Classifications of Consolidated Assets	The aggregate carrying amount and major classifications of the consolidated assets that can be used to settle obligations of the VIEs and liabilities of the consolidated VIEs that are non-recourse to the Company as of December 31, 2018 and 2017 are as follows (in thousands): As of December 31, 2018 2017 Assets: Real estate investment properties, net $ 146,341 $ 174,263 Assets held for sale, net (1) $ 39,601 $ 44,998 Cash $ 342 $ 2,203 Other assets $ 678 $ 384 Deferred rent and lease incentives $ 7,160 $ 3,577 Restricted cash $ 208 $ 1,212 Liabilities: Mortgages and other notes payable, net $ 102,578 $ 118,378 Liabilities associated with assets held for sale (1) $ 30,695 $ 35,848 Accounts payable and accrued liabilities $ 784 $ 3,117 Accrued development costs $ — $ 909 Other liabilities $ 1,321 $ 947 FOOTNOTE: (1) Refer to Note 6. “Assets and Associated Liabilities Held For Sale and Discontinued Operations” for additional information.

Contingent Purchase Price Con_2

Contingent Purchase Price Consideration (Tables)	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Fair Value of Contingent Purchase Price Consideration	The following tables provide a roll-forward of the fair value of the Company’s aggregate contingent purchase price consideration for the years ended December 31, 2017 and 2016: Year Ended December 31, 2017 Property Beginning asset (liability) as of December 31, 2016 Contingent Consideration Payment (Receipt) Change in Fair Value Contingent Consideration in Connection with Acquisition Ending asset (liability) as of December 31, 2017 Superior Residences of Panama City (1) $ (4,000 ) $ 4,000 $ — $ — $ — $ (4,000 ) $ 4,000 $ — $ — $ — 9. Contingent Purchase Price Consideration (continued) Year Ended December 31, 2016 Property Beginning asset (liability) as of December 31, 2015 Contingent Consideration Payment (Receipt) Change in Fair Value Contingent Consideration in Connection with Acquisition Ending asset (liability) as of December 31, 2016 Superior Residences of Panama City (1) $ (3,000 ) $ — $ (1,000 ) $ — $ (4,000 ) The Shores of Lake Phalen (2) (750 ) — 750 — — $ (3,750 ) $ — $ (250 ) $ — $ (4,000 ) FOOTNOTES: (1) In connection with the purchase of Superior Residences of Panama City, the Company entered into an earn-out agreement with the seller whereby up to $4 million in additional consideration was owed in the event that certain performance targets were met (“Panama City Earn-Out”) during the immediate 36 months post-closing. As of December 31, 2017, the Company had no remaining obligations pursuant to the Panama City Earn-Out agreement. (2) In connection with the purchase of Shores of Lake Phalen, the Company entered into an earn-out agreement with the seller whereby up to $0.8 million in additional consideration was owed in the event that certain net operating income targets were met (“Shores of Lake Phalen Earn-Out”) during the immediate 12 months post-closing. The Shores of Lake Phalen Earn-Out expired as of December 31, 2016.

Indebtedness (Tables)

Indebtedness (Tables)	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Details of Indebtedness Excluding Assets Held For Sale	The following table provides details of the Company’s indebtedness as of December 31, 2018 and 2017, excluding indebtedness related to assets held for sale (in thousands): As of December 31, 2018 2017 Mortgages payable and other notes payable: Fixed rate debt $ 358,843 $ 368,873 Variable rate debt (1) (2) 174,046 174,058 Mortgages and other notes payable (3) 532,889 542,931 Premium (discount), net (4) 184 225 Loan costs, net (2,429) (3,658) Total mortgages and other notes payable, net 530,644 539,498 Credit facilities: Revolving Credit Facility (1) (2) (5) ― ― First Term Loan Facility (1) 151,616 99,435 Second Term Loan Facility (1) (2) 275,000 275,000 Loan costs, net related to Term Loan Facilities (1,003) (1,692) Total credit facilities, net 425,613 372,743 Total indebtedness, net $ 956,257 $ 912,241 FOOTNOTES: (1) As of December 31, 2018 and 2017, the Company had entered into interest rate swaps with notional amounts of approximately $151.6 million and $99.4 million, respectively, which were settling on a monthly basis. Refer to Note 12. “Derivative Financial Instruments” for additional information. In February 2019, the Company extended the term of its First Term Loan to February 2020, refer to Note 18. “Subsequent Events” for additional information. (2) As of December 31, 2018 and 2017, the Company had entered into interest rate caps with notional amounts of approximately $330.0 million and $330.0 million, respectively. In addition, as of December 31, 2018 the Company had entered into interest rate caps with forward effective dates with notional amounts of approximately $151.6 million in order to hedge the Company’s exposure to interest rate changes in future periods. Refer to Note 12. “Derivative Financial Instruments” for additional information. (3) As of December 31, 2018 and 2017, the Company’s mortgages and other notes payable are collateralized by 37 and 38 properties, respectively, with total carrying value of approximately $0.8 billion and $0.8 billion, respectively. (4) Premium (discount), net is reflective of the Company recording mortgage note payables assumed at fair value on the respective acquisition dates. (5) As of December 31, 2018 and 2017, the Company had undrawn availability under the Revolving Credit Facility of approximately $14.7 million and $28.4 million, respectively, based on the value of the properties in the unencumbered pool of assets supporting the loan, which includes certain assets held for sale.
Schedule of Maturities of Indebtedness	10. Indebtedness (continued) The following is a schedule of future principal payments and maturity for the Company’s total indebtedness for the next five years and thereafter, in the aggregate, as of December 31, 2018 (in thousands): 2019 $ 238,156 2020 404,822 2021 11,341 2022 282,496 2023 22,874 Thereafter ― $ 959,689
Schedule of Indebtedness	The following table details the Company’s mortgages and other notes payable as of December 31, 2018 and 2017, excluding assets held for sale (in thousands): Interest Rate at December 31, Maturity December 31, Property and Loan Type 2018 (1) Payment Terms Date (2) 2018 2017 Primrose II Communities; Mortgage Loan 3.81% per annum Monthly principal and interest payments based on a 30-year amortization schedule 6/1/20 $ 21,047 $ 21,541 Pacific Northwest Communities; Mortgage Loans (3) 4.30% per annum Monthly principal and interest payments based on a 25-year amortization schedule 1/5/22 202,978 208,990 Capital Health Communities; Mortgage Loans (4) (4) Monthly principal and interest payments based on a 25-year amortization schedule 1/5/22 60,902 62,767 Primrose I Communities; Mortgage Loan (5) 4.11% per annum Monthly principal and interest payments based on a 30-year amortization schedule 9/1/22 48,753 49,899 Watercrest at Mansfield; Mortgage Loan (6) 4.68% per annum Monthly principal and interest payments based on a total payment of $143,330 6/1/23 25,163 25,676 Total fixed rate debt 358,843 368,873 Shores of Lake Phalen; Secured Term Loan 30-day LIBOR plus 2.42% per annum Monthly interest only payments through June 2019 6/30/19 16,859 ― HarborChase of Shorewood; Construction Loan 30-day LIBOR plus 3% per annum Monthly interest only payments through June 2017; principal and interest payments thereafter based on a 25-year amortization schedule 7/5/19 ― 14,706 Wellmore of Lexington; Construction Loan 30-day LIBOR plus 2.5% per annum Monthly interest only payments through September 2019 9/13/19 35,421 33,423 Watercrest at Katy Construction Loan 30-day LIBOR plus 2.75% per annum Monthly principal and interest payments based on a 30-year amortization schedule 12/27/19 21,552 26,300 Wellmore of Tega Cay; Construction Loan (7) 30-day LIBOR plus 2.65% per annum Monthly interest only payments for the first 12 months; principal and interest payments thereafter based on a 30-year amortization schedule 3/1/20 27,715 28,000 Palmilla Senior Living; Mortgage Loan (7) 30-day LIBOR plus 2.0% per annum Monthly interest only payments through April 2017; principal and interest payments thereafter based on a 30-year amortization schedule 3/22/20 26,478 26,799 Waterstone on Augusta; Construction Loan 30-day LIBOR plus 3.0% per annum Monthly interest only payments through September 2018; principal and interest payments thereafter based on a 30-year amortization schedule 9/1/20 18,830 18,302 10. Indebtedness (continued) Interest Rate at December 31, Maturity December 31, Property and Loan Type 2018 (1) Payment Terms Date (2) 2018 2017 Fieldstone at Pear Orchard; Construction Loan 30-day LIBOR plus 2.9% per annum Monthly interest only payments through September 2018; principal payments thereafter based on a 25-year amortization schedule 10/15/20 $ 10,791 $ 10,900 Dogwood Forest of Grayson; Construction Loan 30-day LIBOR plus 3.0% per annum Monthly interest only payments through December 2018; principal payments thereafter based on a 30-year amortization schedule 12/1/20 16,400 15,628 Total variable rate debt 174,046 174,058 Total mortgages and other notes payable, net $ 532,889 $ 542,931 FOOTNOTES: (1) The 30-day and 90-day LIBOR were approximately 2.50% and 2.81%, respectively, as of December 31, 2018 and approximately 1.56% and 1.70%, respectively, as of December 31, 2017. (2) Represents the initial maturity date (or, as applicable, the maturity date as extended). Certain of the Company’s mortgages and other notes payable agreements include extension options held by the Company under which the maturity dates may be extended beyond the date presented, subject to certain lender conditions and/or related fees. (3) In August 2017, the Company extended the maturity date on the existing loan of approximately $201.9 million from December 2018 to January 2022. In addition, the Company received approximately $9.5 million of additional borrowings through a supplemental loan with the same lender, which is co-terminus with the existing mortgage loans, collateralized by the communities and matures in January 2022. The supplemental loan further accrues interest at a fixed rate equal to 4.3% per annum and includes monthly interest only payments for the first 12 months followed by monthly principal and interest payments for the remaining term of the loan using a 30-year amortization period with the remaining principal balance payable at maturity. The loan may be prepaid, in whole or in part, with a prepayment premium equal to the greater of: (i) one percent (1%) of the principal amount being prepaid, multiplied by the quotient of the number of full months remaining until the maturity date of the loan (calculated as of the prepayment date) divided by the number of full months comprising the term of the loan; or (b) a “make-whole” payment equal to the present value of the loan less the amount of principal and accrued interest being prepaid calculated as of the prepayment date for the period between that date and the maturity date . (4) In August 2017, the Company extended the maturity date on the existing loan of approximately $35.4 million from January 2020 to January 2022. In addition, the Company received approximately $28.0 million of additional borrowings through a supplemental loan with the same lender, which is co-terminus with the existing mortgage loans, collateralized by the communities and matures in January 2022. The existing loan accrues interest at a fixed rate equal to 4.25% per annum. The supplemental loan accrues interest at a fixed rate equal to 4.3% per annum and includes monthly interest only payments for the first 12 months followed by monthly principal and interest payments for the remaining term of the loan using a 30-year amortization period with the remaining principal balance payable at maturity. The loan may be prepaid, in whole or in part, with a prepayment premium equal to the greater of: (i) one percent (1%) of the principal amount being prepaid, multiplied by the quotient of the number of full months remaining until the maturity date of the loan (calculated as of the prepayment date) divided by the number of full months comprising the term of the loan; or (b) a “make-whole” payment equal to the present value of the loan less the amount of principal and accrued interest being prepaid calculated as of the prepayment date for the period between that date and the maturity date. 10. Indebtedness (continued) (5) If prepaid prior to March 1, 2022, the Primrose I Communities Mortgage Loan is subject to a prepayment penalty in an amount equal to the greater of (i) 1% of the principal being repaid, or (ii) an amount calculated on the principal being repaid, multiplied by the difference between the Primrose I Communities Mortgage Loan interest rate, and a calculated yield rate tied to the rates on applicable U.S. Treasuries. If prepayment is made between March 1, 2022, and May 31, 2022, the prepayment penalty will be 1% of the outstanding principal balance of the Primrose I Communities Mortgage Loan. No prepayment fee is required if the Primrose I Communities Mortgage Loan is prepaid between June 1, 2022 and maturity. Partial prepayment of a loan is not permitted. The loan is transferable upon sale of the assets subject to lender approval. (6) The balance for this loan excludes a remaining premium of $0.2 million related to the mortgage note payable assumed being recorded at fair value on the acquisition date. (7) The Company entered into an interest rate cap with a remaining notional amount of $117.0 million, of which a portion has been designated to hedge these loans; see Note 12. “Derivative Financial Instruments” for additional information. The following table details the Company’s mortgages and other notes payable included within the liabilities associated with assets held for sale as of December 31, 2018 and 2017 (in thousands): Interest Rate at December 31, Maturity December 31, Property and Loan Type 2018 (1) Payment Terms Date (2) 2018 2017 Novi Orthopaedic Center; Mortgage Loan 3.61% per annum Monthly interest only payments through June 2018; principal and interest payments thereafter based on a 25-year amortization schedule 6/15/20 $ 19,581 $ 19,825 ProMed Medical Building I; Mortgage Loan 3.64% per annum (3) Monthly principal and interest payments based upon a 30-year amortization schedule 1/15/22 6,473 6,673 540 New Waverly Place; Mortgage Loan 4.08% per annum Monthly principal and interest payments based upon a 25-year amortization schedule 5/31/28 6,452 6,665 LaPorte Cancer Center; Mortgage Loan 4.25% per annum (through 2020) Monthly principal and interest payments based on a 25-year amortization schedule 6/14/28 7,335 7,571 Total fixed rate debt 39,841 40,734 Calvert Medical Office Properties; Mortgage Loan 30-day LIBOR plus 2.50% per annum Monthly interest only payments for the first 18 months; principal and interest payments thereafter based on a 30-year amortization schedule 8/29/18 ― 25,121 Welbrook Senior Living Grand Junction; Secured Term Loan 30-day LIBOR plus 2.42% per annum Monthly interest only payments through June 2019 6/30/19 8,141 ― Medical Portfolio II Properties; Mortgage Loan (4) 90-day LIBOR plus 2.35% at 0.25% LIBOR floor Monthly principal and interest payments based on a 25-year amortization schedule 7/14/19 77,074 79,295 Northwest Medical Park; Mortgage Loan 30-day LIBOR plus 2.30% per annum Monthly principal and interest payments based upon a 25-year amortization schedule 10/31/19 6,628 6,765 Lee Hughes Medical Building; Mortgage Loan 30-day LIBOR plus 1.85% per annum Monthly principal and interest payments based on a 30-year amortization schedule 3/5/20 17,043 17,572 10. Indebtedness (continued) Interest Rate at December 31, Maturity December 31, Property and Loan Type 2018 (1) Payment Terms Date (2) 2018 2017 Triangle Orthopaedic; Mortgage Loan (5) 30-day LIBOR plus 2.25% per annum Interest only payments through March 2017; principal payments thereafter based on a 30-year amortization schedule 4/11/21 $ 36,962 $ 37,475 Cobalt Rehabilitation Hospital Surprise; Mortgage Loan 30-day LIBOR plus 2.6% per annum at 0.4% LIBOR floor Monthly interest only payments through May 2017; principal payments thereafter based on a 25-year amortization schedule 5/19/22 14,829 15,167 Knoxville Medical Office Properties and Claremont Medical Office; Mortgage Loan (6) 30-day LIBOR plus 2.45% per annum Monthly principal and interest payments based on a 30-year amortization schedule 5/24/22 51,575 57,350 Cobalt Rehabilitation Hospital New Orleans; Mortgage Loan 30-day LIBOR plus 2.45% per annum at 0.55% LIBOR floor Monthly interest only payments through October 2017; principal payments thereafter based on a 25-year amortization schedule 10/19/22 19,055 19,421 MHOSH;Mortgage Loan (7) 30-day LIBOR plus 2.20% per annum Interest only payments through June 2020; principal payments thereafter based on a 30-year amortization schedule 5/24/23 57,630 47,072 Southeast Medical Office Properties; Mortgage Loan (8) 30-day LIBOR plus 2.0% per annum Interest only payments through January 2021; principal payments thereafter based on a 30-year amortization schedule 6/14/23 175,000 149,864 Total variable rate debt 463,937 455,102 Total indebtedness associated with assets held for sale $ 503,778 $ 495,836 FOOTNOTES: (1) The 30-day and 90-day LIBOR were approximately 2.50% and 2.81%, respectively, as of December 31, 2018 and approximately 1.56% and 1.70%, respectively, as of December 31, 2017. (2) Represents the initial maturity date (or, as applicable, the maturity date as extended). Certain of the Company’s mortgages and other notes payable agreements include extension options held by the Company under which the maturity dates may be extended beyond the date presented, subject to certain lender conditions and/or related fees. (3) (4) The Company entered into an interest rate swap with a remaining notional amount of $79.2 million; see Note 12. “Derivative Financial Instruments” for additional information. (5) The Company entered into an interest rate cap with a remaining notional amount of $117.0 million, of which a portion has been designated to hedge this loan; see Note 12. “Derivative Financial Instruments” for additional information. (6) In May 2017, the Company refinanced the loans related to the Claremont Medical Office property and the Knoxville Medical Office Properties of approximately $12.4 million and $37.2 million, respectively, into a combined loan. The original loans were scheduled to mature January 2018 and July 2018, respectively. The Company entered into an interest rate swap with a remaining notional amount of $51.6 million; see Note 12. “Derivative Financial Instruments” for additional information. 10. Indebtedness (continued) (7) The Company entered into an interest rate cap with a remaining notional amount of $57.6 million; see Note 12. “Derivative Financial Instruments” for additional information. (8) The Company entered into an interest rate cap with a remaining notional amount of $125.1 million; see Note 12. “Derivative Financial Instruments” for additional information.
Schedule of Fair Market Value and Carrying Value of Indebtedness	The following table provides the details of the fair market value and carrying value of the Company’s indebtedness as of December 31, 2018 and 2017 (in millions): December 31, 2018 December 31, 2017 Fair Value Carrying Value Fair Value Carrying Value Mortgages and other notes payable, net $ 528.7 $ 530.6 $ 543.8 $ 539.5 Credit facilities $ 426.6 $ 425.6 $ 374.4 $ 372.7 Indebtedness associated with assets held for sale $ 751.8 $ 748.3 $ 748.7 $ 750.1

Related Party Arrangements (Tab

Related Party Arrangements (Tables)	12 Months Ended
	Dec. 31, 2018
Related Party Arrangement, Fees and Expenses Incurred By, Reimbursable, Settled and Paid	The expenses and fees incurred by and reimbursable to the Company’s related parties, including amounts included in the loss from discontinued operations for the years ended December 31, 2018, 2017 and 2016, and related amounts unpaid as of December 31, 2018 and 2017 are as follows (in thousands): Unpaid amounts (1) Years Ended December 31, as of December 31, 2018 2017 2016 2018 2017 Reimbursable expenses: Operating expenses (2) $ 6,203 $ 5,791 $ 5,966 $ 722 $ 1,042 Acquisition fees and expenses — 6 104 ― 2 6,203 5,797 6,070 722 1,044 Investment services fees (3) 60 126 739 — — Disposition fee (4) 58 — 343 — — Financing coordination fees (5) 2,326 3,601 — — — Property management fees (6) 2,323 4,807 5,059 — 381 Asset management fees (7) 30,385 30,157 29,121 2,533 2,516 $ 41,355 $ 44,488 $ 41,332 $ 3,255 $ 3,941 FOOTNOTES: (1) (2) (3) (4) (5) 11. Related Party Arrangements (continued) (6) (7)
Expense Support Agreements
Related Party Arrangement, Fees and Expenses Incurred By, Reimbursable, Settled and Paid	The following fees have been settled and paid in the form of Restricted Stock in accordance with the expense support agreements for the years ended December 31, 2018, 2017 and 2016, and cumulatively as of December 31, 2018 (in thousands, except per share data): Years Ended As of December 31, December 31, 2018 2017 2016 2018 Asset management fees (1) $ — $ — $ 2,918 $ 13,565 Then-current NAV (2) $ 10.01 (3) $ 10.32 $ 10.04 $ 10.01 Restricted stock shares (3) — — 291 1,332 Cash distributions on Restricted Stock (4) $ 630 $ 571 $ 427 $ 2,012 FOOTNOTES: (1) (2) (3) (4)

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2018
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Summary of Derivative Financial Instruments and Corresponding Asset (Liability), Including Properties Classified as Held for Sale	The following summarizes the terms of the Company’s derivative financial instruments and the corresponding asset (liability) as of December 31, 2018 and 2017, including properties classified as held for sale (in thousands): Fair value asset (liability) as of Notional Amount Strike (1) Credit Spread (1) Trade date Forward date Maturity date December 31, 2018 December 31, 2017 $ — (2) 1.3 % 2.6 % 1/17/2013 1/15/2015 1/16/2018 $ — $ 1 $ — (2) 2.7 % 2.5 % 9/6/2013 8/17/2015 7/10/2018 $ — $ (213 ) $ — (2) 2.8 % 2.5 % 9/6/2013 8/17/2015 8/29/2018 $ — $ (182 ) $ — (2)(3) 2.4 % 2.9 % 8/15/2014 6/1/2016 6/2/2019 $ — $ (280 ) $ 79,201 (2) 2.3 % 2.4 % 9/12/2014 8/1/2015 7/15/2019 $ 168 $ (424 ) $ 175,000 (2) 1.6 % 2.0 % 12/23/2014 12/19/2014 2/19/2019(5) $ 220 $ 464 $ 125,087 (2) 1.7 % 2.0 % 1/9/2015 12/10/2015 12/22/2019 $ 966 $ 516 $ — (3) 1.5 % — % 11/19/2015 11/19/2015 11/30/2018 $ — $ 681 $ — (4) 1.5 % — % 3/1/2016 3/1/2016 11/30/2018 $ — $ 393 $ 117,000 (4) 2.3 % — % 8/29/2017 8/29/2017 9/1/2019 $ 247 $ 95 $ 410,000 (4) 3.0 % — % 3/28/2018 11/30/2018 12/19/2019 $ 44 $ — $ 51,575 (4) 3.0 % — % 3/28/2018 7/10/2018 12/19/2019 $ 6 $ — $ 175,000 (4) 3.0 % — % 3/28/2018 2/19/2019 12/19/2019 $ 19 $ — $ 57,630 (4) 3.0 % — % 5/4/2018 5/4/2018 12/19/2019 $ 6 $ —
Summary of the Gross and Net Presentation of Amounts Related to the Derivative Financial Instruments	The following summarizes the gross and net presentation of amounts related to the Company’s, or its equity method investment’s, derivative financial instruments as of December 31, 2018 and 2017 (in thousands): Gross and net amounts of asset (liability) as of December 31, 2018 Gross amounts as of December 31, 2018 Notional amount Gross amount Offset amount Net amount Financial Instruments Cash Collateral Net Amount $ 79,201 (2) $ 168 $ — $ 168 $ 168 $ — $ 168 $ 175,000 (2) $ 220 $ — $ 220 $ 220 $ — $ 220 $ 125,087 (2) $ 966 $ — $ 966 $ 966 $ — $ 966 $ 117,000 (4) $ 247 $ — $ 247 $ 247 $ — $ 247 $ 410,000 (4) $ 44 $ — $ 44 $ 44 $ — $ 44 $ 51,575 (4) $ 6 $ — $ 6 $ 6 $ — $ 6 $ 175,000 (4) $ 19 $ — $ 19 $ 19 $ — $ 19 $ 57,630 (4) $ 6 $ — $ 6 $ 6 $ — $ 6 Gross and net amounts of asset (liability) as of December 31, 2017 Gross amounts as of December 31, 2017 Notional amount Gross amount Offset amount Net amount Financial Instruments Cash Collateral Net Amount $ 11,842 (2) $ 1 $ — $ 1 $ 1 $ — $ 1 $ 36,839 (2) $ (213 ) $ — $ (213 ) $ (213 ) $ — $ (213 ) $ 25,103 (2) $ (182 ) $ — $ (182 ) $ (182 ) $ — $ (182 ) $ 47,072 (2) $ (280 ) $ — $ (280 ) $ (280 ) $ — $ (280 ) $ 80,841 (2) $ (424 ) $ — $ (424 ) $ (424 ) $ — $ (424 ) $ 175,000 (2) $ 464 $ — $ 464 $ 464 $ — $ 464 $ 129,722 (2) $ 516 $ — $ 516 $ 516 $ — $ 516 $ 260,000 (2) $ 681 $ — $ 681 $ 681 $ — $ 681 $ 150,000 (4) $ 393 $ — $ 393 $ 393 $ — $ 393 $ 117,000 (4) $ 95 $ — $ 95 $ 95 $ — $ 95 FOOTNOTES: (1) The all-in rates are equal to the sum of the Strike and Credit Spread detailed above. (2) Amounts related to interest rate swaps held by the Company which are recorded at fair value and included in either other assets or other liabilities in the accompanying consolidated balance sheets. (3) Amounts related to an interest rate swap that settled in May 2018 in connection with the refinancing of the underlying mortgage loan and the Company received approximately $0.1 million upon settlement. (4) Amounts related to the interest rate caps held by the Company, or its equity method investment, which are recorded at fair value and included in other assets in the accompanying consolidated balance sheets. (5)

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Tax Components of Dividends Declared	The tax composition of the Company’s distributions declared for the years ended December 31, 2018, 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 Ordinary income 0.0 % 0.0 % 21.5 % Capital gain 0.0 % 0.0 % 14.4 % Unrecaptured Sec. 1250 gain 0.0 % 0.0 % 1.2 % Return of capital 100.0 % 100.0 % 62.9 %
Distribution of Promoted Interest to Share Holder	Promoted Interest — In connection with the Company’s promoted interest agreements, certain operating targets have been established which, upon meeting such targets, result in the developer being entitled to additional payments based on enumerated percentages of the assumed net proceeds of a deemed sale, subject to achievement of an established internal rate of return on the Company’s investment in the development. For the years ended December 31, 2018, 2017 and 2016, the Company recorded, as a reduction to capital in excess of par value, the following distributions to holders of promoted interest (in thousands): Years Ended December 31, 2018 2017 2016 Dogwood Forest of Acworth $ — $ — $ (3,850 ) Wellmore of Tega Cay — — (2,800 ) HarborChase of Villages Crossing — (955 ) — Dogwood Forest of Grayson (406 ) — — $ (406 ) $ (955 ) $ (6,650 )
Effect of Derivative Financial Instruments	Other comprehensive income (loss) — The following table reflects the effect of derivative financial instruments held by the Company, or its equity method investment, and included in the consolidated statements of comprehensive loss for the years ended December 31, 2018, 2017 and 2016 (in thousands): Derivative financial instruments Gain (loss) recognized in other comprehensive loss on derivative financial instruments Location of gain (loss) reclassified into earnings Gain (loss) reclassified from accumulated other comprehensive loss into earnings Years Ended Years Ended December 31, December 31, 2018 2017 2016 2018 2017 2016 Interest rate swaps $ 1,219 $ 5,573 $ 3,487 Interest expense and loan cost amortization $ 2,457 $ (3,902 ) $ (7,150 ) Interest rate caps 690 1,013 (1,584 ) Interest expense and loan cost amortization (1,957 ) (849 ) (45 ) Reclassification of interest rate swaps upon derecognition 253 318 — Interest expense and loan cost amortization (253 ) (318 ) — Reclassification of interest rate swaps due to ineffectiveness — (26 ) (18 ) Interest expense and loan cost amortization — 26 18 Interest rate cap held by unconsolidated joint venture — — (1 ) Not applicable — — — Total $ 2,162 $ 6,878 $ 1,884 $ 247 $ (5,043 ) $ (7,177 )

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Components of Income Tax Expense	The components of the income tax (expense) benefit for the years ended December 31, 2018, 2017 and 2016 were as follows (in thousands): Years Ended December 31, 2018 2017 2016 Current: Federal $ 113 $ (245 ) $ — State (477 ) (448 ) (276 ) Total current expense (364 ) (693 ) (276 ) Deferred: Federal (3,333 ) 8,826 ― State 66 305 ― Total deferred benefit (3,267 ) 9,131 ― Income tax (expense) benefit $ (3,631 ) $ 8,438 $ (276 )
Significant Components of Deferred Tax Assets	Significant components of the Company’s deferred tax assets as of December 31, 2018 and 2017 are as follows: 2018 2017 Carryforwards of net operating loss $ 6,046 $ 9,266 Minimum tax credit carryforward (1) 118 189 Prepaid rent 712 648 Valuation allowance (2) (946 ) (972 ) Deferred tax assets, net $ 5,930 $ 9,131 FOOTNOTES: (1) The Company expects to be refunded the full minimum tax credit carryforward over the next four years, beginning with the filing of its tax return for the year ended December 31, 2018 and continuing through to the year ending December 31, 2021. (2) .
Reconciliation of Income Tax (Expense) Benefit	A reconciliation of the income tax (expense) benefit computed at the statutory federal tax rate on income before income taxes is as follows (in thousands): Years Ended December 31, 2018 2017 2016 Tax benefit computed at federal statutory rate $ 3,593 21.00 % $ 9,442 35.00 % $ 8,593 35.00 % Impact of REIT election (6,922 ) (40.45 )% (10,650 ) (39.48 )% (8,593 ) (35.00 )% State income tax expense net of federal benefit (399 ) (2.33 )% (331 ) (1.23 )% (276 ) (1.12 )% Effect of change in future tax rates ― ― % 1,861 6.90 ― ― Effect of change in valuation allowance 97 0.57 % 8,116 30.09 ― ― Income tax (expense) benefit $ (3,631 ) (21.21 )% $ 8,438 31.28 % $ (276) (1.12 )%

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2018
Schedule of Future Minimum Lease Payments to be Received Under Non-Cancellable Operating Leases Excluding Properties Classified as Discontinued Operations	The following are future minimum lease payments to be received under non-cancellable operating leases for the next five years and thereafter, in the aggregate, as of December 31, 2018 (in thousands), excluding the 63 properties classified as discontinued operations: 2019 $ 34,070 2020 36,309 2021 37,073 2022 29,421 2023 18,506 Thereafter 50,655 $ 206,034
Ground Leases
Schedule of Future Minimum Lease Payments to be Received Under Non-Cancellable Operating Leases Excluding Properties Classified as Discontinued Operations	The following is a schedule of future minimum lease payments to be paid under the ground leases for each of the next five years and thereafter, in the aggregate, as of December 31, 2018 (in thousands): 2019 $ 2,024 2020 2,047 2021 2,078 2022 2,108 2023 2,144 Thereafter 106,780 $ 117,181

Concentration of Credit Risk (T

Concentration of Credit Risk (Tables)	12 Months Ended
	Dec. 31, 2018
Risks And Uncertainties [Abstract]
Geographical Concentrations that Individually Accounted for 10% or More of Total Revenues Excluding Assets Classified as Held for Sale	For the years ended December 31, 2018, 2017 and 2016, the Company had a geographical concentration accounting for 10% or more of its total revenues, excluding the 63 properties classified as discontinued operations, as follows: Type of Years Ended December 31, Concentration 2018 2017 2016 State of Texas (1) Geographical 20.6 % 20.8 % 20.4 % FOOTNOTE: (1)

Selected Quarterly Financial _2

Selected Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]
Selected Quarterly Financial Data (Unaudited)	The following table presents selected unaudited quarterly financial data for the years ended December 31, 2018 and 2017 (in thousands, except per share data): 2018 Quarters First Second Third Fourth Full Year Total revenues $ 76,319 $ 77,189 $ 78,471 $ 79,615 $ 311,594 Operating income 5,176 8,597 10,098 118 23,989 Income (loss) from continuing operations (5,720 ) (2,700 ) (635 ) (11,687 ) (20,742 ) (Loss) income from discontinued operations (2,178 ) (4,634 ) (2,634 ) 5,037 (4,409 ) Net loss attributable to common stockholders (7,874 ) (7,308 ) (3,248 ) (6,642 ) (25,072 ) Net loss per share of common stock (basic and diluted) Continuing operations (0.03 ) (0.02 ) (0.00 ) (0.07 ) (0.12 ) Discontinued operations (0.01 ) (0.03 ) (0.02 ) 0.03 (0.03 ) Weighted average number of shares outstanding (basic and diluted) 174,854 174,201 173,974 173,973 174,247 2017 Quarters First Second Third Fourth Full Year Total revenues $ 67,046 $ 69,392 $ 73,219 $ 75,050 $ 284,707 Operating income (loss) 1,658 2,560 994 3,379 8,591 Income (loss) from continuing operations (5,981 ) (6,347 ) (8,562 ) 2,351 (18,539 ) Loss from discontinued operations (1,483 ) (1,649 ) (2,669 ) (1,972 ) (7,773 ) Net income (loss) attributable to common stockholders (7,324 ) (7,901 ) (11,170 ) 433 (25,962 ) Net loss per share of common stock (basic and diluted) Continuing operations (0.03 ) (0.04 ) (0.05 ) 0.01 (0.11 ) Discontinued operations (0.01 ) (0.01 ) (0.01 ) (0.01 ) (0.04 ) Weighted average number of shares outstanding (basic and diluted) 175,277 175,221 175,190 174,918 175,151

Organization - Additional Infor

Organization - Additional Information (Detail) $ in Thousands	Sep. 30, 2015USD ($)	Dec. 31, 2018USD ($)PropertyState	Dec. 31, 2018USD ($)PropertyStateBuildingFacilityHospital	Dec. 31, 2017USD ($)Property	Dec. 31, 2016USD ($)	Oct. 31, 2015shares
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Entity incorporation, date of incorporation			Jun. 8, 2010
Aggregate proceeds received from offering | $	$ 1,700,000		$ 22,013	$ 43,220	$ 42,554
Sale of additional share of common stock | shares						20,000,000
Number of properties held for sale			70	71
Healthcare Investment Portfolio
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Number of properties held for sale			70
Number of states | State		34	34
Number of properties			142
Number of seniors housing properties			72
Number of medical office buildings | Building			53
Number of post acute care facilities | Facility			12
Number of acute care hospitals | Hospital			5
MOB Sale Agreement | Welltower Inc.
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
MOB sale, gross price | $		$ 1,250,000
Number of properties comprised in MOB sale		55

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)OperatingSegment	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Summary Of Significant Accounting Policies [Line Items]
Interest expense and loan cost amortization	$ 41.9	$ 38.2	$ 34.8
Capitalized amount of interest	0	2.1	$ 2.8
Accumulated amortization of loan costs	$ 13.1	$ 10
Lease termination, notice period	30 days
Annualized return of investment	6.00%
Number of segment | OperatingSegment	1
Building and Building Improvements | Maximum
Summary Of Significant Accounting Policies [Line Items]
Real estate assets, estimated useful life	39 years
Building and Building Improvements | Minimum
Summary Of Significant Accounting Policies [Line Items]
Real estate assets, estimated useful life	15 years

Revenue - Summary of Disaggrega

Revenue - Summary of Disaggregation of Revenue (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)Facility	Dec. 31, 2017USD ($)Facility	Dec. 31, 2016USD ($)Facility
Disaggregation Of Revenue [Line Items]
Number of Units | Facility	6,080	6,080	5,470
Revenues	$ 276,623	$ 248,900	$ 232,363
Percentage of Revenues	100.00%	100.00%	100.00%
Independent Living
Disaggregation Of Revenue [Line Items]
Number of Units | Facility	2,261	2,261	1,983
Revenues	$ 71,700	$ 59,500	$ 46,800
Percentage of Revenues	25.90%	23.90%	20.10%
Assisted Living
Disaggregation Of Revenue [Line Items]
Number of Units | Facility	2,966	2,966	2,745
Revenues	$ 137,600	$ 128,800	$ 122,800
Percentage of Revenues	49.70%	51.70%	52.80%
Memory Care
Disaggregation Of Revenue [Line Items]
Number of Units | Facility	853	853	742
Revenues	$ 54,400	$ 48,900	$ 48,000
Percentage of Revenues	19.70%	19.60%	20.70%
Other Revenues
Disaggregation Of Revenue [Line Items]
Revenues	$ 12,900	$ 11,700	$ 14,800
Percentage of Revenues	4.70%	4.80%	6.40%

Schedule of Real Estate Investm

Schedule of Real Estate Investment Properties Excluding Assets Held For Sale (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Real Estate [Abstract]
Land and land improvements	$ 130,133	$ 129,684
Building and building improvements	1,475,789	1,472,257
Furniture, fixtures and equipment	81,666	75,111
Less: accumulated depreciation	(232,439)	(181,478)
Real estate investment properties, net	$ 1,455,149	$ 1,495,574

Real Estate Assets, Net - Addit

Real Estate Assets, Net - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)Property	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Real Estate Properties [Line Items]
Impairment provision | $	$ 7,922	$ 0	$ 0
Welbrook Senior Living Grand Junction
Real Estate Properties [Line Items]
Number of assets classified as held for sale | Property	1
Number of real estate properties | Property	70
Real Estate Investment Properties
Real Estate Properties [Line Items]
Depreciation expense | $	$ 51,600	$ 52,000	$ 54,000

Schedule of Net Book Value of I

Schedule of Net Book Value of Intangibles Excluding Assets Held for Sale (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Finite Lived Intangible Assets [Line Items]
Less: accumulated amortization	$ (81,499)	$ (79,001)
Intangible assets, net	1,614	4,112
In-place lease intangibles
Finite Lived Intangible Assets [Line Items]
Gross carrying amount, assets	$ 83,113	$ 83,113

Intangibles net - Additional In

Intangibles net - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Finite Lived Intangible Assets [Line Items]
Weighted average useful life	4 years 7 months 6 days
Depreciation And Amortization
Finite Lived Intangible Assets [Line Items]
Amortization expense on intangible assets	$ 2.5	$ 12.4	$ 23.6

Schedule of Estimated Future Am

Schedule of Estimated Future Amortization (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2019	$ 394
2020	394
2021	394
2022	253
2023	74
Thereafter	105
Intangible assets, net	$ 1,614	$ 4,112

Assets and Associated Liabili_3

Assets and Associated Liabilities Held for Sale and Discontinued Operations - Additional Information (Detail)	1 Months Ended			12 Months Ended
	Dec. 31, 2018USD ($)Property	Sep. 30, 2018Property	Aug. 31, 2017Facility	Dec. 31, 2018USD ($)Property	Dec. 31, 2017USD ($)Property	Dec. 31, 2016USD ($)
Long Lived Assets Held For Sale [Line Items]
Gain on sale of real estate				$ 1,049,000		$ 15,415,000
Number of remaining properties classified as held for sale | Property				15
Impairment provision				$ 7,922,000	$ 0	0
Number of properties held for sale | Property				70	71
Number of properties owned, discontinued operations | Property	63			63
MOB Sale Agreement | Welltower Inc.
Long Lived Assets Held For Sale [Line Items]
Number of properties committed for sale | Property		63
Number of properties comprised in MOB sale | Property	55
MOB sale, gross price	$ 1,250,000,000
Hurst Specialty Hospital
Long Lived Assets Held For Sale [Line Items]
Impairment provision				$ 4,300,000	$ 0	$ 0
Physicians Regional Medical Center – Central Wing | Disposal Group Held for Sale Qualify as Not Discontinued Operations
Long Lived Assets Held For Sale [Line Items]
Proceeds from sale of property				5,800,000
Gain on sale of real estate				$ 1,000,000
Arkansas
Long Lived Assets Held For Sale [Line Items]
Number of skilled nursing facilities | Facility			6

Assets and Associated Liabili_4

Assets and Associated Liabilities Held for Sale and Discontinued Operations - Schedule of Assets Classified as Held for Sale and Liabilities Associated with Those Assets Held for Sale (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Long Lived Assets Held For Sale [Line Items]
Deferred rent and lease incentives	$ 14,763	$ 11,051
Other assets	23,488	26,248
Assets held for sale, net	1,147,645	1,184,750
Liabilities associated with assets held for sale	774,019	779,709
MOB/Healthcare Portfolio
Long Lived Assets Held For Sale [Line Items]
Real estate held for sale, net	952,656	979,601
Real estate under development	3,490
Intangibles, net	82,417	95,399
Deferred rent and lease incentives	36,562	30,353
Other assets	11,425	9,225
Restricted cash	2,013	2,532
Assets held for sale, net	1,088,563	1,117,110
Mortgages and other notes payable	492,701	492,655
Credit facilities	212,731	218,174
Other liabilities	16,653	19,388
Accounts payable and accrued liabilities	8,425	8,337
Liabilities associated with assets held for sale	730,510	738,554
Other
Long Lived Assets Held For Sale [Line Items]
Real estate held for sale, net	51,339	59,914
Intangibles, net	800	801
Deferred rent and lease incentives	6,501	6,357
Other assets	182	215
Restricted cash	260	353
Assets held for sale, net	59,082	67,640
Mortgages and other notes payable	8,097
Credit facilities	34,778	39,149
Other liabilities	634	1,678
Accounts payable and accrued liabilities		328
Liabilities associated with assets held for sale	43,509	41,155
Disposal Groups Held For Sale
Long Lived Assets Held For Sale [Line Items]
Real estate held for sale, net	1,003,995	1,039,515
Real estate under development	3,490
Intangibles, net	83,217	96,200
Deferred rent and lease incentives	43,063	36,710
Other assets	11,607	9,440
Restricted cash	2,273	2,885
Assets held for sale, net	1,147,645	1,184,750
Mortgages and other notes payable	500,798	492,655
Credit facilities	247,509	257,323
Other liabilities	17,287	21,066
Accounts payable and accrued liabilities	8,425	8,665
Liabilities associated with assets held for sale	$ 774,019	$ 779,709

Assets and Associated Liabili_5

Assets and Associated Liabilities Held for Sale and Discontinued Operations - Summary of Loss from Discontinued Operations (Detail) - MOB/Healthcare Portfolio - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenues:
Rental income and tenant reimbursements	$ 114,719	$ 113,709	$ 111,856
Operating expenses:
Property operating expenses	30,538	30,254	29,228
General and administrative	1,291	1,086	909
Acquisition fees and costs			768
Financing coordination fees	2,326
Contingent purchase price consideration adjustment		47	(540)
Impairment provision	4,392
Loss on lease terminations			785
Depreciation and amortization	31,961	43,567	45,396
Total operating expenses	86,171	91,245	92,449
Operating income	28,548	22,464	19,407
Other income (expense):
Interest and other income (expense)	109	(73)	2
Interest expense and loan cost amortization	(33,060)	(30,089)	(26,283)
Total other expense	(32,951)	(30,162)	(26,281)
Loss before income taxes	(4,403)	(7,698)	(6,874)
Income tax expense	(6)	(75)	(75)
Loss from discontinued operations	(4,409)	(7,773)	(6,949)
Asset Management Fees
Operating expenses:
Asset / Property management fees	11,984	12,042	11,813
Property Management Fees
Operating expenses:
Asset / Property management fees	$ 3,679	$ 4,249	$ 4,090

Operating Leases - Additional I

Operating Leases - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)Property
Operating Leased Assets [Line Items]
Number of properties owned, discontinued operations	63
Triple Net Lease Agreements
Operating Leased Assets [Line Items]
Number of properties owned	85
Number of properties owned, discontinued operations	63
Weighted average remaining lease term	5 years 1 month 6 days
Total annualized property tax | $	$ 5.1
Triple Net Lease Agreements | Single Tenant Properties
Operating Leased Assets [Line Items]
Number of properties owned	42
Real estate investment properties, percentage leased under operating leases	100.00%
Triple Net Lease Agreements | Multi Tenant Properties
Operating Leased Assets [Line Items]
Number of properties owned	43
Triple Net Lease Agreements | Minimum
Operating Leased Assets [Line Items]
Lease, expiration year	2019
Extended lease period	2 years
Triple Net Lease Agreements | Maximum
Operating Leased Assets [Line Items]
Lease, expiration year	2032
Extended lease period	10 years

Schedule of Future Minimum Leas

Schedule of Future Minimum Lease Payments to be Received Under Non-Cancellable Operating Leases Excluding 63 Properties Classified as Discontinued Operations (Detail) $ in Thousands	Dec. 31, 2018USD ($)
Leases [Abstract]
2019	$ 34,070
2020	36,309
2021	37,073
2022	29,421
2023	18,506
Thereafter	50,655
Total	$ 206,034

Variable Interest Entities (VIE

Variable Interest Entities (VIEs) - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)Subsidiary	Dec. 31, 2017Subsidiary
Variable Interest Entity [Line Items]
Maximum exposure to loss VIEs limits | $	$ 57.2
Variable interest entity, description	The Company had eight subsidiaries which are classified as VIEs due to the following factors and circumstances as of December 31, 2018: Two of these subsidiaries are single property entities, designed to own and lease their respective properties to multiple tenants, which are subject to a ground lease that include buy-out and put options held by either the tenant or landlord under the applicable lease. Three of these subsidiaries are entities with completed real estate under development in which there is insufficient equity at risk due to the development nature of each entity. Two of these subsidiaries are joint ventures with completed real estate under development in which there is insufficient equity at risk due to the development nature of each joint venture. One of these subsidiaries is a joint venture with equity interest that consists of non-substantive protective voting rights, but not any participating or kick-out rights.
VIEs
Variable Interest Entity [Line Items]
Number of subsidiaries	8	10
VIEs | Single Property Entities
Variable Interest Entity [Line Items]
Number of subsidiaries	2
VIEs | Real Estate Under Development Entities
Variable Interest Entity [Line Items]
Number of subsidiaries	3
VIEs | Joint Ventures Real Estate Under Development Entities
Variable Interest Entity [Line Items]
Number of subsidiaries	2
VIEs | Joint Venture with Equity Interest
Variable Interest Entity [Line Items]
Number of subsidiaries	1

Aggregate Carrying Amount and M

Aggregate Carrying Amount and Major Classifications of Consolidated Assets and Liabilities (Detail) - USD ($) $ in Thousands		Dec. 31, 2018	Dec. 31, 2017
Variable Interest Entity [Line Items]
Real estate investment properties, net		$ 1,455,149	$ 1,495,574
Assets held for sale, net		1,147,645	1,184,750
Cash		57,109	64,522
Other assets		23,488	26,248
Deferred rent and lease incentives		14,763	11,051
Restricted cash		6,119	7,284
Mortgages and other notes payable, net		530,644	539,498
Liabilities associated with assets held for sale		774,019	779,709
Other liabilities		8,548	6,954
VIEs
Variable Interest Entity [Line Items]
Real estate investment properties, net		146,341	174,263
Assets held for sale, net	[1]	39,601	44,998
Cash		342	2,203
Other assets		678	384
Deferred rent and lease incentives		7,160	3,577
Restricted cash		208	1,212
Mortgages and other notes payable, net		102,578	118,378
Liabilities associated with assets held for sale	[1]	30,695	35,848
Accounts payable and accrued liabilities		784	3,117
Accrued development costs			909
Other liabilities		$ 1,321	$ 947
[1]	Refer to Note 6. “Assets and Associated Liabilities Held For Sale and Discontinued Operations” for additional information.

Contingent Purchase Price Con_3

Contingent Purchase Price Consideration - Additional Information (Detail) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Contingent purchase price consideration	$ 0	$ 4,000,000	$ 3,750,000

Fair Value of Contingent Purcha

Fair Value of Contingent Purchase Price Consideration (Detail) - USD ($)		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance		$ (4,000,000)	$ (3,750,000)
Contingent Consideration Payment (Receipt)		4,000,000
Change in Fair Value			(250,000)
Ending balance		0	(4,000,000)
Superior Residences of Panama City
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	[1]	(4,000,000)	(3,000,000)
Contingent Consideration Payment (Receipt)	[1]	4,000,000
Change in Fair Value	[1]		(1,000,000)
Ending balance		$ 0	(4,000,000)	[1]
The Shores of Lake Phalen
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	[2]		(750,000)
Change in Fair Value	[2]		$ 750,000
[1]	In connection with the purchase of Superior Residences of Panama City, the Company entered into an earn-out agreement with the seller whereby up to $4 million in additional consideration was owed in the event that certain performance targets were met (“Panama City Earn-Out”) during the immediate 36 months post-closing. As of December 31, 2017, the Company had no remaining obligations pursuant to the Panama City Earn-Out agreement.
[2]	In connection with the purchase of Shores of Lake Phalen, the Company entered into an earn-out agreement with the seller whereby up to $0.8 million in additional consideration was owed in the event that certain net operating income targets were met (“Shores of Lake Phalen Earn-Out”) during the immediate 12 months post-closing. The Shores of Lake Phalen Earn-Out expired as of December 31, 2016.

Fair Value of Contingent Purc_2

Fair Value of Contingent Purchase Price Consideration (Parenthetical) (Detail) - USD ($)		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016		Dec. 31, 2015
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Contingent purchase price consideration		$ 0	$ 4,000,000		$ 3,750,000
Superior Residences of Panama City
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Additional purchase price consideration		$ 4,000,000
Additional purchase price consideration period		36 months
Contingent purchase price consideration		$ 0	4,000,000	[1]	3,000,000	[1]
The Shores of Lake Phalen
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Additional purchase price consideration			$ 800,000
Additional purchase price consideration period			12 months
Contingent purchase price consideration	[2]				$ 750,000
[1]	In connection with the purchase of Superior Residences of Panama City, the Company entered into an earn-out agreement with the seller whereby up to $4 million in additional consideration was owed in the event that certain performance targets were met (“Panama City Earn-Out”) during the immediate 36 months post-closing. As of December 31, 2017, the Company had no remaining obligations pursuant to the Panama City Earn-Out agreement.
[2]	In connection with the purchase of Shores of Lake Phalen, the Company entered into an earn-out agreement with the seller whereby up to $0.8 million in additional consideration was owed in the event that certain net operating income targets were met (“Shores of Lake Phalen Earn-Out”) during the immediate 12 months post-closing. The Shores of Lake Phalen Earn-Out expired as of December 31, 2016.

Details of Indebtedness Excludi

Details of Indebtedness Excluding Assets Held For Sale (Detail) - USD ($) $ in Thousands		Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Premium (discount), net	[1]	$ 184	$ 225
Loan costs, net		(2,429)	(3,658)
Total mortgages and other notes payable, net		530,644	539,498
Credit facilities		425,613	372,743
Total indebtedness, net		956,257	912,241
First Term Loan Facility
Debt Instrument [Line Items]
Credit facilities	[2]	151,616	99,435
Second Term Loan Facility
Debt Instrument [Line Items]
Credit facilities	[2],[3]	275,000	275,000
Term Loan Facility
Debt Instrument [Line Items]
Loan costs, net		(1,003)	(1,692)
Mortgages payable and other notes payable
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[4]	532,889	542,931
Fixed rate debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable		358,843	368,873
Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[2],[3]	$ 174,046	$ 174,058
[1]	Premium (discount), net is reflective of the Company recording mortgage note payables assumed at fair value on the respective acquisition dates.
[2]	As of December 31, 2018 and 2017, the Company had entered into interest rate swaps with notional amounts of approximately $151.6 million and $99.4 million, respectively, which were settling on a monthly basis. Refer to Note 12. “Derivative Financial Instruments” for additional information. In February 2019, the Company extended the term of its First Term Loan to February 2020, refer to Note 18. “Subsequent Events” for additional information.
[3]	As of December 31, 2018 and 2017, the Company had entered into interest rate caps with notional amounts of approximately $330.0 million and $330.0 million, respectively. In addition, as of December 31, 2018 the Company had entered into interest rate caps with forward effective dates with notional amounts of approximately $151.6 million in order to hedge the Company’s exposure to interest rate changes in future periods. Refer to Note 12. “Derivative Financial Instruments” for additional information.
[4]	As of December 31, 2018 and 2017, the Company’s mortgages and other notes payable are collateralized by 37 and 38 properties, respectively, with total carrying value of approximately $0.8 billion and $0.8 billion, respectively.

Details of Indebtedness Exclu_2

Details of Indebtedness Excluding Assets Held For Sale (Parenthetical) (Detail) $ in Millions	Feb. 19, 2019	Dec. 31, 2018USD ($)Property	Dec. 31, 2017USD ($)Property
Secured Mortgages and Other Notes Payable
Debt Instrument [Line Items]
Number of collateralized properties owned | Property		37	38
Mortgages and other notes payable carrying value of collateral		$ 800	$ 800
First Term Loan Facility
Debt Instrument [Line Items]
Line of credit facility, extended maturity		2020-02
Revolving Credit Facility
Debt Instrument [Line Items]
Debt Instrument, Current borrowing capacity		$ 14.7	28.4
Subsequet Event | First Term Loan Facility
Debt Instrument [Line Items]
Line of credit facility, extended maturity	2020-02
Interest Rate Swap
Debt Instrument [Line Items]
Notional amounts of derivative contract		151.6	99.4
Interest Rate Cap
Debt Instrument [Line Items]
Notional amounts of derivative contract		330	$ 330
Derivative additional notional amount		$ 151.6

Schedule of Maturities of Indeb

Schedule of Maturities of Indebtedness (Detail) $ in Thousands	Dec. 31, 2018USD ($)
Debt Disclosure [Abstract]
2019	$ 238,156
2020	404,822
2021	11,341
2022	282,496
2023	22,874
Total borrowings	$ 959,689

Indebtedness - Additional Infor

Indebtedness - Additional Information (Detail)	1 Months Ended	12 Months Ended
	Nov. 30, 2015USD ($)	Dec. 31, 2018USD ($)Extension	Dec. 31, 2014USD ($)
Debt Instrument [Line Items]
Indebtedness maturity amount		$ 238,156,000
Maximum allowable distributions as a percentage of adjusted FFO		95.00%
Description of covenants		The Credit Facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage and (viii) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the Credit Facilities, minimum debt service coverage ratio, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions include a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the Credit Facilities) and the minimum amount of distributions required to maintain the Company’s REIT status. As of December 31, 2018, the Company was in compliance with all financial covenants.
After Modification
Debt Instrument [Line Items]
Aggregate maximum principal amount available for borrowing		$ 445,000,000	$ 700,000,000
First Term Loan Facility
Debt Instrument [Line Items]
Indebtedness maturity amount		$ 151,600,000
Line of credit facility, extended maturity		2020-02
Aggregate maximum principal amount available for borrowing			175,000,000
Line of credit facility, initial maturity		2019-02
Number of extension options available | Extension		1
Line of credit facility extension period		12 months
Revolving Credit Facility | Maturity Extension Option One
Debt Instrument [Line Items]
Aggregate maximum principal amount available for borrowing			$ 230,000,000
Line of credit facility, initial maturity		2019-12
Line of credit facility extension period		12 months
Revolving Credit Facility | Maturity Extension Option Two
Debt Instrument [Line Items]
Line of credit facility, initial maturity		2019-12
Line of credit facility extension period		12 months
Second Term Loan Facility
Debt Instrument [Line Items]
Line of credit facility, initial maturity	2020-11
Second Term Loan Facility | 30-day LIBOR
Debt Instrument [Line Items]
Aggregate maximum principal amount available for borrowing	$ 250,000,000
Second Term Loan Facility | After Modification | 30-day LIBOR
Debt Instrument [Line Items]
Aggregate maximum principal amount available for borrowing	$ 350,000,000	$ 275,000,000

Schedule of Indebtedness (Detai

Schedule of Indebtedness (Detail) - USD ($) $ in Thousands		1 Months Ended		12 Months Ended
		Aug. 31, 2017	Jun. 30, 2017	Dec. 31, 2018		Dec. 31, 2017
Debt Instrument [Line Items]
Carrying Value				$ 959,689
Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Carrying Value				748,300		$ 750,100
Fixed rate debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				358,843		368,873
Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[1],[2]			174,046		174,058
Mortgage Loans
Debt Instrument [Line Items]
Carrying Value				532,889		542,931
Mortgage Loans | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Carrying Value				503,778		495,836
Mortgage Loans | Fixed rate debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				358,843		368,873
Mortgage Loans | Fixed rate debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				39,841		40,734
Mortgage Loans | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				174,046		174,058
Mortgage Loans | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				$ 463,937		455,102
Mortgage Loans | Primrose II Communities
Debt Instrument [Line Items]
Interest on Loan accrues - Fixed rate	[3]			3.81%
Payment Terms				Monthly principal and interest payments based on a 30-year amortization schedule
Principal and interest payments amortizable period				30 years
Maturity Date	[4]			Jun. 1, 2020
Mortgage Loans | Primrose II Communities | Fixed rate debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				$ 21,047		21,541
Mortgage Loans | Pacific Northwest Communities
Debt Instrument [Line Items]
Interest on Loan accrues - Fixed rate	[3],[5]			4.30%
Payment Terms	[5]			Monthly principal and interest payments based on a 25-year amortization schedule
Principal and interest payments amortizable period	[5]			25 years
Maturity Date	[4],[5]			Jan. 5, 2022
Mortgage Loans | Pacific Northwest Communities | Fixed rate debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[5]			$ 202,978		208,990
Mortgage Loans | Capital Health
Debt Instrument [Line Items]
Payment Terms	[6]			Monthly principal and interest payments based on a 25-year amortization schedule
Principal and interest payments amortizable period	[6]			25 years
Maturity Date		Jan. 31, 2022	Jan. 31, 2020	Jan. 5, 2022	[4],[6]
Mortgages payable and other notes payable				$ 35,400
Mortgage Loans | Capital Health | Fixed rate debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[6]			$ 60,902		62,767
Mortgage Loans | Primrose I Communities
Debt Instrument [Line Items]
Interest on Loan accrues - Fixed rate	[3],[7]			4.11%
Payment Terms	[7]			Monthly principal and interest payments based on a 30-year amortization schedule
Principal and interest payments amortizable period	[7]			30 years
Maturity Date	[4],[7]			Sep. 1, 2022
Mortgage Loans | Primrose I Communities | Fixed rate debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[7]			$ 48,753		49,899
Mortgage Loans | Watercrest at Mansfield
Debt Instrument [Line Items]
Interest on Loan accrues - Fixed rate	[3],[8]			4.68%
Payment Terms	[8]			Monthly principal and interest payments based on a total payment of $143,330
Maturity Date	[4],[8]			Jun. 1, 2023
Mortgage Loans | Watercrest at Mansfield | Fixed rate debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[8]			$ 25,163		25,676
Mortgage Loans | Palmilla Senior Living | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[9]			$ 26,478		26,799
Mortgage Loans | Novi Orthopaedic Center | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest on Loan accrues - Fixed rate	[3]			3.61%
Payment Terms				Monthly interest only payments through June 2018; principal and interest payments thereafter based on a 25-year amortization schedule
Principal and interest payments amortizable period				25 years
Maturity Date	[4]			Jun. 15, 2020
Mortgage Loans | Novi Orthopaedic Center | Fixed rate debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				$ 19,581		19,825
Mortgage Loans | ProMed Building I | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest on Loan accrues - Fixed rate	[3],[10]			3.64%
Payment Terms	[10]			Monthly principal and interest payments based upon a 30-year amortization schedule
Principal and interest payments amortizable period	[10]			30 years
Maturity Date	[4],[10]			Jan. 15, 2022
Mortgage Loans | ProMed Building I | Fixed rate debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[10]			$ 6,473		6,673
Mortgage Loans | 540 New Waverly Place | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest on Loan accrues - Fixed rate	[3]			4.08%
Payment Terms				Monthly principal and interest payments based upon a 25-year amortization schedule
Principal and interest payments amortizable period				25 years
Maturity Date	[4]			May 31, 2028
Mortgage Loans | 540 New Waverly Place | Fixed rate debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				$ 6,452		6,665
Mortgage Loans | LaPorte Cancer Center Westville, Indiana | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest on Loan accrues - Fixed rate	[3]			4.25%
Payment Terms				Monthly principal and interest payments based on a 25-year amortization schedule
Principal and interest payments amortizable period				25 years
Maturity Date	[4]			Jun. 14, 2028
Mortgage Loans | LaPorte Cancer Center Westville, Indiana | Fixed rate debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				$ 7,335		7,571
Mortgage Loans | Calvert Medical Office Properties | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable						25,121
Mortgage Loans | Medical Portfolio II | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[11]			77,074		79,295
Mortgage Loans | Northwest Medical Park | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				6,628		6,765
Mortgage Loans | Lee Hughes Medical Building | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				17,043		17,572
Mortgage Loans | Triangle Orthopaedic | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[12]			36,962		37,475
Mortgage Loans | Cobalt Rehabilitation Hospital Surprise | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				14,829		15,167
Mortgage Loans | Knoxville Medical Office Properties and Claremont Medical Office | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[13]			51,575		57,350
Mortgage Loans | Cobalt Rehabilitation Hospital New Orleans | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				19,055		19,421
Mortgage Loans | MHOSH MOB | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[14]			57,630		47,072
Mortgage Loans | Southeast Medical Office Properties | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[15]			175,000		149,864
Secured Term Loan | Shores of Lake Phalen | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				16,859
Secured Term Loan | Welbrook Senior Living Grand Junction | Variable Rate Debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Mortgages payable and other notes payable				8,141
Construction Loan | HarborChase Of Shorewood (Shorewood, Wisconsin) | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable						14,706
Construction Loan | Wellmore of Lexington (Lexington, SC) | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				35,421		33,423
Construction Loan | Watercrest at Katy | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				21,552		26,300
Construction Loan | Wellmore of Tega Cay | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable	[9]			27,715		28,000
Construction Loan | Waterstone on Augusta (Greenville, SC) | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				18,830		18,302
Construction Loan | Fieldstone at Pear Orchard (Yakima, Washington) | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				10,791		10,900
Construction Loan | Dogwood Forest of Grayson (Grayson, GA) | Variable Rate Debt
Debt Instrument [Line Items]
Mortgages payable and other notes payable				$ 16,400		$ 15,628
30-day LIBOR | Mortgage Loans | Palmilla Senior Living
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3],[9]			2.00%
Payment Terms	[9]			Monthly interest only payments through April 2017; principal and interest payments thereafter based on a 30-year amortization schedule
Principal and interest payments amortizable period	[9]			30 years
Maturity Date	[4],[9]			Mar. 22, 2020
30-day LIBOR | Mortgage Loans | Calvert Medical Office Properties | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			2.50%
Payment Terms				Monthly interest only payments for the first 18 months; principal and interest payments thereafter based on a 30-year amortization schedule
Principal and interest payments amortizable period				30 years
Maturity Date	[4]			Aug. 29, 2018
30-day LIBOR | Mortgage Loans | Northwest Medical Park | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			2.30%
Payment Terms				Monthly principal and interest payments based upon a 25-year amortization schedule
Principal and interest payments amortizable period				25 years
Maturity Date	[4]			Oct. 31, 2019
30-day LIBOR | Mortgage Loans | Lee Hughes Medical Building | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			1.85%
Payment Terms				Monthly principal and interest payments based on a 30-year amortization schedule
Principal and interest payments amortizable period				30 years
Maturity Date	[4]			Mar. 5, 2020
30-day LIBOR | Mortgage Loans | Triangle Orthopaedic | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3],[12]			2.25%
Payment Terms	[12]			Interest only payments through March 2017; principal payments thereafter based on a 30-year amortization schedule
Principal and interest payments amortizable period	[12]			30 years
Maturity Date	[4],[12]			Apr. 11, 2021
30-day LIBOR | Mortgage Loans | Cobalt Rehabilitation Hospital Surprise | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			2.60%
Payment Terms				Monthly interest only payments through May 2017; principal payments thereafter based on a 25-year amortization schedule
Principal and interest payments amortizable period				25 years
Maturity Date	[4]			May 19, 2022
Payment Terms	[3]			0.40%
30-day LIBOR | Mortgage Loans | Knoxville Medical Office Properties and Claremont Medical Office | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3],[13]			2.45%
Payment Terms	[13]			Monthly principal and interest payments based on a 30-year amortization schedule
Principal and interest payments amortizable period	[13]			30 years
Maturity Date	[4],[13]			May 24, 2022
30-day LIBOR | Mortgage Loans | Cobalt Rehabilitation Hospital New Orleans | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			2.45%
Payment Terms				Monthly interest only payments through October 2017; principal payments thereafter based on a 25-year amortization schedule
Principal and interest payments amortizable period				25 years
Maturity Date	[4]			Oct. 19, 2022
Payment Terms	[3]			0.55%
30-day LIBOR | Mortgage Loans | MHOSH MOB | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3],[14]			2.20%
Payment Terms	[14]			Interest only payments through June 2020; principal payments thereafter based on a 30-year amortization schedule
Principal and interest payments amortizable period	[14]			30 years
Maturity Date	[4],[14]			May 24, 2023
30-day LIBOR | Mortgage Loans | Southeast Medical Office Properties | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3],[15]			2.00%
Payment Terms	[15]			Interest only payments through January 2021; principal payments thereafter based on a 30-year amortization schedule
Principal and interest payments amortizable period	[15]			30 years
Maturity Date	[4],[15]			Jun. 14, 2023
30-day LIBOR | Secured Term Loan | Shores of Lake Phalen
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			2.42%
Payment Terms				Monthly interest only payments through June 2019
Maturity Date	[4]			Jun. 30, 2019
30-day LIBOR | Secured Term Loan | Welbrook Senior Living Grand Junction | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			2.42%
Payment Terms				Monthly interest only payments through June 2019
Maturity Date	[4]			Jun. 30, 2019
30-day LIBOR | Construction Loan | HarborChase Of Shorewood (Shorewood, Wisconsin)
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			3.00%
Payment Terms				Monthly interest only payments through June 2017; principal and interest payments thereafter based on a 25-year amortization schedule
Principal and interest payments amortizable period				25 years
Maturity Date	[4]			Jul. 5, 2019
30-day LIBOR | Construction Loan | Wellmore of Lexington (Lexington, SC)
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			2.50%
Payment Terms				Monthly interest only payments through September 2019
Maturity Date	[4]			Sep. 13, 2019
30-day LIBOR | Construction Loan | Watercrest at Katy
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			2.75%
Payment Terms				Monthly principal and interest payments based on a 30-year amortization schedule
Principal and interest payments amortizable period				30 years
Maturity Date	[4]			Dec. 27, 2019
30-day LIBOR | Construction Loan | Wellmore of Tega Cay
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3],[9]			2.65%
Payment Terms	[9]			Monthly interest only payments for the first 12 months; principal and interest payments thereafter based on a 30-year amortization schedule
Principal and interest payments amortizable period	[9]			30 years
Maturity Date	[4],[9]			Mar. 1, 2020
30-day LIBOR | Construction Loan | Waterstone on Augusta (Greenville, SC)
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			3.00%
Payment Terms				Monthly interest only payments through September 2018; principal and interest payments thereafter based on a 30-year amortization schedule
Principal and interest payments amortizable period				30 years
Maturity Date	[4]			Sep. 1, 2020
30-day LIBOR | Construction Loan | Fieldstone at Pear Orchard (Yakima, Washington)
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			2.90%
Payment Terms				Monthly interest only payments through September 2018; principal payments thereafter based on a 25-year amortization schedule
Principal and interest payments amortizable period				25 years
Maturity Date	[4]			Oct. 15, 2020
30-day LIBOR | Construction Loan | Dogwood Forest of Grayson (Grayson, GA)
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3]			3.00%
Payment Terms				Monthly interest only payments through December 2018; principal payments thereafter based on a 30-year amortization schedule
Principal and interest payments amortizable period				30 years
Maturity Date	[4]			Dec. 1, 2020
Ninety Days London Interbank Offered Rate | Mortgage Loans | Medical Portfolio II | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR	[3],[11]			2.35%
Payment Terms	[11]			Monthly principal and interest payments based on a 25-year amortization schedule
Principal and interest payments amortizable period	[11]			25 years
Maturity Date	[4],[11]			Jul. 14, 2019
Payment Terms	[3],[11]			0.25%
[1]	As of December 31, 2018 and 2017, the Company had entered into interest rate caps with notional amounts of approximately $330.0 million and $330.0 million, respectively. In addition, as of December 31, 2018 the Company had entered into interest rate caps with forward effective dates with notional amounts of approximately $151.6 million in order to hedge the Company’s exposure to interest rate changes in future periods. Refer to Note 12. “Derivative Financial Instruments” for additional information.
[2]	As of December 31, 2018 and 2017, the Company had entered into interest rate swaps with notional amounts of approximately $151.6 million and $99.4 million, respectively, which were settling on a monthly basis. Refer to Note 12. “Derivative Financial Instruments” for additional information. In February 2019, the Company extended the term of its First Term Loan to February 2020, refer to Note 18. “Subsequent Events” for additional information.
[3]	The 30-day and 90-day LIBOR were approximately 2.50% and 2.81%, respectively, as of December 31, 2018 and approximately 1.56% and 1.70%, respectively, as of December 31, 2017.
[4]	Represents the initial maturity date (or, as applicable, the maturity date as extended). Certain of the Company’s mortgages and other notes payable agreements include extension options held by the Company under which the maturity dates may be extended beyond the date presented, subject to certain lender conditions and/or related fees.
[5]	In August 2017, the Company extended the maturity date on the existing loan of approximately $201.9 million from December 2018 to January 2022.  In addition, the Company received approximately $9.5 million of additional borrowings through a supplemental loan with the same lender, which is co-terminus with the existing mortgage loans, collateralized by the communities and matures in January 2022. The supplemental loan further accrues interest at a fixed rate equal to 4.3% per annum and includes monthly interest only payments for the first 12 months followed by monthly principal and interest payments for the remaining term of the loan using a 30-year amortization period with the remaining principal balance payable at maturity.  The loan may be prepaid, in whole or in part, with a prepayment premium equal to the greater of: (i) one percent (1%) of the principal amount being prepaid, multiplied by the quotient of the number of full months remaining until the maturity date of the loan (calculated as of the prepayment date) divided by the number of full months comprising the term of the loan; or (b) a “make-whole” payment equal to the present value of the loan less the amount of principal and accrued interest being prepaid calculated as of the prepayment date for the period between that date and the maturity date.
[6]	In August 2017, the Company extended the maturity date on the existing loan of approximately $35.4 million from January 2020 to January 2022.  In addition, the Company received approximately $28.0 million of additional borrowings through a supplemental loan with the same lender, which is co-terminus with the existing mortgage loans, collateralized by the communities and matures in January 2022.  The existing loan accrues interest at a fixed rate equal to 4.25% per annum. The supplemental loan accrues interest at a fixed rate equal to 4.3% per annum and includes monthly interest only payments for the first 12 months followed by monthly principal and interest payments for the remaining term of the loan using a 30-year amortization period with the remaining principal balance payable at maturity. The loan may be prepaid, in whole or in part, with a prepayment premium equal to the greater of: (i) one percent (1%) of the principal amount being prepaid, multiplied by the quotient of the number of full months remaining until the maturity date of the loan (calculated as of the prepayment date) divided by the number of full months comprising the term of the loan; or (b) a “make-whole” payment equal to the present value of the loan less the amount of principal and accrued interest being prepaid calculated as of the prepayment date for the period between that date and the maturity date.
[7]	If prepaid prior to March 1, 2022, the Primrose I Communities Mortgage Loan is subject to a prepayment penalty in an amount equal to the greater of (i) 1% of the principal being repaid, or (ii) an amount calculated on the principal being repaid, multiplied by the difference between the Primrose I Communities Mortgage Loan interest rate, and a calculated yield rate tied to the rates on applicable U.S. Treasuries. If prepayment is made between March 1, 2022, and May 31, 2022, the prepayment penalty will be 1% of the outstanding principal balance of the Primrose I Communities Mortgage Loan. No prepayment fee is required if the Primrose I Communities Mortgage Loan is prepaid between June 1, 2022 and maturity. Partial prepayment of a loan is not permitted. The loan is transferable upon sale of the assets subject to lender approval.
[8]	The balance for this loan excludes a remaining premium of $0.2 million related to the mortgage note payable assumed being recorded at fair value on the acquisition date.
[9]	The Company entered into an interest rate cap with a remaining notional amount of $117.0 million, of which a portion has been designated to hedge these loans; see Note 12. “Derivative Financial Instruments” for additional information.
[10]	Beginning January 2020, the interest rate transitions to variable rate based on 30-day LIBOR plus 2.20% per annum.
[11]	The Company entered into an interest rate swap with a remaining notional amount of $79.2 million; see Note 12. “Derivative Financial Instruments” for additional information.
[12]	The Company entered into an interest rate cap with a remaining notional amount of $117.0 million, of which a portion has been designated to hedge this loan; see Note 12. “Derivative Financial Instruments” for additional information.
[13]	In May 2017, the Company refinanced the loans related to the Claremont Medical Office property and the Knoxville Medical Office Properties of approximately $12.4 million and $37.2 million, respectively, into a combined loan. The original loans were scheduled to mature January 2018 and July 2018, respectively. The Company entered into an interest rate swap with a remaining notional amount of $51.6 million; see Note 12. “Derivative Financial Instruments” for additional information.
[14]	The Company entered into an interest rate cap with a remaining notional amount of $57.6 million; see Note 12. “Derivative Financial Instruments” for additional information.
[15]	The Company entered into an interest rate cap with a remaining notional amount of $125.1 million; see Note 12. “Derivative Financial Instruments” for additional information.

Schedule of Indebtedness (Paren

Schedule of Indebtedness (Parenthetical) (Detail) - USD ($) $ in Thousands		Oct. 31, 2015	Aug. 31, 2017	Jun. 30, 2017	May 31, 2017	Dec. 31, 2018		Dec. 31, 2017
Interest Rate Cap
Debt Instrument [Line Items]
Notional amount of derivative contract						$ 330,000		$ 330,000
Interest Rate Swap
Debt Instrument [Line Items]
Notional amount of derivative contract						151,600		99,400
Fixed rate debt
Debt Instrument [Line Items]
Debt, Carrying amount						358,843		368,873
Claremont Medical Office | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Maturity Date					Jan. 31, 2018
Debt, refinanced amount					$ 12,400
Knoxville MOBs | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Maturity Date					Jul. 31, 2018
Debt, refinanced amount					$ 37,200
Mortgage Loans | Fixed rate debt
Debt Instrument [Line Items]
Debt, Carrying amount						358,843		368,873
Mortgage Loans | Fixed rate debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Debt, Carrying amount						39,841		40,734
Mortgage Loans | Pacific Northwest II Communities
Debt Instrument [Line Items]
Debt, Carrying amount						201,900
Maturity Date		Dec. 31, 2018	Jan. 31, 2022
Mortgage Loans | Capital Health
Debt Instrument [Line Items]
Debt, Carrying amount						$ 35,400
Maturity Date			Jan. 31, 2022	Jan. 31, 2020		Jan. 5, 2022	[1],[2]
Payment Terms	[1]					Monthly principal and interest payments based on a 25-year amortization schedule
Mortgage Loans | Capital Health | Fixed rate debt
Debt Instrument [Line Items]
Debt, Carrying amount	[1]					$ 60,902		62,767
Mortgage Loans | Primrose I Communities
Debt Instrument [Line Items]
Maturity Date	[2],[3]					Sep. 1, 2022
Interest on Loan accrues - Fixed rate	[3],[4]					4.11%
Payment Terms	[3]					Monthly principal and interest payments based on a 30-year amortization schedule
Mortgage Loans | Primrose I Communities | Fixed rate debt
Debt Instrument [Line Items]
Debt, Carrying amount	[3]					$ 48,753		49,899
Mortgage Loans | Primrose I Communities | Minimum | Period One
Debt Instrument [Line Items]
Percentage of prepayment penalty on principal repaid						1.00%
Mortgage Loans | Watercrest at Mansfield
Debt Instrument [Line Items]
Maturity Date	[2],[5]					Jun. 1, 2023
Interest on Loan accrues - Fixed rate	[4],[5]					4.68%
Payment Terms	[5]					Monthly principal and interest payments based on a total payment of $143,330
Mortgage Loans | Watercrest at Mansfield | Fixed rate debt
Debt Instrument [Line Items]
Debt, Carrying amount	[5]					$ 25,163		25,676
Remaining loan premium						200
Mortgage Loans | Palmilla Senior Living | Interest Rate Cap
Debt Instrument [Line Items]
Notional amount of derivative contract						$ 117,000
Mortgage Loans | ProMed Building I | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Maturity Date	[2],[6]					Jan. 15, 2022
Interest on Loan accrues - Fixed rate	[4],[6]					3.64%
Payment Terms	[6]					Monthly principal and interest payments based upon a 30-year amortization schedule
Mortgage Loans | ProMed Building I | Fixed rate debt | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Debt, Carrying amount	[6]					$ 6,473		$ 6,673
Mortgage Loans | Medical Portfolio II | Interest Rate Swap | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Notional amount of derivative contract						79,200
Mortgage Loans | Triangle Orthopaedic | Interest Rate Cap | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Notional amount of derivative contract						117,000
Mortgage Loans | Knoxville Medical Office Properties and Claremont Medical Office | Interest Rate Swap | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Notional amount of derivative contract					$ 51,600
Mortgage Loans | MHOSH MOB | Interest Rate Cap | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Notional amount of derivative contract						57,600
Mortgage Loans | Southeast Medical Office Properties | Interest Rate Cap | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Notional amount of derivative contract						$ 125,100
Mortgage, Supplemental Loan | Pacific Northwest II Communities
Debt Instrument [Line Items]
Maturity Date			Jan. 31, 2022
Debt, Carrying amount			$ 9,500
Interest on Loan accrues - Fixed rate			4.30%
Payment Terms						monthly interest only payments for the first 12 months followed by monthly principal and interest payments for the remaining term of the loan using a 30-year amortization period with the remaining principal balance payable at maturity.
Mortgage, Supplemental Loan | Pacific Northwest II Communities | Minimum
Debt Instrument [Line Items]
Percentage of prepayment penalty on principal repaid						1.00%
Mortgage, Supplemental Loan | Capital Health
Debt Instrument [Line Items]
Debt, Carrying amount			$ 28,000
Maturity Date			Jan. 31, 2022
Interest on Loan accrues - Fixed rate			4.30%			4.25%
Payment Terms						monthly interest only payments for the first 12 months followed by monthly principal and interest payments for the remaining term of the loan using a 30-year amortization period with the remaining principal balance payable at maturity.
Mortgage, Supplemental Loan | Capital Health | Minimum
Debt Instrument [Line Items]
Percentage of prepayment penalty on principal repaid						1.00%
30-day LIBOR
Debt Instrument [Line Items]
Interest accrues on loan, LIBOR						2.50%		1.56%
30-day LIBOR | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan, LIBOR						2.50%		1.56%
30-day LIBOR | Mortgage Loans | Palmilla Senior Living
Debt Instrument [Line Items]
Maturity Date	[2],[7]					Mar. 22, 2020
Payment Terms	[7]					Monthly interest only payments through April 2017; principal and interest payments thereafter based on a 30-year amortization schedule
Interest accrues on loan in addition to LIBOR	[4],[7]					2.00%
30-day LIBOR | Mortgage Loans | Triangle Orthopaedic | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Maturity Date	[2],[8]					Apr. 11, 2021
Payment Terms	[8]					Interest only payments through March 2017; principal payments thereafter based on a 30-year amortization schedule
Interest accrues on loan in addition to LIBOR	[4],[8]					2.25%
30-day LIBOR | Mortgage Loans | Knoxville Medical Office Properties and Claremont Medical Office | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Maturity Date	[2],[9]					May 24, 2022
Payment Terms	[9]					Monthly principal and interest payments based on a 30-year amortization schedule
Interest accrues on loan in addition to LIBOR	[4],[9]					2.45%
30-day LIBOR | Mortgage Loans | MHOSH MOB | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Maturity Date	[2],[10]					May 24, 2023
Payment Terms	[10]					Interest only payments through June 2020; principal payments thereafter based on a 30-year amortization schedule
Interest accrues on loan in addition to LIBOR	[4],[10]					2.20%
30-day LIBOR | Mortgage Loans | Southeast Medical Office Properties | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Maturity Date	[2],[11]					Jun. 14, 2023
Payment Terms	[11]					Interest only payments through January 2021; principal payments thereafter based on a 30-year amortization schedule
Interest accrues on loan in addition to LIBOR	[4],[11]					2.00%
Ninety Days London Interbank Offered Rate
Debt Instrument [Line Items]
Interest accrues on loan, LIBOR						2.81%		1.70%
Ninety Days London Interbank Offered Rate | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan, LIBOR						2.81%		1.70%
Ninety Days London Interbank Offered Rate | Mortgage Loans | Medical Portfolio II | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Maturity Date	[2],[12]					Jul. 14, 2019
Payment Terms	[12]					Monthly principal and interest payments based on a 25-year amortization schedule
Interest accrues on loan in addition to LIBOR	[4],[12]					2.35%
30-day LIBOR | Mortgage Loans | ProMed Building I | Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Interest accrues on loan in addition to LIBOR						2.20%
[1]	In August 2017, the Company extended the maturity date on the existing loan of approximately $35.4 million from January 2020 to January 2022.  In addition, the Company received approximately $28.0 million of additional borrowings through a supplemental loan with the same lender, which is co-terminus with the existing mortgage loans, collateralized by the communities and matures in January 2022.  The existing loan accrues interest at a fixed rate equal to 4.25% per annum. The supplemental loan accrues interest at a fixed rate equal to 4.3% per annum and includes monthly interest only payments for the first 12 months followed by monthly principal and interest payments for the remaining term of the loan using a 30-year amortization period with the remaining principal balance payable at maturity. The loan may be prepaid, in whole or in part, with a prepayment premium equal to the greater of: (i) one percent (1%) of the principal amount being prepaid, multiplied by the quotient of the number of full months remaining until the maturity date of the loan (calculated as of the prepayment date) divided by the number of full months comprising the term of the loan; or (b) a “make-whole” payment equal to the present value of the loan less the amount of principal and accrued interest being prepaid calculated as of the prepayment date for the period between that date and the maturity date.
[2]	Represents the initial maturity date (or, as applicable, the maturity date as extended). Certain of the Company’s mortgages and other notes payable agreements include extension options held by the Company under which the maturity dates may be extended beyond the date presented, subject to certain lender conditions and/or related fees.
[3]	If prepaid prior to March 1, 2022, the Primrose I Communities Mortgage Loan is subject to a prepayment penalty in an amount equal to the greater of (i) 1% of the principal being repaid, or (ii) an amount calculated on the principal being repaid, multiplied by the difference between the Primrose I Communities Mortgage Loan interest rate, and a calculated yield rate tied to the rates on applicable U.S. Treasuries. If prepayment is made between March 1, 2022, and May 31, 2022, the prepayment penalty will be 1% of the outstanding principal balance of the Primrose I Communities Mortgage Loan. No prepayment fee is required if the Primrose I Communities Mortgage Loan is prepaid between June 1, 2022 and maturity. Partial prepayment of a loan is not permitted. The loan is transferable upon sale of the assets subject to lender approval.
[4]	The 30-day and 90-day LIBOR were approximately 2.50% and 2.81%, respectively, as of December 31, 2018 and approximately 1.56% and 1.70%, respectively, as of December 31, 2017.
[5]	The balance for this loan excludes a remaining premium of $0.2 million related to the mortgage note payable assumed being recorded at fair value on the acquisition date.
[6]	Beginning January 2020, the interest rate transitions to variable rate based on 30-day LIBOR plus 2.20% per annum.
[7]	The Company entered into an interest rate cap with a remaining notional amount of $117.0 million, of which a portion has been designated to hedge these loans; see Note 12. “Derivative Financial Instruments” for additional information.
[8]	The Company entered into an interest rate cap with a remaining notional amount of $117.0 million, of which a portion has been designated to hedge this loan; see Note 12. “Derivative Financial Instruments” for additional information.
[9]	In May 2017, the Company refinanced the loans related to the Claremont Medical Office property and the Knoxville Medical Office Properties of approximately $12.4 million and $37.2 million, respectively, into a combined loan. The original loans were scheduled to mature January 2018 and July 2018, respectively. The Company entered into an interest rate swap with a remaining notional amount of $51.6 million; see Note 12. “Derivative Financial Instruments” for additional information.
[10]	The Company entered into an interest rate cap with a remaining notional amount of $57.6 million; see Note 12. “Derivative Financial Instruments” for additional information.
[11]	The Company entered into an interest rate cap with a remaining notional amount of $125.1 million; see Note 12. “Derivative Financial Instruments” for additional information.
[12]	The Company entered into an interest rate swap with a remaining notional amount of $79.2 million; see Note 12. “Derivative Financial Instruments” for additional information.

Schedule of Fair Market Value a

Schedule of Fair Market Value and Carrying Value of Indebtedness (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Carrying Value	$ 959,689
Indebtedness Associated with Assets Held for Sale
Debt Instrument [Line Items]
Fair Value	751,800	$ 748,700
Carrying Value	748,300	750,100
Mortgages and other notes payable, net
Debt Instrument [Line Items]
Fair Value	528,700	543,800
Carrying Value	530,600	539,500
Credit facilities
Debt Instrument [Line Items]
Fair Value	426,600	374,400
Carrying Value	$ 425,600	$ 372,700

Related Party Arrangements - Ad

Related Party Arrangements - Additional Information (Detail) - USD ($) $ in Thousands		1 Months Ended	12 Months Ended
		Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Related Party Transaction [Line Items]
Annualized return of investment			6.00%
Oversight fee as percentage of gross revenues from property managed			1.00%
Construction management fee as percentage of hard and soft costs			5.00%
Initial purchase price of property percentage			10.00%
Property management fees	[1],[2]			$ 381
Investment services fees	[3]		$ 60	126	$ 739
Single Tenant Properties
Related Party Transaction [Line Items]
Property management fees as percentage of annual gross rental revenue			2.00%
Multi Tenant Properties
Related Party Transaction [Line Items]
Property management fees as percentage of annual gross rental revenue			4.00%
Advisor
Related Party Transaction [Line Items]
Investment service fee as percentage of purchase price of properties			1.85%
Monthly asset management fee as Percentage of real estate value			0.08334%
Financing coordination fee as percentage of gross amount of refinancing			1.00%
Property disposition fee payable as percentage equals to gross market capitalization upon listing on national securities exchange			1.00%
Property disposition fee payable as percentage of gross consideration paid upon liquidity event			1.00%
Property disposition fee payable as percentage equals to gross sales price upon sale or transfer of assets			1.00%
Annualized return of investment			6.00%
Operating expenses reimbursement as percentage average invested assets			2.00%
Operating expenses reimbursement percentage of net income			25.00%
Annualized return of investment			6.00%
Property Manager
Related Party Transaction [Line Items]
Property management agreement expire stated date		Jun. 28, 2018
Property management fees			$ 1,000
CNL Capital Markets Corp
Related Party Transaction [Line Items]
Investment services fees			$ 900	$ 900	$ 900
[1]	Amounts are recorded as due to related parties in the accompanying consolidated balance sheets.
[2]	For the years ended December 31, 2018, 2017 and 2016, the Company incurred approximately $2.3 million, $4.8 million and $5.1 million, respectively, in property and construction management fees payable to the Property Manager of which approximately $5,000, $0.3 million and $0.9 million, respectively, in construction management fees were capitalized and included in real estate under development in the accompanying consolidated balance sheets. The Property Management Agreement was not renewed beyond its expiration date of June 2018.
[3]	For the year ended December 31, 2018, the Company incurred approximately $0.1 million in investment services fees of which approximately $0.1 million, was capitalized and included in real estate assets, net in the accompanying consolidated balance sheets. For the year ended December 31, 2017, the Company incurred approximately $0.1 million in investment service fees of which approximately $0.1 million was capitalized and included in real estate under development. For the December 31, 2016, the Company incurred approximately $0.7 million in investment service fees of which approximately $0.2 million was capitalized and included in real estate under development. Investment service fees, that are not capitalized, are recorded as acquisition fees and expenses in the accompanying consolidated statements of operations.

Schedule of Fees, Reimbursable

Schedule of Fees, Reimbursable Expenses and Related Amounts Unpaid to Related Parties (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018		Dec. 31, 2017		Dec. 31, 2016
Related Party Transaction [Line Items]
Operating expenses	[1]	$ 6,203		$ 5,791		$ 5,966
Acquisition fees and expenses						206
Total reimbursable expenses		6,203		5,797		6,070
Investment services fees	[2]	60		126		739
Disposition fee	[3]	58				343
Financing coordination fees		2,326	[4]	3,601	[4]	0
Property management fees	[5]	2,323		4,807		5,059
Asset management fees	[6]	30,385		30,157		29,121
Total reimbursable expenses, net		41,355		44,488		41,332
Operating expenses, unpaid	[1],[7]	722		1,042
Acquisition fees and expenses, unpaid	[7]			2
Total reimbursable expenses due	[7]	722		1,044
Property management fees, unpaid	[5],[7]			381
Asset management fees, unpaid	[6],[7]	2,533		2,516
Total related amount unpaid	[7]	3,255		3,941
Property Manager
Related Party Transaction [Line Items]
Acquisition fees and expenses				$ 6		$ 104
Property management fees, unpaid		$ 1,000
[1]	Amounts are recorded as general and administrative expenses in the accompanying consolidated statements of operations unless such amounts represent prepaid expenses, which are capitalized in the accompanying consolidated balance sheets.
[2]	For the year ended December 31, 2018, the Company incurred approximately $0.1 million in investment services fees of which approximately $0.1 million, was capitalized and included in real estate assets, net in the accompanying consolidated balance sheets. For the year ended December 31, 2017, the Company incurred approximately $0.1 million in investment service fees of which approximately $0.1 million was capitalized and included in real estate under development. For the December 31, 2016, the Company incurred approximately $0.7 million in investment service fees of which approximately $0.2 million was capitalized and included in real estate under development. Investment service fees, that are not capitalized, are recorded as acquisition fees and expenses in the accompanying consolidated statements of operations.
[3]	Amounts are recorded as a reduction to gain on sale of real estate in the accompanying consolidated statements of operations.
[4]	For the year ended December 31, 2018, the Company incurred approximately $2.3 million in financing coordination fees related to the refinancing of the loans associated with certain operating properties. For the December 31, 2017, the Company incurred approximately $3.6 million in financing coordination fees related to the refinancing of the loans associated with certain operating properties of which approximately $0.9 million in financing coordination fees were capitalized as loan costs and reduced mortgages and other notes payable, net in the accompanying consolidated balance sheets.   There were no financing coordination fees incurred for the year ended December 31, 2016.
[5]	For the years ended December 31, 2018, 2017 and 2016, the Company incurred approximately $2.3 million, $4.8 million and $5.1 million, respectively, in property and construction management fees payable to the Property Manager of which approximately $5,000, $0.3 million and $0.9 million, respectively, in construction management fees were capitalized and included in real estate under development in the accompanying consolidated balance sheets. The Property Management Agreement was not renewed beyond its expiration date of June 2018.
[6]	For the years ended December 31, 2018, 2017 and 2016, the Company incurred approximately $30.4 million, $30.2 million and $29.1 million, respectively, in asset management fees payable to the Advisor, of which approximately $2.9 million for the year ended December 31, 2016 was settled in accordance with the terms of the Advisor Expense Support Agreement. No expense support was received for the years ended December 31, 2018 and 2017. There was approximately $11,000, $0.5 million and $0.8 million, respectively, capitalized and included in real estate under development in the accompanying consolidated balance sheets for the years ended December 31, 2018, 2017 and 2016.
[7]	Amounts are recorded as due to related parties in the accompanying consolidated balance sheets.

Schedule of Fees, Reimbursabl_2

Schedule of Fees, Reimbursable Expenses and Related Amounts Unpaid to Related Parties (Parenthetical) (Detail) - USD ($)		12 Months Ended
		Dec. 31, 2018		Dec. 31, 2017		Dec. 31, 2016
Related Party Transactions [Abstract]
Investment services fees	[1]	$ 60,000		$ 126,000		$ 739,000
Investment service fees capitalized		100,000		100,000		200,000
Financing coordination fees		2,326,000	[2]	3,601,000	[2]	0
Loan costs capitalized				900,000
Property and construction management fees payable		2,300,000		4,800,000		5,100,000
Construction management fees capitalized		5,000		300,000		900,000
Asset management fees	[3]	30,385,000		30,157,000		29,121,000
Asset management fees capitalized		11,000		500,000		800,000
Expense under Support Agreement		$ 0		$ 0		$ 2,900,000
[1]	For the year ended December 31, 2018, the Company incurred approximately $0.1 million in investment services fees of which approximately $0.1 million, was capitalized and included in real estate assets, net in the accompanying consolidated balance sheets. For the year ended December 31, 2017, the Company incurred approximately $0.1 million in investment service fees of which approximately $0.1 million was capitalized and included in real estate under development. For the December 31, 2016, the Company incurred approximately $0.7 million in investment service fees of which approximately $0.2 million was capitalized and included in real estate under development. Investment service fees, that are not capitalized, are recorded as acquisition fees and expenses in the accompanying consolidated statements of operations.
[2]	For the year ended December 31, 2018, the Company incurred approximately $2.3 million in financing coordination fees related to the refinancing of the loans associated with certain operating properties. For the December 31, 2017, the Company incurred approximately $3.6 million in financing coordination fees related to the refinancing of the loans associated with certain operating properties of which approximately $0.9 million in financing coordination fees were capitalized as loan costs and reduced mortgages and other notes payable, net in the accompanying consolidated balance sheets.   There were no financing coordination fees incurred for the year ended December 31, 2016.
[3]	For the years ended December 31, 2018, 2017 and 2016, the Company incurred approximately $30.4 million, $30.2 million and $29.1 million, respectively, in asset management fees payable to the Advisor, of which approximately $2.9 million for the year ended December 31, 2016 was settled in accordance with the terms of the Advisor Expense Support Agreement. No expense support was received for the years ended December 31, 2018 and 2017. There was approximately $11,000, $0.5 million and $0.8 million, respectively, capitalized and included in real estate under development in the accompanying consolidated balance sheets for the years ended December 31, 2018, 2017 and 2016.

Related Party Arrangement, Fees

Related Party Arrangement, Fees and Expenses Incurred (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Related Party Transaction [Line Items]
Asset management fees	[1]	$ 30,385	$ 30,157	$ 29,121
Cash distributions on Restricted Stock		$ 59,051	$ 34,512	31,454
Expense Support Agreements
Related Party Transaction [Line Items]
Asset management fees	[2]			$ 2,918
Then-current NAV	[3]	$ 10.01	$ 10.32	$ 10.04
Restricted Stock shares	[4]			291
Asset management fees	[2]	$ 13,565
Then-current NAV	[3]	$ 10.01
Expense Support Agreements | Restricted Stock
Related Party Transaction [Line Items]
Cash distributions on Restricted Stock	[5]	$ 630	$ 571	$ 427
Restricted Stock shares	[4]	1,332
Cash distributions on Restricted Stock	[5]	$ 2,012
[1]	For the years ended December 31, 2018, 2017 and 2016, the Company incurred approximately $30.4 million, $30.2 million and $29.1 million, respectively, in asset management fees payable to the Advisor, of which approximately $2.9 million for the year ended December 31, 2016 was settled in accordance with the terms of the Advisor Expense Support Agreement. No expense support was received for the years ended December 31, 2018 and 2017. There was approximately $11,000, $0.5 million and $0.8 million, respectively, capitalized and included in real estate under development in the accompanying consolidated balance sheets for the years ended December 31, 2018, 2017 and 2016.
[2]	No other amounts have been settled in connection with the expense support agreements for the years ended December 31, 2018, 2017 and 2016, and cumulatively as of December 31, 2018.
[3]	The number of Restricted Stock shares granted to the Advisor in lieu of payment in cash is determined by dividing the expense support amount for the respective determination date by the then-current NAV per share.
[4]	Restricted stock shares are comprised of approximately 1.3 million issued to the Advisor as of December 31, 2018. No fair value was assigned to the Restricted Stock shares as the shares were valued at zero, which represents the lowest possible value estimated at vesting. In addition, the restricted stock shares were treated as unissued for financial reporting purposes because the vesting criteria had not been met as of December 31, 2018.
[5]	The cash distributions have been recognized as compensation expense as declared and included in general and administrative expense in the accompanying consolidated statements of operations.

Related Party Arrangement, Fe_2

Related Party Arrangement, Fees and Expenses Incurred (Parenthetical) (Detail) shares in Millions	12 Months Ended
	Dec. 31, 2018USD ($)shares
Related Party Transactions [Abstract]
Shares issued to Advisor | shares	1.3
Restricted stock fair value | $	$ 0

Summary of Derivative Financial

Summary of Derivative Financial Instruments and Corresponding Asset (Liability), Including Properties Classified as Held for Sale (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017
Derivative Financial Instruments One
Derivative [Line Items]
Strike	[1]	1.30%
Credit Spread	[1]	2.60%
Trade date		Jan. 17, 2013
Forward date		Jan. 15, 2015
Maturity date		Jan. 16, 2018
Fair value asset (liability)			$ 1
Derivative Financial Instruments Two
Derivative [Line Items]
Strike	[1]	2.70%
Credit Spread	[1]	2.50%
Trade date		Sep. 6, 2013
Forward date		Aug. 17, 2015
Maturity date		Jul. 10, 2018
Fair value asset (liability)			(213)
Derivative Financial Instruments Three
Derivative [Line Items]
Strike	[1]	2.80%
Credit Spread	[1]	2.50%
Trade date		Sep. 6, 2013
Forward date		Aug. 17, 2015
Maturity date		Aug. 29, 2018
Fair value asset (liability)			(182)
Derivative Financial Instruments Four
Derivative [Line Items]
Strike	[1]	2.40%
Credit Spread	[1]	2.90%
Trade date		Aug. 15, 2014
Forward date		Jun. 1, 2016
Maturity date		Jun. 2, 2019
Fair value asset (liability)			(280)
Derivative Financial Instruments Five
Derivative [Line Items]
Notional amount of derivative contract	[2]	$ 79,201
Strike	[1]	2.30%
Credit Spread	[1]	2.40%
Trade date		Sep. 12, 2014
Forward date		Aug. 1, 2015
Maturity date		Jul. 15, 2019
Fair value asset (liability)		$ 168	(424)
Derivative Financial Instruments Six
Derivative [Line Items]
Notional amount of derivative contract	[2]	$ 175,000
Strike	[1]	1.60%
Credit Spread	[1]	2.00%
Trade date		Dec. 23, 2014
Forward date		Dec. 19, 2014
Maturity date	[3]	Feb. 19, 2019
Fair value asset (liability)		$ 220	464
Derivative Financial Instruments Seven
Derivative [Line Items]
Notional amount of derivative contract	[2]	$ 125,087
Strike	[1]	1.70%
Credit Spread	[1]	2.00%
Trade date		Jan. 9, 2015
Forward date		Dec. 10, 2015
Maturity date		Dec. 22, 2019
Fair value asset (liability)		$ 966	516
Derivative Financial Instruments Eight
Derivative [Line Items]
Strike	[1]	1.50%
Trade date		Nov. 19, 2015
Forward date		Nov. 19, 2015
Maturity date		Nov. 30, 2018
Fair value asset (liability)			681
Derivative Financial Instruments Nine
Derivative [Line Items]
Strike	[1]	1.50%
Trade date		Mar. 1, 2016
Forward date		Mar. 1, 2016
Maturity date		Nov. 30, 2018
Fair value asset (liability)			393
Derivative Financial Instruments Ten
Derivative [Line Items]
Notional amount of derivative contract	[4]	$ 117,000
Strike	[1]	2.30%
Trade date		Aug. 29, 2017
Forward date		Aug. 29, 2017
Maturity date		Sep. 1, 2019
Fair value asset (liability)		$ 247	$ 95
Derivative Financial Instruments Eleven
Derivative [Line Items]
Notional amount of derivative contract	[4]	$ 410,000
Strike	[1]	3.00%
Trade date		Mar. 28, 2018
Forward date		Nov. 30, 2018
Maturity date		Dec. 19, 2019
Fair value asset (liability)		$ 44
Derivative Financial Instruments Twelve
Derivative [Line Items]
Notional amount of derivative contract	[4]	$ 51,575
Strike	[1]	3.00%
Trade date		Mar. 28, 2018
Forward date		Jul. 10, 2018
Maturity date		Dec. 19, 2019
Fair value asset (liability)		$ 6
Derivative Financial Instruments Thirteen
Derivative [Line Items]
Notional amount of derivative contract	[4]	$ 175,000
Strike	[1]	3.00%
Trade date		Mar. 28, 2018
Forward date		Feb. 19, 2019
Maturity date		Dec. 19, 2019
Fair value asset (liability)		$ 19
Derivative Financial Instruments Fourteen
Derivative [Line Items]
Notional amount of derivative contract	[4]	$ 57,630
Strike	[1]	3.00%
Trade date		May 4, 2018
Forward date		May 4, 2018
Maturity date		Dec. 19, 2019
Fair value asset (liability)		$ 6
[1]	The all-in rates are equal to the sum of the Strike and Credit Spread detailed above.
[2]	Amounts related to interest rate swaps held by the Company which are recorded at fair value and included in either other assets or other liabilities in the accompanying consolidated balance sheets.
[3]	Refer to Note 18 – “Subsequent Events” for additional information regarding the extension of the First Term Loan.
[4]	Amounts related to the interest rate caps held by the Company, or its equity method investment, which are recorded at fair value and included in other assets in the accompanying consolidated balance sheets.

Summary of the Gross and Net Pr

Summary of the Gross and Net Presentation of Amounts Related to the Derivative Financial Instruments (Detail) - USD ($) $ in Thousands		Dec. 31, 2018		Dec. 31, 2017
Interest Rate Swap Agreement One
Derivative [Line Items]
Notional amount of derivative contract	[1]	$ 79,201		$ 11,842
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount		168		1
Fair value asset (liability)		168		1
Interest Rate Swap Agreement Two
Derivative [Line Items]
Notional amount of derivative contract	[1]	175,000		36,839
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount		220		(213)
Fair value asset (liability)		220		(213)
Interest Rate Swap Agreement Three
Derivative [Line Items]
Notional amount of derivative contract	[1]	125,087		25,103
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount		966		(182)
Fair value asset (liability)		966		(182)
Interest Rate Swap Agreement Four
Derivative [Line Items]
Notional amount of derivative contract		117,000	[2]	47,072	[1]
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount		247		(280)
Fair value asset (liability)		247		(280)
Interest Rate Swap Agreement Five
Derivative [Line Items]
Notional amount of derivative contract		410,000	[2]	80,841	[1]
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount		44		(424)
Fair value asset (liability)		44		(424)
Interest Rate Swap Six Agreement
Derivative [Line Items]
Notional amount of derivative contract		51,575	[2]	175,000	[1]
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount		6		464
Fair value asset (liability)		6		464
Interest Rate Swap Seven Agreement
Derivative [Line Items]
Notional amount of derivative contract		175,000	[2]	129,722	[1]
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount		19		516
Fair value asset (liability)		19		516
Interest Rate Swap Eight Agreement
Derivative [Line Items]
Notional amount of derivative contract		57,630	[2]	260,000	[1]
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount		6		681
Fair value asset (liability)		$ 6		681
Interest Rate Swap Nine Agreement
Derivative [Line Items]
Notional amount of derivative contract	[2]			150,000
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount				393
Fair value asset (liability)				393
Interest Rate Swap Ten Agreement
Derivative [Line Items]
Notional amount of derivative contract	[2]			117,000
Amounts of asset (liability) presented in the accompanying condensed consolidated balance sheet, Gross amount				95
Fair value asset (liability)				$ 95
[1]	Amounts related to interest rate swaps held by the Company which are recorded at fair value and included in either other assets or other liabilities in the accompanying consolidated balance sheets.
[2]	Amounts related to the interest rate caps held by the Company, or its equity method investment, which are recorded at fair value and included in other assets in the accompanying consolidated balance sheets.

Summary of Derivative Financi_2

Summary of Derivative Financial Instruments and Corresponding Asset (Liability), Including Properties Classified as Held for Sale (Parenthetical) (Detail) $ in Millions	1 Months Ended
	May 31, 2018USD ($)
Mortgage Loans
Derivative [Line Items]
Proceeds from the settlement of interest rate swaps	$ 0.1

Equity - Additional Information

Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions	Sep. 30, 2015	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Class Of Stock [Line Items]
Aggregate proceeds received from offering	$ 1,700,000	$ 22,013	$ 43,220	$ 42,554
Subscriptions received for common stock through public offering and reinvestment plan (in shares)		2.1	4.3	4.4
Cash distribution declared		$ 81,064	$ 77,732	$ 74,008
Cash paid to stockholders		59,051	34,512	31,454
Redemptions of common stock		4,400	4,700	3,700
Common stock approved for redemption value		$ 2,800	$ 4,700	$ 3,700
Redemption of common stock, per share		$ 10.14	$ 9.99	$ 9.73
Redemptions of common stock		$ 28,443	$ 47,332	$ 36,243
Suspended redemption request common stock, value		$ 16,400
Suspended redemption request common stock, shares		1.6
Redemption plan suspended date		Jul. 11, 2018
Description of redemption plan		There can be no guarantee that the Redemption Plan will be reinstated by the Company’s board of directors.
Reinvestment Plan
Class Of Stock [Line Items]
Cash distribution declared		$ 22,000	$ 43,200	$ 42,600
Watercrest Katy
Class Of Stock [Line Items]
Redeemable noncontrolling interest in joint venture		5.00%

Tax Composition of Company's Di

Tax Composition of Company's Distributions Declared (Detail)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Uncategorized [Abstract]
Ordinary income	0.00%	0.00%	21.50%
Capital gain	0.00%	0.00%	14.40%
Unrecaptured Sec. 1250 gain	0.00%	0.00%	1.20%
Return of capital	100.00%	100.00%	62.90%

Distributions of promoted inter

Distributions of promoted interest to share holders (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Class Of Stock [Line Items]
Distributions to holders of promoted interest	$ (406)	$ (955)	$ (6,650)
Dogwood Forest of Acworth
Class Of Stock [Line Items]
Distributions to holders of promoted interest			(3,850)
Wellmore of Tega Cay
Class Of Stock [Line Items]
Distributions to holders of promoted interest			$ (2,800)
HarborChase of Villages Crossing
Class Of Stock [Line Items]
Distributions to holders of promoted interest		$ (955)
Dogwood Forest of Grayson (Grayson, GA)
Class Of Stock [Line Items]
Distributions to holders of promoted interest	$ (406)

Effect of Derivative Financial

Effect of Derivative Financial Instruments (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss	$ 2,162	$ 6,878	$ 1,884
Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	247	(5,043)	(7,177)
Interest Rate Swap
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss	1,219	5,573	3,487
Interest Rate Swap | Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	2,457	(3,902)	(7,150)
Interest Rate Cap
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss	690	1,013	(1,584)
Interest Rate Cap | Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	(1,957)	(849)	(45)
Interest Rate Cap | Unconsolidated Joint Venture
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss			(1)
Reclassification of Interest Rate Swaps Upon Derecognition
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss	253	318
Reclassification of Interest Rate Swaps Upon Derecognition | Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings	$ (253)	(318)
Reclassification of Interest Rate Swaps Due to Ineffectiveness
Derivative Instruments Gain Loss [Line Items]
Derivative instruments, Gain (loss) recognized in other comprehensive loss		(26)	(18)
Reclassification of Interest Rate Swaps Due to Ineffectiveness | Interest Expense and Loan Cost Amortization
Derivative Instruments Gain Loss [Line Items]
Gain (loss) reclassified from accumulated other comprehensive loss into earnings		$ 26	$ 18

Components of Income Tax Expens

Components of Income Tax Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Current:
Federal	$ 113	$ (245)
State	(477)	(448)	$ (276)
Total current expense	(364)	(693)	(276)
Deferred:
Federal	(3,333)	8,826
State	66	305
Total deferred benefit	(3,267)	9,131
Income tax (expense) benefit	$ (3,631)	$ 8,438	$ (276)

Significant Components of Defer

Significant Components of Deferred Tax Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Carryforwards of net operating loss	$ 6,046	$ 9,266
Minimum tax credit carryforward	118	189
Prepaid rent	712	648
Valuation allowance	(946)	(972)
Deferred tax assets, net	$ 5,930	$ 9,131

Reconciliation of Income Tax (E

Reconciliation of Income Tax (Expense) Benefit (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Tax benefit computed at federal statutory rate	$ 3,593	$ 9,442	$ 8,593
Impact of REIT election	(6,922)	(10,650)	(8,593)
State income tax expense net of federal benefit	(399)	(331)	(276)
Effect of change in future tax rates		1,861
Effect of change in valuation allowance	97	8,116
Income tax (expense) benefit	$ (3,631)	$ 8,438	$ (276)
Tax benefit computed at federal statutory rate	21.00%	35.00%	35.00%
Impact of REIT election	(40.45%)	(39.48%)	(35.00%)
State income tax expense net of federal benefit	(2.33%)	(1.23%)	(1.12%)
Effect of change in future tax rates		6.90%
Effect of change in valuation allowance	0.57%	30.09%
Income tax (expense) benefit	(21.21%)	31.28%	(1.12%)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Taxes [Line Items]
Net operating loss carryforwards for federal and state	$ 23.3	$ 39
U.S. federal corporate tax rate	21.00%	35.00%	35.00%
Earliest Tax Year
Income Taxes [Line Items]
Tax year subject to examination	2015
Latest Tax Year
Income Taxes [Line Items]
Tax year subject to examination	2018
Domestic Tax Authority
Income Taxes [Line Items]
Net Operating loss carryforwards, beginning of expiration year	2019
State and Local Jurisdiction
Income Taxes [Line Items]
Net Operating loss carryforwards, beginning of expiration year	2035

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)Agreementshares	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Commitments And Contingencies [Line Items]
Number of promoted interest agreements	6
Number of promoted interest agreements not met established performance metrics	5
Number of promoted interest agreements met established performance metrics	1
Company accrued interest to holder's | $	$ 0.4
Ground Leases
Commitments And Contingencies [Line Items]
Operating lease rental expense | $	$ 2	$ 2	$ 1.9
Advisor Expense Support Agreement | Restricted Stock
Commitments And Contingencies [Line Items]
Contingently issuable restricted stock shares | shares	1.3

Schedule of Future Minimum Le_2

Schedule of Future Minimum Lease Payments to be Paid Under Ground Leases (Detail) - Ground Leases $ in Thousands	Dec. 31, 2018USD ($)
Operating Leased Assets [Line Items]
2019	$ 2,024
2020	2,047
2021	2,078
2022	2,108
2023	2,144
Thereafter	106,780
Total	$ 117,181

Concentration of Credit Risk -

Concentration of Credit Risk - Additional Information (Detail)	Dec. 31, 2018Property
Risks And Uncertainties [Abstract]
Number of properties owned, discontinued operations	63

Geographical Concentrations tha

Geographical Concentrations that Individually Accounted for 10% or More of Total Revenues Excluding Assets Classified as Held for Sale (Detail)		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Geographical | Total Revenue | State of Texas
Concentration Risk [Line Items]
Concentration risk, percentage	[1]	20.60%	20.80%	20.40%
[1]	Includes rental income and tenant reimbursements and resident fees and services. Adverse economic developments in this geographical area could significantly impact the Company’s results of operations and cash flows from operations, which in turn would impact its ability to pay debt service and make distributions to stockholders.

Selected Quarterly Financial _3

Selected Quarterly Financial Data (Unaudited) (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]
Total revenues	$ 79,615	$ 78,471	$ 77,189	$ 76,319	$ 75,050	$ 73,219	$ 69,392	$ 67,046	$ 311,594	$ 284,707	$ 265,199
Operating income (loss)	118	10,098	8,597	5,176	3,379	994	2,560	1,658	23,989	8,591	7,155
Income (loss) from continuing operations	(11,687)	(635)	(2,700)	(5,720)	2,351	(8,562)	(6,347)	(5,981)	(20,742)	(18,539)	(24,835)
(Loss) income from discontinued operations	5,037	(2,634)	(4,634)	(2,178)	(1,972)	(2,669)	(1,649)	(1,483)	(4,409)	(7,773)	(6,949)
Net income (loss) attributable to common stockholders	$ (6,642)	$ (3,248)	$ (7,308)	$ (7,874)	$ 433	$ (11,170)	$ (7,901)	$ (7,324)	$ (25,072)	$ (25,962)	$ (31,667)
Net loss per share of common stock (basic and diluted)
Continuing operations	$ (0.07)	$ 0	$ (0.02)	$ (0.03)	$ 0.01	$ (0.05)	$ (0.04)	$ (0.03)	$ (0.12)	$ (0.11)	$ (0.14)
Discontinued operations	$ 0.03	$ (0.02)	$ (0.03)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.04)	$ (0.04)
Weighted average number of shares outstanding (basic and diluted)	173,973	173,974	174,201	174,854	174,918	175,190	175,221	175,277	174,247	175,151	175,121

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail)	Feb. 19, 2019	Mar. 20, 2019USD ($)Property	Dec. 31, 2018Property	Dec. 31, 2017Property	Dec. 31, 2014USD ($)
Subsequent Event [Line Items]
Number of properties held for sale | Property			70	71
First Term Loan Facility
Subsequent Event [Line Items]
Line of credit facility extension period			12 months
Aggregate maximum principal amount available for borrowing					$ 175,000,000
Line of credit facility, initial maturity			2019-02
Line of credit facility, extended maturity			2020-02
Subsequet Event | IRF Sale Agreement | MOB/Healthcare Portfolio
Subsequent Event [Line Items]
Number of properties held for sale | Property		4
Gross sales price of properties		$ 94,000,000
Amount placed by buyer in escrow		$ 1,500,000
Subsequet Event | First Term Loan Facility
Subsequent Event [Line Items]
Line of credit facility extension period	12 months
Line of credit facility, initial maturity	2019-02
Line of credit facility, extended maturity	2020-02

Schedule II-Valuation and Qua_2

Schedule II-Valuation and Qualifying Accounts (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Valuation And Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Year	$ (3,437)	$ (11,068)	$ (7,009)
Charged to Costs and Expenses	(2,318)	7,631	(4,059)
Charged to Other Accounts	0	0	0
Balance at End of Year	(5,755)	(3,437)	(11,068)
Valuation Allowance of Deferred Tax Assets
Valuation And Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Year	(1,087)	(9,552)	(5,839)
Charged to Costs and Expenses	(829)	8,465	(3,713)
Charged to Other Accounts	0	0	0
Balance at End of Year	(1,916)	(1,087)	(9,552)
Allowance for Doubtful Accounts
Valuation And Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Year	(2,350)	(1,516)	(1,170)
Charged to Costs and Expenses	(1,489)	(834)	(346)
Charged to Other Accounts	0	0	0
Balance at End of Year	$ (3,839)	$ (2,350)	$ (1,516)

Schedule III-Real Estate And _2

Schedule III-Real Estate And Accumulated Depreciation (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 1,036,667
Initial Costs, Land & Land Improvements	[1]	240,642
Initial Costs, Building and Building Improvements	[1]	2,226,500
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	12,603
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	230,446
Costs Capitalized Subsequent to Acquisition, Construction in Process	[1]	3,490
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	253,244
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	2,456,947
Gross Amounts at which Carried at Close of period, Construction in Process	[1],[2]	3,490
Total		2,713,680	[1],[2]	$ 2,721,805	$ 2,692,074	$ 2,588,903
Accumulated Depreciation		(279,645)	[1]	$ (219,457)	$ (153,124)	$ (90,201)
Primrose Retirement Community Casper, Wyoming
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	11,270
Initial Costs, Land & Land Improvements	[1]	1,910
Initial Costs, Building and Building Improvements	[1]	16,310
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	30
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	296
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,940
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	16,606
Total	[1],[2]	18,546
Accumulated Depreciation	[1]	$ (3,004)
Date of construction	[1]	2004
Date Acquired	[1]	Feb. 16, 2012
Primrose Retirement Community Of Grand Island
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances		$ 7,950
Initial Costs, Land & Land Improvements		719
Initial Costs, Building and Building Improvements		12,140
Costs Capitalized Subsequent to Acquisition, Land & Improvements		56
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements		0
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[2]	775
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[2]	12,140
Total	[2]	12,915
Accumulated Depreciation		$ (2,296)
Date of construction		2005
Date Acquired		Feb. 16, 2012
Primrose Retirement Community Mansfield, Ohio
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 10,817
Initial Costs, Land & Land Improvements	[1]	650
Initial Costs, Building and Building Improvements	[1]	16,720
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	229
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	71
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	879
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	16,791
Total	[1],[2]	17,670
Accumulated Depreciation	[1]	$ (3,182)
Date of construction	[1]	2007
Date Acquired	[1]	Feb. 16, 2012
Primrose Retirement Community Marion, Ohio
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 8,972
Initial Costs, Land & Land Improvements	[1]	889
Initial Costs, Building and Building Improvements	[1]	16,305
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	889
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	16,305
Total	[1],[2]	17,194
Accumulated Depreciation	[1]	$ (3,040)
Date of construction	[1]	2006
Date Acquired	[1]	Feb. 16, 2012
Sweetwater Retirement Community Billings, Montana
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 9,744
Initial Costs, Land & Land Improvements	[1]	1,578
Initial Costs, Building and Building Improvements	[1]	14,205
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	19
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	0
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,597
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	14,205
Total	[1],[2]	15,802
Accumulated Depreciation	[1]	$ (2,583)
Date of construction	[1]	2006
Date Acquired	[1]	Feb. 16, 2012
HarborChase Community Lady Lake, Florida
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,165
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	986
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	15,424
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,151
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	15,424
Total	[1],[2]	18,575
Accumulated Depreciation	[1]	$ (2,106)
Date of construction	[1]	2013
Date Acquired	[1]	Aug. 29, 2012
Primrose Retirement Community Aberdeen, South Dakota
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 311
Initial Costs, Building and Building Improvements	[1]	3,794
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	311
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	3,794
Total	[1],[2]	4,105
Accumulated Depreciation	[1]	$ (631)
Date of construction	[1]	2005
Date Acquired	[1]	Dec. 19, 2012
Primrose Retirement Community Council Bluffs, Iowa
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,144
Initial Costs, Building and Building Improvements	[1]	11,117
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	5
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,149
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	11,117
Total	[1],[2]	12,266
Accumulated Depreciation	[1]	$ (1,903)
Date of construction	[1]	2008
Date Acquired	[1]	Dec. 19, 2012
Primrose Retirement Community Decatur, Illinois
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 9,888
Initial Costs, Land & Land Improvements	[1]	513
Initial Costs, Building and Building Improvements	[1]	16,706
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	154
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	513
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	16,860
Total	[1],[2]	17,373
Accumulated Depreciation	[1]	$ (2,751)
Date of construction	[1]	2009
Date Acquired	[1]	Dec. 19, 2012
Primrose Retirement Community Lima, Ohio
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 944
Initial Costs, Building and Building Improvements	[1]	17,115
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	8
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	4
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	952
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	17,119
Total	[1],[2]	18,071
Accumulated Depreciation	[1]	$ (2,796)
Date of construction	[1]	2006
Date Acquired	[1]	Dec. 19, 2012
Primrose Retirement Community Zanesville, Ohio
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 11,159
Initial Costs, Land & Land Improvements	[1]	1,184
Initial Costs, Building and Building Improvements	[1]	17,292
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	67
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,184
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	17,359
Total	[1],[2]	18,543
Accumulated Depreciation	[1]	$ (2,837)
Date of construction	[1]	2008
Date Acquired	[1]	Dec. 19, 2012
Capital Health of Symphony Manor Baltimore, Maryland
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 14,167
Initial Costs, Land & Land Improvements	[1]	2,319
Initial Costs, Building and Building Improvements	[1]	19,444
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	81
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,319
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	19,525
Total	[1],[2]	21,844
Accumulated Depreciation	[1]	$ (3,139)
Date of construction	[1]	2011
Date Acquired	[1]	Dec. 21, 2012
Curry House Assisted Living & Memory Care Cadillac, Michigan
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 7,452
Initial Costs, Land & Land Improvements	[1]	995
Initial Costs, Building and Building Improvements	[1]	11,072
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	8
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	2
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,003
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	11,074
Total	[1],[2]	12,077
Accumulated Depreciation	[1]	$ (1,805)
Date of construction	[1]	1966
Date Acquired	[1]	Dec. 21, 2012
Tranquillity at Fredericktowne, Maryland
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 20,125
Initial Costs, Land & Land Improvements	[1]	808
Initial Costs, Building and Building Improvements	[1]	14,291
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	5,960
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	808
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	20,251
Total	[1],[2]	21,059
Accumulated Depreciation	[1]	$ (2,697)
Date of construction	[1]	2000
Date Acquired	[1]	Dec. 21, 2012
Brookridge Heights Assisted Living and Memory Care Marquette, Michigan
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 12,697
Initial Costs, Land & Land Improvements	[1]	595
Initial Costs, Building and Building Improvements	[1]	11,339
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	4,697
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	595
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	16,036
Total	[1],[2]	16,631
Accumulated Depreciation	[1]	$ (2,288)
Date of construction	[1]	1998
Date Acquired	[1]	Dec. 21, 2012
Woodholme Gardens Assisted Living and Memory Care Pikesville, Maryland
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 6,460
Initial Costs, Land & Land Improvements	[1]	1,603
Initial Costs, Building and Building Improvements	[1]	13,472
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	54
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	8
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,657
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	13,480
Total	[1],[2]	15,137
Accumulated Depreciation	[1]	$ (2,195)
Date of construction	[1]	2010
Date Acquired	[1]	Dec. 21, 2012
Batesville Healthcare Center Batesville, Arkansas
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 397
Initial Costs, Building and Building Improvements	[1]	5,382
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	113
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	510
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	5,382
Total	[1],[2]	5,892
Accumulated Depreciation	[1]	$ (598)
Date of construction	[1]	1975
Date Acquired	[1]	May 31, 2013
Broadway Healthcare Center West Memphis, Arkansas
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 438
Initial Costs, Building and Building Improvements	[1]	10,560
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	77
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	438
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	10,637
Total	[1],[2]	11,075
Accumulated Depreciation	[1]	$ (1,189)
Date of construction	[1]	1994
Date Acquired	[1]	May 31, 2013
Jonesboro Healthcare Center Jonesboro, Arkansas
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 527
Initial Costs, Building and Building Improvements	[1]	13,493
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	5
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	527
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	13,498
Total	[1],[2]	14,025
Accumulated Depreciation	[1]	$ (1,494)
Date of construction	[1]	2012
Date Acquired	[1]	May 31, 2013
Magnolia Healthcare Center Magnolia, Arkansas
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 421
Initial Costs, Building and Building Improvements	[1]	10,454
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	421
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	10,454
Total	[1],[2]	10,875
Accumulated Depreciation	[1]	$ (1,177)
Date of construction	[1]	2009
Date Acquired	[1]	May 31, 2013
Mine Creek Healthcare Center Nashville, Arkansas
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 135
Initial Costs, Building and Building Improvements	[1]	2,942
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	11
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	36
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	146
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	2,978
Total	[1],[2]	3,124
Accumulated Depreciation	[1]	$ (347)
Date of construction	[1]	1978
Date Acquired	[1]	May 31, 2013
Searcy Healthcare Center Searcy, Arkansas
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 648
Initial Costs, Building and Building Improvements	[1]	6,017
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	222
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	648
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	6,239
Total	[1],[2]	6,887
Accumulated Depreciation	[1]	$ (710)
Date of construction	[1]	1973
Date Acquired	[1]	May 31, 2013
LaPorte Cancer Center Westville, Indiana
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 7,335
Initial Costs, Land & Land Improvements	[1]	433
Initial Costs, Building and Building Improvements	[1]	10,846
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	96
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	0
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	529
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	10,846
Total	[1],[2]	11,375
Accumulated Depreciation	[1]	$ (1,554)
Date of construction	[1]	2010
Date Acquired	[1]	Jun. 14, 2013
Jefferson Medical Commons Jefferson City, Tennessee
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 8,086
Initial Costs, Land & Land Improvements	[1]	151
Initial Costs, Building and Building Improvements	[1]	10,236
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	381
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	151
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	10,617
Total	[1],[2]	10,768
Accumulated Depreciation	[1]	$ (1,433)
Date of construction	[1]	2001
Date Acquired	[1]	Jul. 10, 2013
Physicians Plaza A at North Knoxville Medical Center Powell, Tennessee
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 13,234
Initial Costs, Land & Land Improvements	[1]	262
Initial Costs, Building and Building Improvements	[1]	16,976
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	85
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	262
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	17,061
Total	[1],[2]	17,323
Accumulated Depreciation	[1]	$ (2,379)
Date of construction	[1]	2005
Date Acquired	[1]	Jul. 10, 2013
Physicians Plaza B at North Knoxville Medical Center Powell, Tennessee
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 16,081
Initial Costs, Land & Land Improvements	[1]	303
Initial Costs, Building and Building Improvements	[1]	18,754
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	435
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	303
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	19,189
Total	[1],[2]	19,492
Accumulated Depreciation	[1]	$ (2,638)
Date of construction	[1]	2008
Date Acquired	[1]	Jul. 10, 2013
HarborChase of Jasper Jasper, Alabama
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 355
Initial Costs, Building and Building Improvements	[1]	6,358
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	0
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	36
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	355
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	6,394
Total	[1],[2]	6,749
Accumulated Depreciation	[1]	$ (918)
Date of construction	[1]	1998
Date Acquired	[1]	Jul. 31, 2013
Chestnut Commons MOB Elyria, Ohio
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,053
Initial Costs, Building and Building Improvements	[1]	15,650
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	59
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,112
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	15,650
Total	[1],[2]	17,762
Accumulated Depreciation	[1]	$ (2,352)
Date of construction	[1]	2008
Date Acquired	[1]	Aug. 16, 2013
Doctor's Specialty Hospital Leawood, Kansas
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 924
Initial Costs, Building and Building Improvements	[1]	5,771
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	69
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	993
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	5,771
Total	[1],[2]	6,764
Accumulated Depreciation	[1]	$ (842)
Date of construction	[1]	2001
Date Acquired	[1]	Aug. 16, 2013
Escondido Medical Arts Center Escondido, California
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,863
Initial Costs, Building and Building Improvements	[1]	12,199
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	50
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,863
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	12,249
Total	[1],[2]	14,112
Accumulated Depreciation	[1]	$ (1,645)
Date of construction	[1]	1994
Date Acquired	[1]	Aug. 16, 2013
John C. Lincoln Medical Office Plaza I Phoenix, Arizona
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 233
Initial Costs, Building and Building Improvements	[1]	2,779
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	146
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	233
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	2,925
Total	[1],[2]	3,158
Accumulated Depreciation	[1]	$ (463)
Date of construction	[1]	1980
Date Acquired	[1]	Aug. 16, 2013
John C. Lincoln Medical Office Plaza II Phoenix, Arizona
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 138
Initial Costs, Building and Building Improvements	[1]	1,908
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	100
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	138
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	2,008
Total	[1],[2]	2,146
Accumulated Depreciation	[1]	$ (274)
Date of construction	[1]	1984
Date Acquired	[1]	Aug. 16, 2013
North Mountain Medical Plaza Phoenix, Arizona
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 297
Initial Costs, Building and Building Improvements	[1]	4,079
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	204
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	297
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	4,283
Total	[1],[2]	4,580
Accumulated Depreciation	[1]	$ (635)
Date of construction	[1]	1994
Date Acquired	[1]	Aug. 16, 2013
Raider Ranch Development (Lubbock, TX)
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 4,992
Initial Costs, Building and Building Improvements	[1]	48,818
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	481
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	13,048
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	5,473
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	61,866
Total	[1],[2]	67,339
Accumulated Depreciation	[1]	$ (7,896)
Date of construction	[1]	2009
Date Acquired	[1]	Aug. 29, 2013
Town Village Oklahoma City, Oklahoma
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,020
Initial Costs, Building and Building Improvements	[1]	19,847
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	87
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	1,271
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,107
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	21,118
Total	[1],[2]	22,225
Accumulated Depreciation	[1]	$ (2,955)
Date of construction	[1]	2004
Date Acquired	[1]	Aug. 29, 2013
Calvert Medical Arts Center Prince Frederick, Maryland
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 20
Initial Costs, Building and Building Improvements	[1]	17,838
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	1
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	86
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	21
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	17,924
Total	[1],[2]	17,945
Accumulated Depreciation	[1]	$ (2,352)
Date of construction	[1]	2009
Date Acquired	[1]	Aug. 30, 2013
Calvert MOBs I, II, III Prince Frederick, Maryland
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 51
Initial Costs, Building and Building Improvements	[1]	14,334
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	329
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	51
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	14,663
Total	[1],[2]	14,714
Accumulated Depreciation	[1]	$ (1,959)
Date Acquired	[1]	Aug. 30, 2013
Calvert Medical Office Building I Prince Frederick, Maryland
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	1991
Calvert Medical Office Building II Prince Frederick, Maryland
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	1999
Calvert Medical Office Building III Prince Frederick, Maryland
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2000
Dunkirk Medical Center Dunkirk, Maryland
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 351
Initial Costs, Building and Building Improvements	[1]	2,991
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	20
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	34
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	371
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	3,025
Total	[1],[2]	3,396
Accumulated Depreciation	[1]	$ (518)
Date of construction	[1]	1997
Date Acquired	[1]	Aug. 30, 2013
Prestige Senior Living Beaverton Hills
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 8,747
Initial Costs, Land & Land Improvements	[1]	1,387
Initial Costs, Building and Building Improvements	[1]	10,324
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	6
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,393
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	10,324
Total	[1],[2]	11,717
Accumulated Depreciation	[1]	$ (1,413)
Date of construction	[1]	2000
Date Acquired	[1]	Dec. 2, 2013
Prestige Senior Living High Desert
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 7,659
Initial Costs, Land & Land Improvements	[1]	835
Initial Costs, Building and Building Improvements	[1]	11,252
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	13
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	37
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	848
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	11,289
Total	[1],[2]	12,137
Accumulated Depreciation	[1]	$ (1,602)
Date of construction	[1]	2003
Date Acquired	[1]	Dec. 2, 2013
MorningStar of Billings
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 19,167
Initial Costs, Land & Land Improvements	[1]	4,067
Initial Costs, Building and Building Improvements	[1]	41,373
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	51
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	109
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	4,118
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	41,482
Total	[1],[2]	45,600
Accumulated Depreciation	[1]	$ (5,972)
Date of construction	[1]	2009
Date Acquired	[1]	Dec. 2, 2013
MorningStar of Boise
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 20,539
Initial Costs, Land & Land Improvements	[1]	1,663
Initial Costs, Building and Building Improvements	[1]	35,752
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	14
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	229
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,677
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	35,981
Total	[1],[2]	37,658
Accumulated Depreciation	[1]	$ (4,869)
Date of construction	[1]	2007
Date Acquired	[1]	Dec. 2, 2013
Prestige Senior Living Huntington Terrace
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 9,815
Initial Costs, Land & Land Improvements	[1]	1,236
Initial Costs, Building and Building Improvements	[1]	12,083
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	2
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	64
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,238
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	12,147
Total	[1],[2]	13,385
Accumulated Depreciation	[1]	$ (1,684)
Date of construction	[1]	2000
Date Acquired	[1]	Dec. 2, 2013
MorningStar of Idaho Falls
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 17,104
Initial Costs, Land & Land Improvements	[1]	2,006
Initial Costs, Building and Building Improvements	[1]	40,397
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	5
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	193
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,011
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	40,590
Total	[1],[2]	42,601
Accumulated Depreciation	[1]	$ (5,620)
Date of construction	[1]	2009
Date Acquired	[1]	Dec. 2, 2013
Prestige Senior Living Arbor Place
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 8,069
Initial Costs, Land & Land Improvements	[1]	355
Initial Costs, Building and Building Improvements	[1]	14,083
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	6
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	29
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	361
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	14,112
Total	[1],[2]	14,473
Accumulated Depreciation	[1]	$ (1,908)
Date of construction	[1]	2003
Date Acquired	[1]	Dec. 2, 2013
Prestige Senior Living Orchard Heights
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 11,769
Initial Costs, Land & Land Improvements	[1]	545
Initial Costs, Building and Building Improvements	[1]	15,544
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	8
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	81
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	553
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	15,625
Total	[1],[2]	16,178
Accumulated Depreciation	[1]	$ (2,102)
Date of construction	[1]	2002
Date Acquired	[1]	Dec. 2, 2013
Prestige Senior Living Southern Hills
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 7,344
Initial Costs, Land & Land Improvements	[1]	653
Initial Costs, Building and Building Improvements	[1]	10,753
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	37
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	2
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	690
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	10,755
Total	[1],[2]	11,445
Accumulated Depreciation	[1]	$ (1,482)
Date of construction	[1]	2001
Date Acquired	[1]	Dec. 2, 2013
MorningStar of Sparks
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 22,755
Initial Costs, Land & Land Improvements	[1]	3,986
Initial Costs, Building and Building Improvements	[1]	47,968
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	3
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	36
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,989
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	48,004
Total	[1],[2]	51,993
Accumulated Depreciation	[1]	$ (6,714)
Date of construction	[1]	2009
Date Acquired	[1]	Dec. 2, 2013
Prestige Senior Living Five Rivers
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 7,530
Initial Costs, Land & Land Improvements	[1]	1,298
Initial Costs, Building and Building Improvements	[1]	14,064
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	18
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	62
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,316
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	14,126
Total	[1],[2]	15,442
Accumulated Depreciation	[1]	$ (2,048)
Date of construction	[1]	2002
Date Acquired	[1]	Dec. 2, 2013
Prestige Senior Living Riverwood
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 4,446
Initial Costs, Land & Land Improvements	[1]	1,028
Initial Costs, Building and Building Improvements	[1]	7,429
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	12
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	80
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,040
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	7,509
Total	[1],[2]	8,549
Accumulated Depreciation	[1]	$ (1,064)
Date of construction	[1]	1999
Date Acquired	[1]	Dec. 2, 2013
Chula Vista Medical Arts Center - Plaza II
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,462
Initial Costs, Building and Building Improvements	[1]	7,453
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	9
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	802
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,471
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	8,255
Total	[1],[2]	10,726
Accumulated Depreciation	[1]	$ (1,006)
Date of construction	[1]	1985
Date Acquired	[1]	Dec. 23, 2013
Coral Springs MOB I
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,614
Initial Costs, Building and Building Improvements	[1]	11,220
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	1
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,615
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	11,220
Total	[1],[2]	13,835
Accumulated Depreciation	[1]	$ (1,575)
Date of construction	[1]	2005
Date Acquired	[1]	Dec. 23, 2013
Coral Springs MOB II
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,614
Initial Costs, Building and Building Improvements	[1]	12,130
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	1
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	59
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,615
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	12,189
Total	[1],[2]	14,804
Accumulated Depreciation	[1]	$ (1,575)
Date of construction	[1]	2008
Date Acquired	[1]	Dec. 23, 2013
Chula Vista Medical Arts Center - Plaza I
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 6,130
Initial Costs, Building and Building Improvements	[1]	10,293
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	14
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	350
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	6,144
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	10,643
Total	[1],[2]	16,787
Accumulated Depreciation	[1]	$ (1,346)
Date of construction	[1]	1975
Date Acquired	[1]	Jan. 21, 2014
Prestige Senior Living Auburn Meadows
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 10,261
Initial Costs, Land & Land Improvements	[1]	2,537
Initial Costs, Building and Building Improvements	[1]	17,261
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	174
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,537
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	17,435
Total	[1],[2]	19,972
Accumulated Depreciation	[1]	$ (2,338)
Date Acquired	[1]	Feb. 3, 2014
Prestige Senior Living Auburn Meadows One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2003
Prestige Senior Living Auburn Meadows Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2010
Prestige Senior Living Bridgewood
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 12,918
Initial Costs, Land & Land Improvements	[1]	1,603
Initial Costs, Building and Building Improvements	[1]	18,172
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	10
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	9
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,613
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	18,181
Total	[1],[2]	19,794
Accumulated Depreciation	[1]	$ (2,424)
Date of construction	[1]	2001
Date Acquired	[1]	Feb. 3, 2014
Prestige Senior Living Monticello Park
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 17,234
Initial Costs, Land & Land Improvements	[1]	1,981
Initial Costs, Building and Building Improvements	[1]	23,056
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	1
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	20
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,982
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	23,076
Total	[1],[2]	25,058
Accumulated Depreciation	[1]	$ (3,036)
Date Acquired	[1]	Feb. 3, 2014
Prestige Senior Living Monticello Park One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2001
Prestige Senior Living Monticello Park Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2010
Prestige Senior Living Rosemont
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 9,062
Initial Costs, Land & Land Improvements	[1]	668
Initial Costs, Building and Building Improvements	[1]	14,564
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	26
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	668
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	14,590
Total	[1],[2]	15,258
Accumulated Depreciation	[1]	$ (1,898)
Date of construction	[1]	2004
Date Acquired	[1]	Feb. 3, 2014
Wellmore of Tega Cay
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 27,715
Initial Costs, Land & Land Improvements	[1]	2,445
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	2,743
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	23,447
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	5,188
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	23,447
Total	[1],[2]	28,635
Accumulated Depreciation	[1]	$ (2,743)
Date Acquired	[1]	Feb. 7, 2014
Isle at Cedar Ridge
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,525
Initial Costs, Building and Building Improvements	[1]	16,277
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	185
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,525
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	16,462
Total	[1],[2]	17,987
Accumulated Depreciation	[1]	$ (2,226)
Date of construction	[1]	2011
Date Acquired	[1]	Feb. 28, 2014
Prestige Senior Living West Hills
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 8,561
Initial Costs, Land & Land Improvements	[1]	842
Initial Costs, Building and Building Improvements	[1]	12,603
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	11
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	4
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	853
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	12,607
Total	[1],[2]	13,460
Accumulated Depreciation	[1]	$ (1,698)
Date of construction	[1]	2002
Date Acquired	[1]	Mar. 3, 2014
HarborChase of Plainfield
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,596
Initial Costs, Building and Building Improvements	[1]	21,832
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,596
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	21,832
Total	[1],[2]	23,428
Accumulated Depreciation	[1]	$ (2,811)
Date of construction	[1]	2010
Date Acquired	[1]	Mar. 28, 2014
Legacy Ranch Alzheimer's Special Care Center
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 917
Initial Costs, Building and Building Improvements	[1]	9,982
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	917
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	9,982
Total	[1],[2]	10,899
Accumulated Depreciation	[1]	$ (1,310)
Date of construction	[1]	2012
Date Acquired	[1]	Mar. 28, 2014
The Springs Alzheimer's Special Care Center
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 595
Initial Costs, Building and Building Improvements	[1]	9,658
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	595
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	9,658
Total	[1],[2]	10,253
Accumulated Depreciation	[1]	$ (1,267)
Date of construction	[1]	2012
Date Acquired	[1]	Mar. 28, 2014
Isle at Watercrest - Bryan
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 3,223
Initial Costs, Building and Building Improvements	[1]	40,581
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	36
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	972
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,259
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	41,553
Total	[1],[2]	44,812
Accumulated Depreciation	[1]	$ (5,399)
Date of construction	[1]	2011
Date Acquired	[1]	Apr. 21, 2014
Isle at Watercrest - Mansfield
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 997
Initial Costs, Building and Building Improvements	[1]	24,635
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	82
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	997
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	24,717
Total	[1],[2]	25,714
Accumulated Depreciation	[1]	$ (3,053)
Date of construction	[1]	2011
Date Acquired	[1]	May 5, 2014
Houston Orthopedic & Spine Hospital
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 32,273
Initial Costs, Land & Land Improvements	[1]	3,867
Initial Costs, Building and Building Improvements	[1]	32,761
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,867
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	32,761
Total	[1],[2]	36,628
Accumulated Depreciation	[1]	$ (3,702)
Date of construction	[1]	2007
Date Acquired	[1]	Jun. 2, 2014
Houston Orthopedic & Spine Hospital Medical Office Building
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 25,353
Initial Costs, Land & Land Improvements	[1]	3,738
Initial Costs, Building and Building Improvements	[1]	20,525
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	792
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	257
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	4,530
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	20,782
Total	[1],[2]	25,312
Accumulated Depreciation	[1]	$ (2,422)
Date of construction	[1]	2007
Date Acquired	[1]	Jun. 2, 2014
Watercrest at Katy (Katy, Texas)
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 21,551
Initial Costs, Land & Land Improvements	[1]	4,000
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	90
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	32,374
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	4,090
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	32,374
Total	[1],[2]	36,464
Accumulated Depreciation	[1]	$ (2,161)
Date Acquired	[1]	Jun. 27, 2014
Watercrest at Mansfield
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 25,163
Initial Costs, Land & Land Improvements	[1]	2,191
Initial Costs, Building and Building Improvements	[1]	42,740
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	921
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,191
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	43,661
Total	[1],[2]	45,852
Accumulated Depreciation	[1]	$ (5,169)
Date of construction	[1]	2010
Date Acquired	[1]	Jun. 30, 2014
HarborChase Of Shorewood (Shorewood, Wisconsin)
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,200
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	301
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	19,862
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,501
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	19,862
Total	[1],[2]	22,363
Accumulated Depreciation	[1]	$ (1,630)
Date Acquired	[1]	Jul. 8, 2014
Oklahoma City Inpatient Rehabilitation Hospital
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 14,994
Initial Costs, Land & Land Improvements	[1]	3,341
Initial Costs, Building and Building Improvements	[1]	19,249
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,341
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	19,249
Total	[1],[2]	22,590
Accumulated Depreciation	[1]	$ (2,305)
Date of construction	[1]	2012
Date Acquired	[1]	Jul. 15, 2014
Las Vegas Inpatient Rehabilitation Hospital
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 13,106
Initial Costs, Land & Land Improvements	[1]	2,650
Initial Costs, Building and Building Improvements	[1]	16,979
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,650
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	16,979
Total	[1],[2]	19,629
Accumulated Depreciation	[1]	$ (2,056)
Date of construction	[1]	2007
Date Acquired	[1]	Jul. 15, 2014
South Bend Inpatient Rehabilitation Hospital
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 11,899
Initial Costs, Land & Land Improvements	[1]	2,339
Initial Costs, Building and Building Improvements	[1]	16,239
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	4
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,343
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	16,239
Total	[1],[2]	18,582
Accumulated Depreciation	[1]	$ (1,992)
Date of construction	[1]	2009
Date Acquired	[1]	Jul. 15, 2014
Beaumont Specialty Hospital
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 19,753
Initial Costs, Land & Land Improvements	[1]	2,749
Initial Costs, Building and Building Improvements	[1]	28,863
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,749
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	28,863
Total	[1],[2]	31,612
Accumulated Depreciation	[1]	$ (3,241)
Date of construction	[1]	2013
Date Acquired	[1]	Aug. 15, 2014
Hurst Specialty Hospital
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 17,324
Initial Costs, Land & Land Improvements	[1]	2,082
Initial Costs, Building and Building Improvements	[1]	20,186
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	155
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,082
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	20,341
Total	[1],[2]	22,423
Accumulated Depreciation	[1]	$ (2,708)
Date Acquired	[1]	Aug. 15, 2014
Hurst Specialty Hospital One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2004
Hurst Specialty Hospital Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2012
Claremont Medical Office
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 14,173
Initial Costs, Land & Land Improvements	[1]	6,324
Initial Costs, Building and Building Improvements	[1]	13,533
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	3
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	46
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	6,327
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	13,579
Total	[1],[2]	19,906
Accumulated Depreciation	[1]	$ (1,630)
Date of construction	[1]	2008
Date Acquired	[1]	Aug. 29, 2014
Lee Hughes Medical Building
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 17,043
Initial Costs, Land & Land Improvements	[1]	69
Initial Costs, Building and Building Improvements	[1]	22,967
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	232
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	69
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	23,199
Total	[1],[2]	23,268
Accumulated Depreciation	[1]	$ (2,378)
Date of construction	[1]	2008
Date Acquired	[1]	Sep. 29, 2014
Newburyport Medical Center
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,614
Initial Costs, Building and Building Improvements	[1]	12,135
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	41
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,655
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	12,135
Total	[1],[2]	14,790
Accumulated Depreciation	[1]	$ (1,452)
Date of construction	[1]	2008
Date Acquired	[1]	Oct. 31, 2014
Northwest Medical Park
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 6,628
Initial Costs, Land & Land Improvements	[1]	610
Initial Costs, Building and Building Improvements	[1]	6,170
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	155
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	610
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	6,325
Total	[1],[2]	6,935
Accumulated Depreciation	[1]	$ (779)
Date of construction	[1]	2004
Date Acquired	[1]	Oct. 31, 2014
Fairfield Village of Layton
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 5,217
Initial Costs, Building and Building Improvements	[1]	54,167
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	66
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	5
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	5,283
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	54,172
Total	[1],[2]	59,455
Accumulated Depreciation	[1]	$ (6,289)
Date of construction	[1]	2010
Date Acquired	[1]	Nov. 20, 2014
ProMed Building I
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 6,473
Initial Costs, Land & Land Improvements	[1]	2,486
Initial Costs, Building and Building Improvements	[1]	6,728
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	49
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,486
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	6,777
Total	[1],[2]	9,263
Accumulated Depreciation	[1]	$ (756)
Date of construction	[1]	2006
Date Acquired	[1]	Dec. 19, 2014
Midtown Medical Plaza
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 37,121
Initial Costs, Land & Land Improvements	[1]	10
Initial Costs, Building and Building Improvements	[1]	51,237
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	436
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	10
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	51,673
Total	[1],[2]	51,683
Accumulated Depreciation	[1]	$ (4,949)
Date of construction	[1]	1994
Date Acquired	[1]	Dec. 22, 2014
Presbyterian Medical Tower
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 23,622
Initial Costs, Land & Land Improvements	[1]	40
Initial Costs, Building and Building Improvements	[1]	32,345
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	260
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	40
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	32,605
Total	[1],[2]	32,645
Accumulated Depreciation	[1]	$ (3,135)
Date of construction	[1]	1989
Date Acquired	[1]	Dec. 22, 2014
Metroview Professional Building
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 12,936
Initial Costs, Land & Land Improvements	[1]	11
Initial Costs, Building and Building Improvements	[1]	15,910
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	109
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	11
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	16,019
Total	[1],[2]	16,030
Accumulated Depreciation	[1]	$ (1,539)
Date of construction	[1]	1971
Date Acquired	[1]	Dec. 22, 2014
Physicians Plaza Huntersville
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 18,785
Initial Costs, Land & Land Improvements	[1]	520
Initial Costs, Building and Building Improvements	[1]	26,134
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	112
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	520
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	26,246
Total	[1],[2]	26,766
Accumulated Depreciation	[1]	$ (2,643)
Date of construction	[1]	2004
Date Acquired	[1]	Dec. 22, 2014
Matthews Medical Office Building
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 14,736
Initial Costs, Land & Land Improvements	[1]	350
Initial Costs, Building and Building Improvements	[1]	19,624
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	46
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	350
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	19,670
Total	[1],[2]	20,020
Accumulated Depreciation	[1]	$ (1,975)
Date of construction	[1]	1994
Date Acquired	[1]	Dec. 22, 2014
Outpatient Care Center
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 10,500
Initial Costs, Land & Land Improvements	[1]	1,169
Initial Costs, Building and Building Improvements	[1]	12,079
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	15
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,184
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	12,079
Total	[1],[2]	13,263
Accumulated Depreciation	[1]	$ (1,191)
Date of construction	[1]	2012
Date Acquired	[1]	Dec. 22, 2014
Clyde, NC ("Asheville") 330 Physicians Center
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 19,380
Initial Costs, Land & Land Improvements	[1]	12
Initial Costs, Building and Building Improvements	[1]	26,868
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	4
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	16
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	26,868
Total	[1],[2]	26,884
Accumulated Depreciation	[1]	$ (2,587)
Date Acquired	[1]	Dec. 22, 2014
Clyde, NC ("Asheville") 330 Physicians Center one
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	1987
Clyde, NC ("Asheville") 330 Physicians Center Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2005
Spivey Station Physicians Center
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 8,700
Initial Costs, Land & Land Improvements	[1]	1,026
Initial Costs, Building and Building Improvements	[1]	12,246
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	11
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,037
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	12,246
Total	[1],[2]	13,283
Accumulated Depreciation	[1]	$ (1,292)
Date of construction	[1]	2007
Date Acquired	[1]	Dec. 22, 2014
Spivey Station ASC Building
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 8,700
Initial Costs, Land & Land Improvements	[1]	929
Initial Costs, Building and Building Improvements	[1]	13,769
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	6
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	2
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	935
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	13,771
Total	[1],[2]	14,706
Accumulated Depreciation	[1]	$ (1,428)
Date of construction	[1]	2009
Date Acquired	[1]	Dec. 22, 2014
Novi Orthopaedic Center
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 19,581
Initial Costs, Land & Land Improvements	[1]	1,314
Initial Costs, Building and Building Improvements	[1]	26,239
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	61
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	27
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,375
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	26,266
Total	[1],[2]	27,641
Accumulated Depreciation	[1]	$ (2,794)
Date of construction	[1]	2008
Date Acquired	[1]	Feb. 13, 2015
UT Cancer Institute Building
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 20,520
Initial Costs, Land & Land Improvements	[1]	421
Initial Costs, Building and Building Improvements	[1]	27,621
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	130
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	421
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	27,751
Total	[1],[2]	28,172
Accumulated Depreciation	[1]	$ (2,642)
Date of construction	[1]	2012
Date Acquired	[1]	Feb. 20, 2015
Fieldstone Memory Care
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,297
Initial Costs, Building and Building Improvements	[1]	9,965
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,297
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	9,965
Total	[1],[2]	11,262
Accumulated Depreciation	[1]	$ (1,060)
Date of construction	[1]	2014
Date Acquired	[1]	Mar. 31, 2015
Bend Memorial Clinic MOB
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 9,069
Initial Costs, Building and Building Improvements	[1]	19,867
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	9,069
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	19,867
Total	[1],[2]	28,936
Accumulated Depreciation	[1]	$ (2,102)
Date of construction	[1]	1976
Date Acquired	[1]	May 11, 2015
Stoneterra Medical Plaza
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,864
Initial Costs, Building and Building Improvements	[1]	10,412
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	23
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,864
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	10,435
Total	[1],[2]	13,299
Accumulated Depreciation	[1]	$ (998)
Date of construction	[1]	2006
Date Acquired	[1]	May 29, 2015
Primrose Retirement Center of Anderson
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,342
Initial Costs, Building and Building Improvements	[1]	19,083
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	33
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,342
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	19,116
Total	[1],[2]	20,458
Accumulated Depreciation	[1]	$ (1,933)
Date of construction	[1]	2008
Date Acquired	[1]	May 29, 2015
Primrose Retirement Center of Lancaster
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,840
Initial Costs, Building and Building Improvements	[1]	21,884
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,840
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	21,884
Total	[1],[2]	24,724
Accumulated Depreciation	[1]	$ (2,437)
Date of construction	[1]	2007
Date Acquired	[1]	May 29, 2015
Primrose Retirement Center of Wausau
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,089
Initial Costs, Building and Building Improvements	[1]	18,653
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,089
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	18,653
Total	[1],[2]	19,742
Accumulated Depreciation	[1]	$ (1,813)
Date of construction	[1]	2008
Date Acquired	[1]	May 29, 2015
Triangle Orthopaedic Durham
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 12,516
Initial Costs, Land & Land Improvements	[1]	3,191
Initial Costs, Building and Building Improvements	[1]	14,523
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	134
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,325
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	14,523
Total	[1],[2]	17,848
Accumulated Depreciation	[1]	$ (1,393)
Date of construction	[1]	2000
Date Acquired	[1]	Jun. 29, 2015
Triangle Orthopaedic Roxboro
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 1,271
Initial Costs, Land & Land Improvements	[1]	287
Initial Costs, Building and Building Improvements	[1]	1,406
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	287
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	1,406
Total	[1],[2]	1,693
Accumulated Depreciation	[1]	$ (144)
Date of construction	[1]	2000
Date Acquired	[1]	Jun. 29, 2015
Triangle Orthopaedic Chapel Hill
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 1,858
Initial Costs, Land & Land Improvements	[1]	360
Initial Costs, Building and Building Improvements	[1]	2,306
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	360
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	2,306
Total	[1],[2]	2,666
Accumulated Depreciation	[1]	$ (214)
Date of construction	[1]	2011
Date Acquired	[1]	Jun. 29, 2015
Triangle Orthopaedic Oxford
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 2,738
Initial Costs, Land & Land Improvements	[1]	658
Initial Costs, Building and Building Improvements	[1]	3,074
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	658
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	3,074
Total	[1],[2]	3,732
Accumulated Depreciation	[1]	$ (313)
Date of construction	[1]	2011
Date Acquired	[1]	Jun. 29, 2015
North Carolina Specialty Hospital
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 18,579
Initial Costs, Land & Land Improvements	[1]	3,173
Initial Costs, Building and Building Improvements	[1]	22,762
Costs Capitalized Subsequent to Acquisition, Construction in Process	[1]	3,490
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,173
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	22,762
Gross Amounts at which Carried at Close of period, Construction in Process	[1],[2]	3,490
Total	[1],[2]	29,425
Accumulated Depreciation	[1]	$ (2,048)
Date of construction	[1]	2004
Date Acquired	[1]	Jun. 29, 2015
Doctor's Park Building B
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,161
Initial Costs, Building and Building Improvements	[1]	2,919
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,161
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	2,919
Total	[1],[2]	4,080
Accumulated Depreciation	[1]	$ (278)
Date of construction	[1]	2008
Date Acquired	[1]	Jun. 30, 2015
Doctor's Park Building C
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,323
Initial Costs, Building and Building Improvements	[1]	6,351
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,323
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	6,351
Total	[1],[2]	8,674
Accumulated Depreciation	[1]	$ (597)
Date of construction	[1]	2006
Date Acquired	[1]	Jun. 30, 2015
Superior Residences of Panama City
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,099
Initial Costs, Building and Building Improvements	[1]	19,367
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,099
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	19,367
Total	[1],[2]	21,466
Accumulated Depreciation	[1]	$ (1,909)
Date of construction	[1]	2015
Date Acquired	[1]	Jul. 15, 2015
540 New Waverly Place
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 6,452
Initial Costs, Land & Land Improvements	[1]	2,476
Initial Costs, Building and Building Improvements	[1]	11,009
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	23
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,476
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	11,032
Total	[1],[2]	13,508
Accumulated Depreciation	[1]	$ (1,034)
Date of construction	[1]	2007
Date Acquired	[1]	Jul. 20, 2015
MedHelp
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,270
Initial Costs, Building and Building Improvements	[1]	10,359
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	11
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,281
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	10,359
Total	[1],[2]	12,640
Accumulated Depreciation	[1]	$ (902)
Date of construction	[1]	2015
Date Acquired	[1]	Jul. 31, 2015
Patriot Professional Center
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 3,912
Initial Costs, Building and Building Improvements	[1]	11,781
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	18
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	50
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,930
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	11,831
Total	[1],[2]	15,761
Accumulated Depreciation	[1]	$ (1,115)
Date Acquired	[1]	Jul. 31, 2015
Patriot Professional Center One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2006
Patriot Professional Center Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2014
Liberty Professional Center
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,977
Initial Costs, Building and Building Improvements	[1]	4,462
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	10
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,987
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	4,462
Total	[1],[2]	6,449
Accumulated Depreciation	[1]	$ (414)
Date Acquired	[1]	Jul. 31, 2015
Liberty Professional Center One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	1979
Liberty Professional Center Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2013
The Hampton at Meadows Place
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 715
Initial Costs, Building and Building Improvements	[1]	24,281
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	34
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	715
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	24,315
Total	[1],[2]	25,030
Accumulated Depreciation	[1]	$ (2,169)
Date Acquired	[1]	Jul. 31, 2015
The Hampton at Meadows Place One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2007
The Hampton at Meadows Place Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2013
The Hampton at Meadows Place Three
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2014
The Pavilion at Great Hills
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,783
Initial Costs, Building and Building Improvements	[1]	29,318
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	30
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	97
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,813
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	29,415
Total	[1],[2]	31,228
Accumulated Depreciation	[1]	$ (2,646)
Date of construction	[1]	2010
Date Acquired	[1]	Jul. 31, 2015
The Beacon at Gulf Breeze
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 824
Initial Costs, Building and Building Improvements	[1]	24,106
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	72
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	55
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	896
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	24,161
Total	[1],[2]	25,057
Accumulated Depreciation	[1]	$ (2,240)
Date of construction	[1]	2008
Date Acquired	[1]	Jul. 31, 2015
Parc at Piedmont
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 3,529
Initial Costs, Building and Building Improvements	[1]	43,080
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	18
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	78
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,547
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	43,158
Total	[1],[2]	46,705
Accumulated Depreciation	[1]	$ (4,015)
Date Acquired	[1]	Jul. 31, 2015
Parc at Piedmont One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2001
Parc at Piedmont Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2011
Parc at Duluth
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 5,951
Initial Costs, Building and Building Improvements	[1]	42,458
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	13
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	58
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	5,964
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	42,516
Total	[1],[2]	48,480
Accumulated Depreciation	[1]	$ (3,950)
Date Acquired	[1]	Jul. 31, 2015
Parc at Duluth One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2003
Parc at Duluth Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2012
Broadway Medical Plaza 1
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 437
Initial Costs, Building and Building Improvements	[1]	9,281
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	135
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	437
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	9,416
Total	[1],[2]	9,853
Accumulated Depreciation	[1]	$ (831)
Date of construction	[1]	1994
Date Acquired	[1]	Aug. 21, 2015
Broadway Medical Plaza 2
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 386
Initial Costs, Building and Building Improvements	[1]	12,460
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	386
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	12,460
Total	[1],[2]	12,846
Accumulated Depreciation	[1]	$ (1,064)
Date of construction	[1]	1999
Date Acquired	[1]	Aug. 21, 2015
Broadway Medical Plaza 4
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 170
Initial Costs, Building and Building Improvements	[1]	12,118
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	86
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	170
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	12,204
Total	[1],[2]	12,374
Accumulated Depreciation	[1]	$ (993)
Date of construction	[1]	2007
Date Acquired	[1]	Aug. 21, 2015
Waterstone on Augusta (Greenville, SC)
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 18,830
Initial Costs, Land & Land Improvements	[1]	2,253
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	2,116
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	20,770
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	4,369
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	20,770
Total	[1],[2]	25,139
Accumulated Depreciation	[1]	$ (1,172)
Date of construction	[1]	2017
Date Acquired	[1]	Aug. 31, 2015
Welbrook Senior Living Grand Junction (Grand Junction, CO)
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 8,141
Initial Costs, Land & Land Improvements	[1]	966
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	3,847
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	966
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	3,847
Total	[1],[2]	4,813
Accumulated Depreciation	[1]	$ (630)
Date of construction	[1]	2017
Date Acquired	[1]	Sep. 4, 2015
Wellmore of Lexington (Lexington, SC)
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 35,421
Initial Costs, Land & Land Improvements	[1]	2,300
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	3,150
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	43,081
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	5,450
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	43,081
Total	[1],[2]	48,531
Accumulated Depreciation	[1]	$ (1,972)
Date of construction	[1]	2017
Date Acquired	[1]	Sep. 14, 2015
Palmilla Senior Living
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 26,478
Initial Costs, Land & Land Improvements	[1]	4,701
Initial Costs, Building and Building Improvements	[1]	38,321
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	4,701
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	38,321
Total	[1],[2]	43,022
Accumulated Depreciation	[1]	$ (3,412)
Date of construction	[1]	2013
Date Acquired	[1]	Sep. 30, 2015
Cedar Lake Assisted Living and Memory Care
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,412
Initial Costs, Building and Building Improvements	[1]	25,126
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	6
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,412
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	25,132
Total	[1],[2]	27,544
Accumulated Depreciation	[1]	$ (2,233)
Date of construction	[1]	2014
Date Acquired	[1]	Sep. 30, 2015
Fieldstone at Pear Orchard (Yakima, Washington)
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances		$ 10,791
Initial Costs, Land & Land Improvements		1,035
Costs Capitalized Subsequent to Acquisition, Land & Improvements		102
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements		13,498
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[2]	1,137
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[2]	13,498
Total	[2]	14,635
Accumulated Depreciation		$ (733)
Date of construction		2016
Date Acquired		Oct. 12, 2015
The Shores of Lake Phalen
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances		$ 16,859
Initial Costs, Land & Land Improvements		2,724
Initial Costs, Building and Building Improvements		25,093
Costs Capitalized Subsequent to Acquisition, Land & Improvements		10
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements		55
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[2]	2,734
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[2]	25,148
Total	[2]	27,882
Accumulated Depreciation		$ (2,158)
Date of construction		2012
Date Acquired		Nov. 10, 2015
Dogwood Forest of Grayson (Grayson, GA)
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances		$ 16,400
Initial Costs, Land & Land Improvements		1,788
Costs Capitalized Subsequent to Acquisition, Land & Improvements		109
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements		22,257
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[2]	1,897
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[2]	22,257
Total	[2]	24,154
Accumulated Depreciation		$ (910)
Date of construction		2017
Date Acquired		Nov. 24, 2015
Center One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements		$ 8,294
Initial Costs, Building and Building Improvements		21,756
Costs Capitalized Subsequent to Acquisition, Land & Improvements		34
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements		173
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[2]	8,328
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[2]	21,929
Total	[2]	30,257
Accumulated Depreciation		$ (1,789)
Date of construction		2006
Date Acquired		Nov. 30, 2015
Red Bank Professional Office Building
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements		$ 1,721
Initial Costs, Building and Building Improvements		7,721
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements		11
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[2]	1,721
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[2]	7,732
Total	[2]	9,453
Accumulated Depreciation		$ (618)
Date of construction		2001
Date Acquired		Dec. 14, 2015
Park Place Senior Living at WingHaven
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,283
Initial Costs, Building and Building Improvements	[1]	48,221
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	40
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	398
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,323
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	48,619
Total	[1],[2]	49,942
Accumulated Depreciation	[1]	$ (3,839)
Date Acquired	[1]	Dec. 17, 2015
Park Place Senior Living at WingHaven One
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2006
Park Place Senior Living at WingHaven Two
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Date of construction	[1]	2014
Siena Pavilion IV
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,454
Initial Costs, Building and Building Improvements	[1]	4,786
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	12
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,454
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	4,798
Total	[1],[2]	6,252
Accumulated Depreciation	[1]	$ (385)
Date of construction	[1]	2002
Date Acquired	[1]	Dec. 18, 2015
Siena Pavilion V
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 3,944
Initial Costs, Building and Building Improvements	[1]	20,355
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	34
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,944
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	20,389
Total	[1],[2]	24,333
Accumulated Depreciation	[1]	$ (1,607)
Date of construction	[1]	2003
Date Acquired	[1]	Dec. 18, 2015
Siena Pavilion VI
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 2,599
Initial Costs, Building and Building Improvements	[1]	18,725
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	76
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,599
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	18,801
Total	[1],[2]	21,400
Accumulated Depreciation	[1]	$ (1,390)
Date of construction	[1]	2005
Date Acquired	[1]	Dec. 18, 2015
Hearthside Senior Living of Collierville
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,756
Initial Costs, Building and Building Improvements	[1]	13,379
Costs Capitalized Subsequent to Acquisition, Land & Improvements	[1]	7
Costs Capitalized Subsequent to Acquisition, Buildings and Building Improvements	[1]	18
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,763
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	13,397
Total	[1],[2]	15,159
Accumulated Depreciation	[1]	$ (1,122)
Date of construction	[1]	2014
Date Acquired	[1]	Dec. 29, 2015
Cobalt Rehabilitation Hospital Surprise
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 14,829
Initial Costs, Land & Land Improvements	[1]	2,464
Initial Costs, Building and Building Improvements	[1]	17,983
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	2,464
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	17,983
Total	[1],[2]	20,447
Accumulated Depreciation	[1]	$ (1,404)
Date of construction	[1]	2015
Date Acquired	[1]	Dec. 30, 2015
Cobalt Rehabilitation Hospital New Orleans
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	[1]	$ 19,055
Initial Costs, Land & Land Improvements	[1]	3,283
Initial Costs, Building and Building Improvements	[1]	20,142
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	3,283
Gross Amounts at which Carried at Close of period, Building & Building Improvements	[1],[2]	20,142
Total	[1],[2]	23,425
Accumulated Depreciation	[1]	$ (1,050)
Date of construction	[1]	2016
Date Acquired	[1]	Oct. 19, 2016
Albuquerque, New Mexico - Unimproved Land
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Initial Costs, Land & Land Improvements	[1]	$ 1,056
Gross Amounts at which Carried at Close of period, Land & Land Improvements	[1],[2]	1,056
Total	[1],[2]	$ 1,056
Date Acquired	[1]	Sep. 7, 2017
[1]	Buildings and building improvements are depreciated over 39 and 15 years, respectively. Tenant improvements are depreciated over the terms of their respective leases.
[2]	The aggregate cost for federal income tax purposes is approximately $3.0 billion.

Schedule III-Real Estate And _3

Schedule III-Real Estate And Accumulated Depreciation Transactions in Real Estate and Accumulated Depreciation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018		Dec. 31, 2017	Dec. 31, 2016
Real Estate And Accumulated Depreciation Disclosure [Abstract]
Real Estate gross carrying value, Beginning Balance	$ 2,721,805		$ 2,692,074	$ 2,588,903
Acquisitions			1,056	23,425
Improvements	9,052		28,675	97,767
Dispositions	(5,359)			(18,021)
Impairments	(11,818)
Real Estate gross carrying value, Ending Balance	2,713,680	[1],[2]	2,721,805	2,692,074
Real Estate accumulated depreciation, Beginning Balance	(219,457)		(153,124)	(90,201)
Depreciation	(60,821)		(66,333)	(63,745)
Accumulated depreciation on dispositions	633			822
Real Estate accumulated depreciation, Ending Balance	$ (279,645)	[1]	$ (219,457)	$ (153,124)
[1]	Buildings and building improvements are depreciated over 39 and 15 years, respectively. Tenant improvements are depreciated over the terms of their respective leases.
[2]	The aggregate cost for federal income tax purposes is approximately $3.0 billion.

Schedule III-Real Estate And _4

Schedule III-Real Estate And Accumulated Depreciation (Parenthetical) (Detail) $ in Billions	12 Months Ended
	Dec. 31, 2018USD ($)
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Aggregate cost for federal income tax purpose	$ 3
Building
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Buildings and improvements useful life	39 years
Building Improvements
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]
Buildings and improvements useful life	15 years

Schedule IV-Mortgage Loans On_2

Schedule IV-Mortgage Loans On Real Estate (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance at beginning of year	$ 1,179	$ 0	$ 0
New mortgage loans and additional advances	432	1,168	0
Accrued and deferred interest	77	11	0
Collection of principal	0	0	0
Balance at end of year	$ 1,688	$ 1,179	$ 0